Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011985	p-reninm	mu/l (mu/l)	3854	5835	0.46%
3011985	fp-reninm	mu/l (mu/l)	1032	1544	0.00%
3011985	p-reninm	— (—)	593	701	100.00%	Distribution not available
3011985	fp-renin	— (—)	152	183	100.00%	Distribution not available
3011985	fp-renin	mu/l (mu/l)	149	175	0.00%
3011985	fp-reninm	— (—)	115	136	100.00%	Distribution not available
3011985	fp-reniini,konsentraatio	mu/l (mu/l)	31	37	0.00%
3011985	p-reniinm	mu/l (mu/l)	24	27	0.00%
3011985	p-areninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-oreninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-vreninm	— (—)	19	19	100.00%	Distribution not available
3011985	p-reniini,konsentraatio	mu/l (mu/l)	11	11	0.00%
3011985	p-vreninm	mu/l (mu/l)	7	7	0.00%	Distribution not available
3011985	p-areninm	mu/l (mu/l)	6	6	0.00%	Distribution not available
3011985	p-oreninm	mu/l (mu/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of other endocrine glands

1255

2032

6.36

307.65

2.7

1.2

73.85

57.58

mu/l

1.02

1146

1811

Other disorders of fluid, electrolyte and acid-base balance

1078

1097

9.98

307.65

1.9

1.3

73.05

53.69

mu/l

0.96

936

968

Benign neoplasm of other and unspecified endocrine glands

1151

517

27.76

307.65

1.5

1.4

59.35

53.25

mu/l

0.29

1087

453

Hyperaldosteronism

356

57.65

307.65

2.6

1.2

64.54

54.32

mu/l

0.13

318

Cardiovascular diseases

938

862

5.96

307.65

1.7

2.1

59.11

63.81

mu/l

0.14

862

793

Metabolic disorders

1722

2738

3.92

307.65

1.8

1.4

79.70

58.52

mu/l

1.87

1543

2459

Benign neoplasm: Adrenal gland

1039

284

55.42

307.65

1.4

1.5

60.31

52.93

mu/l

0.26

985

249

Antihypertensive medication - note that there are other indications

918

742

6.68

307.65

1.7

2.1

64.61

52.64

mu/l

0.42

836

690

Hypertension, essential

1715

1335

7.50

307.65

1.5

1.7

75.16

45.95

mu/l

4.36

1555

1216

Adrenocortical insufficiency

384

125

41.93

307.65

4.5

1.3

92.70

43.36

mu/l

2.71

362

113

Hypertension

1717

1364

7.32

307.65

1.6

1.7

72.42

52.82

mu/l

1.40

1556

1243

Exclusions for E4_PCOS_BROAD

671

758

9.57

307.65

3.3

1.3

84.11

56.96

mu/l

1.89

628

669

Hypokalaemia

703

410

19.57

307.65

1.8

1.4

63.17

47.64

mu/l

0.78

605

365

Cardiovascular diseases (excluding rheumatic etc)

1129

1002

6.63

307.65

1.6

2.0

63.85

61.17

mu/l

0.09

1039

922

Other disorders of adrenal gland

433

150

37.65

307.65

4.2

1.2

95.03

42.53

mu/l

3.43

407

135

Endocrine, nutritional and metabolic diseases

1088

1291

4.33

307.65

1.9

1.3

70.95

53.60

mu/l

0.95

991

1166

Secondary hypertension

449

133

37.84

307.65

2.2

1.4

85.37

35.33

mu/l

3.55

397

117

Hypertensive diseases

1716

1366

7.31

307.65

1.6

1.7

72.47

52.77

mu/l

1.41

1555

1245

Hypertensive diseases (excluding secondary)

1334

787

10.23

307.65

1.6

1.8

70.53

62.55

mu/l

0.25

1217

722

Anaemias

341

192

11.85

260.16

1.8

1.5

83.72

90.91

mu/l

0.05

303

182

Other heart diseases

620

786

5.24

254.28

1.4

1.8

70.93

62.88

mu/l

0.22

567

720

Diseases of arteries, arterioles and capillaries (FINNGEN)

376

363

7.35

215.21

1.4

1.6

86.49

50.88

mu/l

2.12

320

330

Hypertensive heart and/or renal disease

384

435

6.75

212.27

1.4

1.6

70.58

41.28

mu/l

2.28

337

390

Hypothyroidism (congenital or acquired)

337

198

9.78

210.71

2.4

1.6

80.31

45.67

mu/l

1.42

311

188

Hypothyroidism, levothyroxine purchases

327

197

9.54

201.62

2.4

1.6

83.23

37.13

mu/l

2.73

301

187

Hypothyroidism and >3 levothyroxin purchases

327

197

9.54

201.62

2.4

1.6

83.23

37.13

mu/l

2.73

301

187

Cerebrovascular diseases (FINNGEN)

416

511

5.87

197.99

1.4

1.6

68.71

49.52

mu/l

1.15

375

466

Disorders of lipoprotein metabolism and other lipidaemias

1058

2353

2.82

184.15

1.5

1.4

79.65

59.15

mu/l

2.02

956

2103

Heart failure and antihypertensive medication

320

290

7.37

178.78

1.5

1.7

94.01

60.25

mu/l

0.49

281

266

Hypo-osmolality and hyponatraemia

331

599

5.69

172.85

2.1

1.3

98.02

46.57

mu/l

0.97

289

531

Benign neoplasms

1234

2734

2.52

166.98

1.6

62.21

74.12

mu/l

0.87

1132

2420

Type 2 diabetes, wide definition

1095

2717

2.62

166.90

1.5

82.97

53.64

mu/l

3.59

980

2420

Hypothyroidism, drug reimbursement

201

119

12.19

163.68

2.7

1.4

51.00

31.97

mu/l

1.73

184

111

Hypertensive Heart Disease

316

413

6.13

163.62

1.4

1.6

57.04

39.85

mu/l

1.14

280

370

All chronic kidney diseases

784

2203

2.96

160.22

1.6

1.5

100.68

58.26

mu/l

3.82

689

1966

Diabetes mellitus

1336

3394

2.33

155.91

1.6

75.61

55.28

mu/l

2.34

1196

3049

Diabetes, varying definitions

1324

3399

2.31

152.07

1.6

75.83

55.23

mu/l

2.36

1185

3055

Type 2 diabetes

1270

3243

2.31

146.37

1.5

1.6

79.88

54.50

mu/l

2.91

1136

2904

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1226

3214

2.32

144.00

1.6

76.46

55.44

mu/l

2.63

1098

2879

Drug-induced adrenocortical insufficiency

113

19.54

137.82

2.7

1.2

84.39

44.14

mu/l

0.58

100

Diabetes medication

1321

3585

2.21

137.32

1.6

74.90

57.92

mu/l

1.73

1180

3224

Sleep apnoea

1229

3571

2.25

137.09

1.5

70.00

63.89

mu/l

0.42

1087

3200

Pure hypercholesterolaemia

868

2178

2.63

135.21

1.5

1.4

78.07

58.62

mu/l

1.62

780

1943

All kidney diseases

1255

3971

2.18

131.52

1.5

1.6

80.03

61.77

mu/l

1.97

1109

3578

Malaise and fatigue

694

2017

2.81

129.10

1.8

1.5

61.16

65.96

mu/l

0.24

603

1814

Atrial fibrillation and flutter

347

479

4.77

128.88

1.4

1.6

69.04

48.98

mu/l

0.84

309

437

Sleep apnoea, including avohilmo

1265

3634

2.18

128.86

1.5

67.32

62.64

mu/l

0.32

1121

3261

Diabetes, insulin treatment (Kela reimbursement)

1266

3587

2.15

124.63

1.6

1.5

77.13

58.21

mu/l

2.21

1136

3208

Other CVD (FINNGEN)

175

155

9.00

123.94

1.5

1.6

66.54

38.70

mu/l

0.76

153

141

Other nutritional deficiencies

898

3601

2.38

123.31

1.5

1.6

80.24

64.96

mu/l

1.10

797

3223

Atrial fibrillation and flutter with reimbursement

296

358

5.35

123.00

1.4

1.5

76.03

46.14

mu/l

1.17

260

327

General symptoms and signs

1298

3034

2.16

122.79

1.6

65.90

67.65

mu/l

0.08

1143

2754

Pain in throat and chest

1027

2667

2.34

122.24

1.5

1.6

73.21

65.34

mu/l

0.40

918

2392

Type 2 diabetes, definitions combined

1159

3112

2.21

120.47

1.4

1.5

79.53

54.70

mu/l

2.51

1042

2778

Abnormalities of breathing

1068

2740

2.29

120.07

1.5

1.6

60.13

68.43

mu/l

0.59

966

2459

Type 2 diabetes, strict (exclude DM1)

1163

3133

2.20

119.96

1.4

1.5

79.33

54.85

mu/l

2.47

1045

2796

Hypopituitarism

173

238

7.65

119.63

2.2

1.3

78.03

62.39

mu/l

0.36

159

210

Depression medications

265

210

6.41

115.79

1.8

1.6

63.17

36.93

mu/l

1.96

239

200

Headache

833

2790

2.41

114.20

1.5

60.34

66.72

mu/l

0.29

735

2527

Episodal and paroxysmal disorders

1273

3098

2.11

113.81

1.5

1.6

61.30

62.95

mu/l

0.10

1154

2782

Heart failure, not strict

958

2861

2.30

113.69

1.4

1.5

92.59

59.75

mu/l

3.01

843

2549

Other (not insulin) diabetes medications

1185

3332

2.13

113.18

1.4

1.5

76.79

58.07

mu/l

1.74

1059

2979

First line medication for Crohn's disease

1318

3497

2.06

112.00

2.1

1.3

64.72

65.48

mu/l

0.04

1186

3140

Cardiac arrhythmias

710

1762

2.65

111.99

1.5

1.7

66.32

56.24

mu/l

0.59

641

1592

Type 2 diabetes, definitions combined, including avohilmo

1135

3125

2.14

108.54

1.4

1.5

79.64

54.41

mu/l

2.53

1022

2793

Obesity

833

3515

2.32

108.21

1.5

1.6

78.33

63.50

mu/l

1.18

740

3151

Obesity and other hyperalimentation

835

3523

2.31

108.10

1.5

1.6

78.44

63.51

mu/l

1.20

742

3159

Abnormal blood-pressure reading, without diagnosis

131

147

9.48

107.47

1.6

1.3

39.52

39.39

mu/l

0.01

117

127

Obesity due to excess calories

644

2601

2.51

100.94

1.5

1.6

78.94

59.89

mu/l

1.53

561

2337

Symptoms and signs involving the circulatory and respiratory systems

1138

2749

2.09

99.28

1.6

56.28

68.27

mu/l

1.07

1030

2468

Renal tubulo-interstitial diseases

1044

3793

2.07

97.73

1.5

75.05

58.68

mu/l

1.68

916

3408

Other heart diseases, wide

1100

3296

2.06

97.21

1.4

1.7

65.16

66.08

mu/l

0.05

980

2979

Renal failure

577

1967

2.63

96.96

1.5

1.4

88.76

58.57

mu/l

2.46

501

1738

Nausea and vomiting

395

1234

3.19

96.51

2.0

1.5

59.93

65.13

mu/l

0.18

340

1102

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1158

4071

1.98

94.45

1.6

76.02

62.54

mu/l

1.02

1015

3666

Tramadol

965

2797

2.14

94.25

1.5

1.6

73.79

61.37

mu/l

0.72

859

2520

Chronic kidney disease

401

1284

3.12

94.16

1.4

79.69

54.26

mu/l

1.88

342

1133

Used for control exclusion in common control thyroid runs

1179

2975

2.02

94.03

1.9

1.4

67.49

62.26

mu/l

0.35

1062

2659

Neoplasms

824

1925

2.29

90.72

1.7

59.28

72.12

mu/l

0.64

760

1702

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

482

1798

2.73

89.15

2.0

1.4

63.57

57.41

mu/l

0.32

433

1605

Any reimbursement code in KELA

598

1131

2.67

88.96

1.8

1.4

60.73

56.31

mu/l

0.16

543

1035

Biguanides

1102

3415

1.98

88.05

1.4

1.5

78.98

58.22

mu/l

1.88

994

3050

Paroxysmal tachycardia

221

405

4.63

87.77

1.4

1.7

56.96

50.79

mu/l

0.20

199

367

Postprocedural endocrine and metabolic disorders, not elsewhere classified

201

430

4.81

87.58

2.8

1.3

57.71

44.09

mu/l

0.78

182

382

Sleep disorders (combined)

1259

3494

1.91

86.42

1.4

1.6

64.68

60.92

mu/l

0.25

1121

3141

Hyperkalaemia

119

155

8.03

86.28

2.3

1.3

91.33

54.67

mu/l

0.90

105

138

Other metabolic disorders

208

467

4.57

85.35

2.7

1.4

57.07

51.73

mu/l

0.22

188

415

STROKE

663

1915

2.38

85.22

1.4

1.5

70.92

48.64

mu/l

2.05

606

1713

Dyspnoea

1040

3948

1.96

84.28

1.5

66.27

62.22

mu/l

0.25

935

3517

Implicit Sepsis

958

3496

2.02

84.01

1.5

74.80

61.90

mu/l

0.91

862

3106

Glucagon-like peptide-1 (GLP-1) analogues

411

1461

2.87

83.47

1.4

1.5

105.92

58.82

mu/l

3.03

364

1296

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

411

1461

2.87

83.47

1.4

1.5

105.92

58.82

mu/l

3.03

364

1296

Hyperlipidaemia, other/unspecified

434

1447

2.80

83.22

1.4

1.3

97.70

55.88

mu/l

2.31

377

1280

Abnormalities of heart beat

436

1581

2.74

81.45

1.4

1.5

54.97

61.16

mu/l

0.34

372

1400

Insulin medication

686

2592

2.25

81.44

1.7

1.5

92.54

59.82

mu/l

2.57

610

2315

Implicit Sepsis

880

3264

2.05

81.03

1.5

73.97

63.98

mu/l

0.61

793

2887

Condition for Implicit Sepsis (Organ dysfunction codes)

1035

3707

1.94

80.03

1.5

73.72

64.35

mu/l

0.62

926

3312

Statin medication

765

1969

2.20

78.67

1.6

1.7

74.79

51.15

mu/l

2.21

693

1794

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

361

726

3.17

77.73

1.5

1.8

76.47

51.72

mu/l

0.94

324

664

Disorders of mineral metabolism

150

282

5.51

76.09

2.2

1.4

68.49

44.31

mu/l

0.46

133

248

Any gastric operation

842

2011

2.12

75.99

1.6

65.06

65.31

mu/l

0.01

764

1809

GASTRO-related operations

842

2011

2.12

75.99

1.6

65.06

65.31

mu/l

0.01

764

1809

Condition for Implicit Sepsis (Organ dysfunction codes)

978

3588

1.94

75.94

1.5

76.63

64.14

mu/l

0.87

876

3197

Autoimmune diseases excluding thyroid diseases

1132

3322

1.87

74.69

1.8

1.4

64.95

61.56

mu/l

0.24

1020

2974

Autoimmune diseases

1201

3333

1.85

74.39

1.9

1.4

68.81

61.51

mu/l

0.57

1084

2984

Hypertensive Renal Disease

13.24

73.81

1.3

1.5

132.66

26.09

mu/l

2.29

Hard cardiovascular diseases

956

2948

1.95

72.61

1.4

1.5

75.07

63.81

mu/l

0.60

856

2631

Insulin, intermediate and long-acting

645

2914

2.18

72.49

1.7

1.5

91.13

61.35

mu/l

2.29

576

2593

Neurological diseases

905

2298

1.99

69.98

1.5

1.7

66.92

66.58

mu/l

0.01

821

2076

Exclusions for E4_PCOS_CONSORTIUM

841

2656

2.00

69.47

2.0

1.5

62.45

58.93

mu/l

0.18

769

2374

Asthma, unspecified (mode), excluding more controls

610

2068

2.23

69.26

1.5

54.82

64.24

mu/l

0.76

543

1866

Medical observation and evaluation for suspected diseases and conditions

734

1764

2.15

69.01

1.6

1.5

69.80

67.88

mu/l

0.05

644

1576

Other soft tissue disorders, not elsewhere classified

1024

3233

1.87

68.53

1.5

1.6

68.64

64.26

mu/l

0.26

921

2909

Disorders of the thyroid gland

1030

3649

1.85

68.46

1.9

1.4

70.01

57.87

mu/l

1.04

922

3264

Disorders of parathyroid gland

277

877

3.18

67.52

1.9

1.2

55.29

50.62

mu/l

0.18

245

769

Non-invasive ventilation

263

724

3.29

66.42

1.4

1.6

47.72

63.37

mu/l

0.54

238

656

Other bacterial diseases

1113

3976

1.79

65.84

1.6

1.5

75.43

63.59

mu/l

0.77

981

3576

Hypothyroidism, other/unspecified

964

3444

1.86

64.58

2.0

1.4

69.53

58.44

mu/l

0.85

859

3083

Oedema, not elsewhere classified

384

1481

2.59

64.48

1.6

1.4

79.29

58.09

mu/l

1.09

326

1324

Insulin, combination of fast acting with intermediate-acting or long-acting

687

3117

2.03

64.17

1.7

1.5

92.54

61.34

mu/l

2.40

610

2774

Autoimmune diseases excluding thyroid diseases, strict definition

1047

3163

1.82

63.96

1.8

1.4

67.37

61.97

mu/l

0.37

944

2837

Asthma, unspecified (mode)

619

2199

2.14

63.74

1.5

54.34

63.96

mu/l

0.80

551

1983

Hypothyreosis and Thyroxine purchase for inclusion criteria

997

3624

1.82

62.68

2.0

1.4

68.82

57.64

mu/l

0.90

889

3245

Pain in limb

882

3152

1.89

62.50

1.5

1.6

68.52

64.48

mu/l

0.21

781

2836

Dipeptidyl peptidase 4 (DPP-4) inhibitors

599

2283

2.12

61.17

1.3

1.4

77.29

56.34

mu/l

1.77

519

2010

Ischemic heart diseases

916

2979

1.86

60.84

1.4

1.5

73.67

63.85

mu/l

0.50

816

2660

Other diseases of intestines

1119

3657

1.75

60.29

1.5

1.6

60.92

68.35

mu/l

0.50

1005

3296

Insulin, fast-acting

436

1870

2.36

60.00

1.8

1.5

94.38

59.66

mu/l

2.02

383

1662

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

141

310

4.71

59.71

1.7

1.8

99.59

45.93

mu/l

1.23

129

287

Oral corticosteroids

1138

3925

1.73

59.48

1.6

66.00

66.66

mu/l

0.03

1009

3533

Type 1 diabetes

305

1107

2.79

59.43

2.3

1.6

90.64

52.87

mu/l

1.66

267

991

Asthma, excluding more controls

820

2223

1.94

59.36

1.5

1.6

60.69

63.49

mu/l

0.16

737

2014

Other bacterial diseases

1027

3933

1.77

59.19

1.7

1.5

72.45

64.83

mu/l

0.50

901

3535

ILD medications: prednisolone, methylprednisolone, prednisone

1162

3801

1.72

58.67

1.6

65.75

65.20

mu/l

0.03

1031

3414

Disorders of thyroid, IBD co-morbidities

201

377

3.80

58.55

2.2

1.7

77.59

49.55

mu/l

1.22

173

342

Symptoms and signs involving cognition, perception, emotional state and behaviour

1041

4079

1.75

58.35

1.4

1.6

71.54

62.56

mu/l

0.51

918

3669

Migraine

532

1998

2.18

58.34

1.7

54.51

55.68

mu/l

0.05

486

1796

Diarrhoea and gastroenteritis of presumed infectious origin

769

3690

1.89

58.28

2.1

1.5

74.41

66.81

mu/l

0.40

685

3315

Neurological diseases, wide definition

310

515

3.05

58.18

1.6

1.8

60.85

71.93

mu/l

0.23

282

473

Other headache syndromes

463

2065

2.26

57.98

1.5

1.6

47.62

56.02

mu/l

0.72

426

1825

Other arrhythmias

702

2717

1.97

57.66

1.4

1.6

56.83

58.75

mu/l

0.10

626

2440

Codeine

986

3003

1.80

57.20

1.5

1.6

69.10

60.25

mu/l

0.50

873

2709

Persons encountering health services in other circumstances, wide

1228

3768

1.69

56.76

1.5

1.6

70.64

65.15

mu/l

0.29

1094

3380

Asthma (mode)

840

2400

1.89

56.74

1.5

1.6

56.84

65.96

mu/l

0.73

750

2175

Asthma

846

2368

1.89

56.72

1.5

1.6

59.98

63.17

mu/l

0.20

760

2145

Symptoms and signs involving the nervous and musculoskeletal systems

642

3276

1.98

56.42

1.5

62.96

63.70

mu/l

0.03

584

2903

Insulin, fast-acting or short human

438

1935

2.29

56.28

1.8

1.5

93.93

62.11

mu/l

1.77

385

1723

Obesity related asthma

432

1901

2.31

56.20

1.5

75.24

59.63

mu/l

0.87

388

1691

Syncope and collapse

479

1859

2.23

56.07

1.5

1.4

68.79

61.78

mu/l

0.29

432

1666

Inflammatory bowel disease treatment related agents

1199

4013

1.68

55.71

1.6

63.12

66.39

mu/l

0.21

1067

3614

Disorders of gallbladder, biliary tract and pancreas

1047

3841

1.73

55.38

1.5

68.71

61.15

mu/l

0.50

954

3415

Percutaneous Coronary Intervention

849

2849

1.84

54.83

1.4

1.5

74.25

62.37

mu/l

0.61

766

2542

ILD medications

1183

3840

1.68

54.47

1.6

69.83

64.83

mu/l

0.30

1055

3453

Diseases of oesophagus, stomach and duodenum

1116

3959

1.70

54.40

1.7

1.5

69.16

66.32

mu/l

0.15

997

3553

Coronary revascularization (ANGIO or CABG)

848

2850

1.84

54.29

1.4

1.5

74.53

62.36

mu/l

0.63

764

2543

Asthma (only as main-diagnosis), excluding more controls

743

2223

1.93

54.11

1.5

1.6

60.31

63.49

mu/l

0.18

666

2014

Codeine or tramadol medication

1183

3890

1.67

53.84

1.5

1.6

70.66

61.44

mu/l

0.64

1051

3486

Intestinal infectious diseases

994

4415

1.72

53.37

2.0

1.5

70.07

64.02

mu/l

0.35

887

3963

Parasetamol

749

1981

1.93

53.18

1.5

1.6

55.91

71.39

mu/l

1.35

659

1801

Other functional intestinal disorders

494

2169

2.13

52.79

1.6

1.5

57.91

64.99

mu/l

0.35

428

1935

Complications of surgical and medical care, not elsewhere classified

1042

4223

1.70

52.74

1.5

1.6

68.26

64.40

mu/l

0.22

924

3788

Ischaemic heart disease, wide definition

828

2825

1.83

52.62

1.4

1.5

85.36

58.48

mu/l

1.69

730

2517

Implicit bacterial Sepsis

480

1936

2.16

52.36

1.5

1.4

80.35

57.85

mu/l

1.41

430

1691

Pain, not elsewhere classified

322

1289

2.53

51.74

1.6

1.5

57.25

69.24

mu/l

0.47

287

1168

Malignant neoplasm of endocrine gland

132

310

4.41

51.55

2.6

1.4

45.80

48.17

mu/l

0.07

122

275

Benzodiazepine use

1055

4343

1.68

51.43

1.5

1.6

59.49

66.03

mu/l

0.50

920

3913

Persons encountering health services for specific procedures and health care

1127

4081

1.67

51.42

1.7

1.6

65.82

66.72

mu/l

0.05

1004

3665

Hyperparathyroidism

225

744

3.04

51.11

1.5

1.2

55.71

50.26

mu/l

0.18

197

657

Major coronary heart disease event

890

3046

1.78

51.08

1.4

1.5

75.58

62.76

mu/l

0.70

799

2709

Emergency coronary revascularization (for ACS)

896

3097

1.77

51.05

1.4

1.5

77.58

63.20

mu/l

0.79

806

2746

Hypothyroidism, strict autoimmune

727

2566

1.88

50.75

2.0

1.3

74.74

57.70

mu/l

1.12

651

2289

Implicit viral Sepsis

335

1383

2.45

50.39

1.6

1.4

86.31

53.01

mu/l

1.37

301

1204

Implicit bacterial Sepsis

440

1793

2.20

50.23

1.5

1.4

81.18

56.26

mu/l

1.49

392

1567

Asthma (only as main-diagnosis)

757

2368

1.86

50.22

1.5

1.6

60.19

63.17

mu/l

0.17

677

2145

Opioids

1001

3035

1.72

50.09

1.6

63.48

60.06

mu/l

0.22

898

2739

Obesity, other/unspecified

402

1803

2.26

49.98

1.6

83.25

56.80

mu/l

1.52

365

1635

Type 1 diabetes, wide definition, subgroup 1

252

911

2.81

49.65

2.2

1.6

90.19

55.01

mu/l

1.36

223

812

Disorders of calcium metabolism

105

211

5.14

49.54

2.4

1.3

77.29

37.70

mu/l

0.58

183

Asthma (diagnoses ohter than nonallergic)

909

4417

1.72

49.52

1.5

1.6

57.95

63.64

mu/l

0.47

809

3958

Dizziness and giddiness

791

3530

1.79

49.18

1.4

1.5

72.24

59.68

mu/l

0.62

693

3157

Other symptoms and signs involving the nervous and musculoskeletal systems

475

2295

2.09

48.82

1.5

57.52

64.54

mu/l

0.37

432

2040

Bacterial Sepsis

489

2021

2.09

48.66

1.5

1.4

82.32

58.03

mu/l

1.56

435

1763

Type 1 diabetes, wide definition

260

967

2.72

48.49

2.2

1.6

88.94

55.82

mu/l

1.28

228

864

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1132

3764

1.64

48.12

1.5

1.6

68.04

65.19

mu/l

0.16

1009

3378

Volume depletion

119

271

4.49

48.11

1.9

1.3

139.28

52.61

mu/l

1.35

100

238

Dorsalgia

1008

3203

1.70

47.99

1.5

1.6

67.71

63.34

mu/l

0.22

897

2880

Mood disorders, excluding more controls

985

3495

1.69

47.75

1.5

1.6

62.93

59.66

mu/l

0.22

868

3154

Spondylopathies

818

2756

1.79

47.74

1.4

1.5

63.54

64.71

mu/l

0.06

728

2467

Complications of procedures, not elsewhere classified

848

4098

1.72

46.78

1.5

1.6

67.77

63.43

mu/l

0.23

754

3673

Lower back pain or/and sciatica

1083

4355

1.63

46.72

1.5

1.6

64.46

62.13

mu/l

0.12

958

3911

Other antidepressants

1035

3183

1.68

46.67

1.5

1.6

70.69

57.97

mu/l

0.84

908

2873

Benign neoplasm: Pituitary gland, craniopharyngeal duct

100

204

5.10

46.50

2.1

1.4

49.41

40.60

mu/l

0.39

181

Infections, IBD-co-morbidities

165

325

3.67

46.30

1.7

1.6

93.63

86.88

mu/l

0.06

143

293

Viral Sepsis

238

868

2.79

46.28

1.7

1.4

87.58

49.89

mu/l

1.25

216

762

Implicit viral Sepsis

237

866

2.78

45.92

1.7

1.4

87.69

49.69

mu/l

1.25

215

760

Low back pain

767

3130

1.77

45.34

1.6

67.89

63.36

mu/l

0.18

677

2812

Symptoms and signs involving the digestive system and abdomen

991

2966

1.68

45.30

1.5

61.27

67.73

mu/l

0.42

883

2663

Care involving use of rehabilitation procedures

690

3545

1.80

45.26

1.6

1.5

57.87

67.15

mu/l

0.61

624

3172

Mood disorders

1062

4243

1.63

45.25

1.6

61.60

63.93

mu/l

0.15

940

3817

Diarrhoea and gastroenteritis of presumed infectious origin

1033

4180

1.64

45.21

1.9

1.5

73.72

62.98

mu/l

0.62

926

3752

Mood [affective] disorders

1058

4244

1.63

44.67

1.6

61.44

63.99

mu/l

0.17

936

3818

Fever of other and unknown origin

538

2477

1.95

44.66

1.7

1.5

68.82

67.32

mu/l

0.06

472

2240

Abdominal and pelvic pain

985

2966

1.68

44.48

1.5

65.18

67.73

mu/l

0.13

883

2663

Intestinal infectious diseases

1159

4173

1.60

44.23

1.7

1.5

74.57

61.95

mu/l

0.79

1039

3746

Depression or dysthymia

704

2135

1.83

43.95

1.6

86.45

58.80

mu/l

1.46

617

1933

Abnormal findings on examination of blood, without diagnosis

493

2295

1.99

43.74

1.6

1.4

83.14

63.63

mu/l

1.05

445

2023

Chronic lower respiratory diseases

1213

4125

1.57

43.14

1.5

1.6

63.86

66.40

mu/l

0.16

1082

3710

Nutritional anaemias

506

2516

1.96

43.04

1.5

89.98

58.98

mu/l

1.43

432

2234

Persons encountering health services in other circumstances

435

2129

2.05

42.60

1.6

54.02

58.95

mu/l

0.29

386

1910

Fibromyalgia

143

408

3.59

42.46

1.6

57.37

47.30

mu/l

0.44

131

372

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

340

707

2.43

42.45

1.6

48.57

72.84

mu/l

0.88

304

646

Depression

989

4146

1.63

42.27

1.6

63.53

64.63

mu/l

0.06

881

3730

Acute renal failure

243

943

2.62

41.86

1.5

1.4

111.36

54.46

mu/l

2.43

219

839

Hypotension

199

697

2.90

41.82

1.5

1.4

64.04

53.67

mu/l

0.24

173

613

Heart failure,strict

528

1931

1.95

41.78

1.3

1.4

89.12

58.91

mu/l

1.95

454

1720

Intracranial trauma

530

1938

1.94

41.37

1.6

1.7

68.34

68.89

mu/l

0.02

477

1750

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

669

3402

1.77

41.30

1.5

1.4

66.04

60.33

mu/l

0.29

603

3006

Diverticular disease of intestine

714

2592

1.77

41.26

1.4

62.54

64.61

mu/l

0.09

640

2307

Complications of medical and surgical care

755

4112

1.70

40.33

1.5

63.01

61.55

mu/l

0.07

677

3670

Other CVD

220

828

2.70

40.31

1.5

1.4

61.93

50.05

mu/l

0.32

193

731

Examination and observation for other reasons

572

1760

1.89

40.01

1.6

1.5

66.00

68.04

mu/l

0.06

528

1572

Diseases of arteries, arterioles and capillaries

658

2751

1.78

39.82

1.3

1.4

73.26

60.09

mu/l

1.04

572

2433

Thyroiditis, ILD-related definition

157

497

3.23

39.50

3.3

1.4

134.00

46.99

mu/l

2.36

141

442

Coronary atherosclerosis

655

2327

1.80

39.48

1.4

96.76

57.54

mu/l

2.36

574

2060

Panhypopituitarism

8.59

39.33

2.3

1.3

61.35

55.20

mu/l

0.10

Cholelithiasis

834

3481

1.66

39.01

1.5

70.52

56.71

mu/l

0.98

763

3086

Other and unspecified iron deficiency

357

1688

2.14

38.94

1.4

1.5

83.86

60.60

mu/l

0.76

305

1509

Asthma, hospital admission 2, infections

589

3228

1.80

38.89

1.5

1.6

61.32

64.88

mu/l

0.18

522

2880

Asthma-related infections

589

3228

1.80

38.89

1.5

1.6

61.32

64.88

mu/l

0.18

522

2880

Cholelithiasis, broad definition with cholecystitis

862

3545

1.65

38.72

1.5

72.06

57.40

mu/l

1.11

791

3143

General examination and investigation of persons without complaint and reported diagnosis

617

1763

1.84

38.47

1.6

1.5

62.96

67.92

mu/l

0.20

559

1575

Spondylosis

554

2473

1.84

38.15

1.4

1.5

52.46

64.16

mu/l

1.13

502

2198

Concussion

454

1902

1.96

38.01

1.6

1.7

61.46

69.43

mu/l

0.34

409

1716

Sciatica+with lumbago

529

2659

1.85

37.50

1.5

59.07

64.25

mu/l

0.32

473

2372

Nerve, nerve root and plexus disorders

1050

4137

1.56

37.41

1.5

1.6

67.86

62.44

mu/l

0.30

930

3712

Iron deficiency anaemia

427

2164

1.96

36.89

1.4

1.5

83.38

59.33

mu/l

0.98

364

1932

Other disorders of kidney and ureter

172

602

2.92

36.38

1.4

84.95

59.89

mu/l

0.75

147

532

Sub-endpoint used in defining T1D endpoints

313

1420

2.19

36.37

2.2

1.5

83.01

60.67

mu/l

0.85

276

1269

Bacterial infection, other or unspecified

567

2692

1.79

36.20

1.7

1.4

70.40

62.12

mu/l

0.46

504

2386

Pain in joint

565

1987

1.83

36.18

1.7

1.6

76.83

60.19

mu/l

0.66

496

1790

Acute tubulo-interstitial nephritis

600

2965

1.76

35.91

1.6

1.5

61.56

57.38

mu/l

0.24

517

2657

Other intervertebral disc disorders

812

2985

1.65

35.81

1.5

1.6

69.07

64.05

mu/l

0.20

726

2675

Other dorsopathies, not elsewhere classified

967

3211

1.58

35.36

1.6

55.82

63.27

mu/l

0.64

861

2888

Combinations of oral blood glucose lowering drugs

293

1335

2.22

35.28

1.4

117.36

58.73

mu/l

2.47

254

1175

Spinal stenosis

500

2058

1.86

35.16

1.3

1.4

61.43

63.15

mu/l

0.08

440

1819

Vocal cord dysfunction

136

373

3.31

35.14

1.6

64.76

74.09

mu/l

0.11

123

337

Certain infectious and parasitic diseases

963

3057

1.59

35.02

1.7

1.5

64.19

63.28

mu/l

0.04

865

2748

Other special examinations and investigations of persons without complaint or reported diagnosis

618

1764

1.78

34.86

1.6

1.5

58.64

67.88

mu/l

0.49

555

1576

Osteopathies and chondropathies

571

3045

1.76

34.73

1.7

1.5

62.21

58.51

mu/l

0.20

498

2713

878

3346

1.60

34.31

1.5

68.52

63.18

mu/l

0.31

773

3009

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

878

3346

1.60

34.31

1.5

68.52

63.18

mu/l

0.31

773

3009

Autoimmune diseases related-to ILD

839

4538

1.59

34.25

1.8

1.5

83.13

59.93

mu/l

1.53

753

4062

Migraine without aura

205

808

2.57

34.25

2.0

1.7

56.96

51.93

mu/l

0.19

193

731

Convulsions, not elsewhere classified

244

1028

2.37

34.20

1.8

1.5

55.90

73.75

mu/l

0.73

216

929

Anxiety disorders, excluding more controls

822

3328

1.62

34.19

1.6

71.94

60.38

mu/l

0.69

720

3005

Other septicaemia

369

1785

2.01

33.91

1.7

1.4

84.93

62.85

mu/l

0.83

329

1583

Other pulmonary diagnosis

784

2386

1.66

33.85

1.5

1.6

61.00

62.86

mu/l

0.10

695

2160

Genitourinary diseases

566

1571

1.82

33.84

1.5

63.17

79.59

mu/l

0.79

508

1441

Bacterial infection, other or unspecified

517

2513

1.80

33.50

1.7

1.4

72.87

61.75

mu/l

0.62

456

2227

Explicit Sepsis

424

2095

1.91

33.39

1.7

1.5

80.38

62.70

mu/l

0.73

376

1839

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

608

3545

1.71

33.34

1.5

63.32

61.28

mu/l

0.09

544

3151

Aplastic and other anaemias

436

2173

1.89

33.25

1.4

75.17

60.20

mu/l

0.77

382

1921

Migraine with aura

244

1057

2.33

33.13

1.6

1.7

61.43

52.99

mu/l

0.28

221

952

Valvular heart disease excluding rheumatic fever

444

1700

1.90

33.12

1.3

1.5

77.51

65.97

mu/l

0.39

393

1517

Continuous positive airway pressure

176

541

2.77

32.96

1.3

1.6

96.62

67.31

mu/l

0.57

151

484

Cholecystectomy

698

3678

1.65

32.94

1.6

1.5

65.67

57.24

mu/l

0.54

649

3248

Glomerular disorders in diseases classified elsewhere

150

515

2.97

32.90

1.4

99.59

63.83

mu/l

1.02

129

464

Glomerular diseases

210

859

2.48

32.56

1.4

1.5

105.34

56.99

mu/l

1.93

175

764

Non-rheumatic valve diseases

440

1688

1.90

32.56

1.3

1.5

77.77

65.82

mu/l

0.40

390

1507

445

2400

1.85

32.54

1.6

1.5

66.38

64.22

mu/l

0.08

396

2155

Excluding asthma or asthma-COPD overlap

777

2386

1.64

32.43

1.5

1.6

61.40

62.86

mu/l

0.07

687

2160

Influenza and pneumonia

1028

4333

1.52

32.27

1.6

69.81

64.44

mu/l

0.34

910

3900

Symptoms and signs involving the urinary system

736

3482

1.62

31.87

1.6

1.4

56.38

67.14

mu/l

0.90

650

3099

Hypothyroidism, strict autoimmune, 3 medication purchases required

795

3380

1.60

31.80

1.9

1.4

73.04

54.79

mu/l

1.41

708

3019

Septicaemia

405

2012

1.90

31.59

1.7

1.4

81.21

65.08

mu/l

0.60

360

1783

Osteoporosis

284

1244

2.16

31.55

1.8

1.3

62.31

55.04

mu/l

0.29

246

1102

Any mental disorder

1064

3541

1.51

31.41

1.4

1.6

62.92

62.49

mu/l

0.02

933

3199

Asthma, including avohilmo

1132

4303

1.48

31.37

1.5

1.6

62.90

66.47

mu/l

0.25

1013

3863

Anxiety disorders

896

4062

1.55

31.26

1.6

71.77

62.40

mu/l

0.57

791

3653

Finngen Rheumatological endpoints

926

3421

1.55

31.26

1.5

1.6

71.12

62.37

mu/l

0.46

826

3082

Gastrointestinal diseases

539

1511

1.80

31.16

1.6

1.7

55.37

74.05

mu/l

1.05

488

1371

Other anaemias

400

2025

1.89

31.04

1.3

1.4

73.28

60.40

mu/l

0.60

351

1792

Other and unspecified anaemias

396

2004

1.90

31.02

1.3

1.4

73.31

60.81

mu/l

0.57

347

1774

Neurotic, stress-related and somatoform disorders

886

4033

1.55

30.93

1.6

72.24

61.87

mu/l

0.64

781

3626

Hernia of abdominal wall, postoperative

184

724

2.57

30.92

1.4

103.78

57.25

mu/l

1.04

165

637

Recurrent or chronic depression

411

1526

1.91

30.92

1.7

1.6

80.23

60.44

mu/l

0.76

359

1380

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

937

4008

1.53

30.87

1.4

1.6

73.61

64.95

mu/l

0.45

829

3618

Bleeding

791

3572

1.58

30.86

1.4

1.5

69.05

65.17

mu/l

0.19

696

3185

Exposure to unspecified factor

960

4580

1.52

30.85

1.5

1.6

73.94

63.28

mu/l

0.44

840

4127

Angina pectoris

546

2093

1.75

30.84

1.3

1.4

93.97

56.58

mu/l

1.85

489

1846

Disorder of lipoprotein metabolism, unspecified

136

459

3.01

30.70

1.8

1.4

74.56

49.19

mu/l

0.65

127

405

Diseases of the skin and subcutaneous tissue

968

3181

1.53

30.58

1.5

1.6

63.64

67.51

mu/l

0.22

866

2872

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

564

3347

1.70

30.39

1.5

64.10

61.96

mu/l

0.09

504

2982

Epilepsy

289

1386

2.10

30.28

1.5

94.49

66.83

mu/l

0.54

259

1229

Cerebrovascular diseases

703

3062

1.62

30.28

1.4

72.48

58.36

mu/l

1.05

628

2704

Other diseases of liver

211

896

2.39

30.17

1.7

1.4

86.77

57.50

mu/l

1.18

188

801

Dorsopathies

966

3229

1.53

30.08

1.5

1.6

54.46

63.81

mu/l

0.90

865

2906

Anxiety (asthma-related co-morbidities)

587

2705

1.69

30.02

1.7

68.33

61.48

mu/l

0.30

512

2454

ILD differential diagnosis

768

2400

1.61

29.96

1.5

1.6

59.82

65.96

mu/l

0.37

680

2175

Heart failure, strict

549

2257

1.73

29.95

1.3

1.4

86.44

59.48

mu/l

1.79

472

2006

Asthma, hospital admissions , main diagnosis only

788

4477

1.56

29.93

1.5

1.6

59.02

65.88

mu/l

0.51

704

4014

COPD differential diagnosis

767

2402

1.61

29.67

1.5

1.6

59.89

65.90

mu/l

0.37

679

2177

Hypocalcemia

6.42

29.56

3.2

1.3

90.33

46.61

mu/l

0.30

Constipation

847

3816

1.54

29.49

1.5

56.83

65.75

mu/l

0.65

741

3418

Diseases of liver

359

1888

1.92

29.31

1.7

1.5

88.72

61.85

mu/l

1.15

317

1678

Soft tissue disorders

959

3264

1.52

29.27

1.5

1.7

65.66

64.19

mu/l

0.07

862

2939

Functional dyspepsia

285

1386

2.08

29.12

1.5

1.4

36.85

56.82

mu/l

2.48

252

1226

Elevated blood glucose level

111

345

3.29

28.95

1.7

1.4

83.36

60.20

mu/l

0.59

100

300

Gastro-oesophageal reflux disease

654

3511

1.62

28.75

1.6

1.5

66.66

65.37

mu/l

0.05

578

3133

Pneumonia, organism unspecified

877

4059

1.52

28.67

1.5

69.33

65.38

mu/l

0.21

772

3643

COPD/asthma related infections

998

3346

1.50

28.54

1.5

57.49

63.18

mu/l

0.47

889

3009

COPD/asthma/ILD related infections

998

3346

1.50

28.54

1.5

57.49

63.18

mu/l

0.47

889

3009

Selective serotonin reuptake inhibitors

927

3199

1.52

28.42

1.5

1.6

69.23

58.62

mu/l

0.77

821

2889

All pneumoniae

970

4375

1.49

28.29

1.5

1.6

68.39

65.01

mu/l

0.19

856

3939

Other/unspecified dorsalgia

365

1934

1.89

28.27

1.5

59.97

63.22

mu/l

0.12

326

1725

Cough

368

1862

1.88

28.21

1.5

53.08

67.03

mu/l

0.83

331

1653

Major coronary heart disease event excluding revascularizations

558

2209

1.69

28.10

1.3

1.4

95.32

61.91

mu/l

1.54

498

1943

Psychiatric diseases

946

3147

1.51

28.10

1.5

1.6

62.55

62.94

mu/l

0.02

833

2840

All-cause Heart Failure

535

2227

1.71

28.04

1.3

1.4

85.32

59.25

mu/l

1.67

461

1976

Primary hyperparathyroidism

142

519

2.79

27.85

1.6

1.4

48.03

45.67

mu/l

0.07

129

459

Use of hypnotics and sedatives

1011

3947

1.48

27.60

1.5

1.6

65.49

65.90

mu/l

0.02

870

3570

Erysipelas

678

3268

1.59

27.51

1.4

1.5

78.82

61.50

mu/l

0.87

591

2920

Pneumonias (Asthma/COPD co-morbidities)

961

4375

1.48

27.42

1.5

1.6

68.63

64.99

mu/l

0.21

847

3938

Lumbar disc prolapse

607

2866

1.63

27.37

1.5

1.6

70.72

64.96

mu/l

0.18

545

2565

Polyarthropathies

641

2594

1.62

27.34

1.5

1.6

71.54

63.89

mu/l

0.41

563

2348

Pain (limb, back, neck, head abdominally)

657

2024

1.63

27.20

1.5

1.6

59.90

63.27

mu/l

0.15

587

1827

Nonalcoholic fatty liver disease

127

448

2.89

26.64

1.4

1.5

83.67

45.98

mu/l

1.36

117

403

Other specific joint derangements/joint disorders

695

2857

1.58

26.51

1.6

74.99

63.19

mu/l

0.52

610

2592

All anxiety disorders

595

2912

1.62

26.34

1.7

1.6

68.37

63.38

mu/l

0.20

519

2636

Diseases of pulp and periapical tissues, including avohilmo

977

3440

1.48

26.19

1.6

61.47

67.66

mu/l

0.40

879

3083

Polycystic ovarian syndrome, consortium definition

682

2558

1.59

26.13

1.7

1.6

66.43

48.94

mu/l

1.62

605

2300

Pregnancy hypertension

404

2041

1.79

25.92

1.7

59.74

53.59

mu/l

0.25

369

1842

Infections of the skin and subcutaneous tissue

553

3376

1.63

25.88

1.5

1.6

69.21

68.43

mu/l

0.03

487

3027

Caries of dentine

240

1115

2.12

25.68

1.6

1.5

80.90

75.59

mu/l

0.10

210

1005

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

933

4350

1.47

25.67

1.5

1.6

67.89

65.67

mu/l

0.12

822

3919

Rheumatism, unspecified

160

648

2.51

25.49

1.4

1.5

65.13

49.28

mu/l

0.61

143

582

Asthma/COPD (KELA code 203)

886

4121

1.48

25.38

1.5

1.6

61.77

66.36

mu/l

0.29

802

3706

Atherosclerosis, excluding cerebral and coronary sclerosis

363

1573

1.84

25.17

1.3

1.4

102.94

51.77

mu/l

4.03

303

1390

Covid-19 confirmed case

349

1914

1.84

25.04

1.6

1.5

60.48

66.56

mu/l

0.28

306

1693

Erysipelas

514

2766

1.65

24.97

1.4

72.37

64.75

mu/l

0.36

442

2462

Dermatitis and eczema

1032

4471

1.44

24.85

1.6

70.39

64.04

mu/l

0.38

914

4018

Disorders of eyelid, lacrimal system and orbit

797

4052

1.50

24.83

1.6

1.5

53.22

61.98

mu/l

0.80

710

3616

Dental caries

264

1275

2.01

24.57

1.6

1.5

87.65

79.05

mu/l

0.17

232

1153

Abnormal findings on diagnostic imaging of other body structures

159

654

2.47

24.53

1.7

1.4

56.57

51.63

mu/l

0.17

149

578

Substance abuse, excluding more controls

505

2621

1.65

24.30

1.3

1.6

72.02

63.98

mu/l

0.25

434

2372

Systemic connective tissue disorders

339

1861

1.84

24.29

1.5

1.4

76.47

54.37

mu/l

0.60

299

1643

Haemorrhage from respiratory passages

289

1352

1.94

24.18

1.5

1.4

66.90

70.15

mu/l

0.11

249

1189

1061

3852

1.43

23.95

1.6

1.5

59.15

62.89

mu/l

0.29

951

3448

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

443

2284

1.70

23.73

1.7

1.6

59.15

54.59

mu/l

0.19

403

2053

Other neurological diseases

662

3388

1.54

23.68

1.5

1.4

65.14

58.73

mu/l

0.37

604

2993

Codes for special purposes

484

2955

1.65

23.49

1.5

54.29

63.65

mu/l

0.73

431

2641

Visual disturbances and blindness

487

2983

1.64

23.47

1.6

1.5

61.13

62.63

mu/l

0.05

444

2649

Provisional assignment of new diseases of uncertain etiology

483

2948

1.65

23.47

1.5

54.38

63.70

mu/l

0.73

430

2634

Myocardial infarction

439

1815

1.71

23.37

1.3

1.4

84.48

61.60

mu/l

1.10

391

1602

Unspecified kidney failure

104

355

2.98

23.16

1.5

1.4

96.80

70.23

mu/l

0.51

318

152

630

2.45

23.07

1.9

1.6

58.48

54.90

mu/l

0.15

135

570

Other disorders of urethra and urinary system

632

2952

1.55

22.94

1.5

1.6

55.95

57.83

mu/l

0.10

546

2672

Other and unspecified dermatitis

481

2964

1.63

22.68

1.5

61.01

59.14

mu/l

0.08

417

2642

Non-selective monoamine reuptake inhibitors

355

1944

1.77

22.55

1.4

1.5

60.24

55.76

mu/l

0.20

315

1736

Symptoms and signs concerning food and fluid intake

108

383

2.86

22.37

1.4

62.31

85.03

mu/l

0.32

345

Other systemic involvement of connective tissue (FG)

252

1274

1.97

22.35

1.6

1.4

47.31

55.99

mu/l

0.51

221

1127

Viral and other specified intestinal infections

199

914

2.14

22.20

2.1

1.5

81.28

72.62

mu/l

0.16

178

825

Viral and other specified intestinal infections

257

1279

1.95

22.20

2.0

1.5

92.05

67.00

mu/l

0.64

229

1155

Symptoms and signs involving the skin and subcutaneous tissue

649

4210

1.52

22.13

1.6

1.5

52.32

61.23

mu/l

0.77

573

3766

Cystitis

773

3109

1.48

21.98

1.6

55.89

62.83

mu/l

0.47

674

2813

Other general symptoms and signs

143

4.17

21.88

1.2

1.4

68.88

102.34

mu/l

0.19

130

Disorders of choroid and retina

732

3508

1.49

21.87

1.6

1.5

56.88

61.78

mu/l

0.35

634

3127

Paralytic ileus and intestinal obstruction

234

1179

2.00

21.77

1.5

1.4

54.75

70.28

mu/l

0.42

206

1045

Stroke, including SAH

561

2597

1.58

21.74

1.4

73.41

58.73

mu/l

0.90

497

2282

Visual disturbances

451

2766

1.64

21.73

1.7

1.5

62.65

64.40

mu/l

0.06

415

2453

Dermatitis

565

3639

1.56

21.73

1.5

67.56

59.92

mu/l

0.35

493

3252

Other retinal disorders

570

2853

1.57

21.70

1.6

1.4

53.43

61.86

mu/l

0.70

500

2529

Myalgia

232

1170

2.00

21.59

1.6

70.50

50.78

mu/l

0.93

203

1044

Stroke, excluding SAH

527

2424

1.60

21.59

1.4

74.14

57.31

mu/l

1.03

466

2124

Other disorders of lacrimal gland

335

1907

1.77

21.34

1.7

1.4

56.57

57.47

mu/l

0.03

296

1701

Certain infectious and parasitic diseases

675

2228

1.52

21.00

1.6

1.5

69.78

58.30

mu/l

0.69

602

2003

Extracorporeal dialysis

224

3.43

20.99

1.4

61.35

57.27

mu/l

0.07

195

Irritable bowel syndrome

260

1380

1.90

20.82

1.6

1.5

51.55

59.30

mu/l

0.36

232

1236

ILD medications: immunosuppressive drugs

580

3536

1.53

20.63

1.5

76.79

66.71

mu/l

0.48

524

3176

Dialysis, with operation codes

132

542

2.47

20.53

1.4

116.80

58.58

mu/l

1.06

117

486

Certain disorders involving the immune mechanism

196

951

2.09

20.38

1.6

1.5

91.99

65.46

mu/l

0.52

174

851

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

115

445

2.63

20.28

1.6

1.4

51.37

69.16

mu/l

0.51

102

393

Asthma-related pneumonia

319

1817

1.76

20.13

1.5

1.4

62.95

65.67

mu/l

0.09

284

1610

Chronic apical periodontitis

1017

4185

1.39

20.09

1.6

66.51

62.83

mu/l

0.22

888

3770

Shoulder lesions

683

2785

1.49

20.06

1.5

1.6

67.83

61.21

mu/l

0.35

608

2494

Peripheral artery disease

366

1714

1.71

19.98

1.3

1.4

89.39

53.77

mu/l

2.75

311

1512

Asthma, hospital admissions 3, pneumonia

319

1822

1.76

19.95

1.5

1.4

62.95

65.63

mu/l

0.09

284

1613

Asthma-related pneumonia or sepsis

319

1822

1.76

19.95

1.5

1.4

62.95

65.63

mu/l

0.09

284

1613

Diseases of the eye and adnexa

728

2469

1.48

19.94

1.6

60.35

68.26

mu/l

0.50

653

2245

Migraine without aura and triptan purchases

165

756

2.21

19.88

1.9

1.8

50.98

52.14

mu/l

0.03

155

683

Amenorrhoea

242

3.23

19.82

2.8

1.8

78.25

51.26

mu/l

1.00

221

Other diseases of pancreas

101

372

2.77

19.68

1.3

1.4

43.56

50.09

mu/l

0.19

326

Ovarian cyst

331

1076

1.79

19.67

1.6

1.5

55.04

52.73

mu/l

0.09

299

965

Diabetic nephropathy, excluding more controls

194

773

2.10

19.66

1.5

1.6

115.90

81.19

mu/l

0.81

167

705

Other anxiety disorders

422

2253

1.63

19.58

1.7

1.6

63.84

60.44

mu/l

0.14

373

2046

Acute upper respiratory infections

937

4145

1.40

19.51

1.7

1.5

65.08

62.46

mu/l

0.15

848

3704

Early onset COPD, excluding more controls

191

932

2.07

19.50

1.2

1.4

84.15

77.23

mu/l

0.15

168

832

Somatoform disorder

173

815

2.15

19.46

1.8

1.5

74.27

56.77

mu/l

0.53

154

730

Other reaction to severe stress, and adjustment disorders

338

1985

1.71

19.30

1.7

1.6

67.99

62.17

mu/l

0.20

301

1802

Irregular menses

431

2108

1.62

19.30

1.9

1.6

70.16

51.11

mu/l

1.48

389

1911

Mental and behavioural disorders due to psychoactive substance use

526

3185

1.54

19.14

1.3

1.6

80.90

67.34

mu/l

0.45

453

2866

Heart failure and coronary heart disease

354

1472

1.72

19.10

1.3

1.4

92.18

60.30

mu/l

1.48

309

1292

Rotator cuff syndrome

546

2560

1.54

19.07

1.5

67.90

60.64

mu/l

0.33

479

2285

COPD (mode)

274

1180

1.84

19.05

1.2

1.4

77.06

64.41

mu/l

0.46

237

1053

Persons encountering health services for examination and investigation

547

1764

1.56

19.04

1.5

52.13

67.88

mu/l

1.08

492

1576

Oxycodone

332

1756

1.72

18.96

1.7

1.4

81.52

55.92

mu/l

0.93

294

1557

Diabetic maculopathy, excluding more controls

108

419

2.61

18.94

2.1

1.4

78.20

50.93

mu/l

0.91

366

Fall on same level

1038

4149

1.37

18.81

1.5

1.6

59.44

68.21

mu/l

0.78

915

3745

Care involving dialysis

353

2.77

18.78

1.4

66.50

59.25

mu/l

0.14

311

Dental pulpitis, including avohilmo

839

3871

1.41

18.75

1.6

59.46

68.09

mu/l

0.72

753

3474

Adverse effects, not elsewhere classified

195

976

2.02

18.65

1.5

1.6

63.49

62.40

mu/l

0.02

178

868

Migraine with aura and triptan purchases

156

718

2.20

18.62

1.8

54.48

51.13

mu/l

0.11

144

651

Chronic pancreatitis

132

568

2.36

18.55

1.5

1.4

48.04

56.69

mu/l

0.34

110

508

Cervical disc disorders

325

1914

1.71

18.41

1.5

69.09

64.35

mu/l

0.13

294

1699

Insulin, fast-acting (human)

142

632

2.27

18.41

2.1

1.5

86.50

63.24

mu/l

0.83

124

567

Hypoglycaemia, other or unspecified

259

3.07

18.35

2.5

1.4

63.64

87.90

mu/l

0.27

228

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

477

2998

1.55

18.33

1.5

55.02

67.48

mu/l

0.75

430

2694

Malignant neoplasm of kidney, except renal pelvis

101

386

2.66

18.32

1.7

1.4

53.54

65.75

mu/l

0.29

342

Personality disorders, excluding more controls

231

1233

1.89

18.23

1.6

61.14

57.65

mu/l

0.11

205

1129

Malignant neoplasm of urinary organs

106

416

2.59

18.21

1.7

1.4

51.40

70.28

mu/l

0.50

369

Nephropathy related operations

130

561

2.35

18.17

1.4

110.41

57.23

mu/l

0.95

116

501

Other disorders of skin and subcutaneous tissue

613

3712

1.47

18.12

1.7

1.5

67.29

57.75

mu/l

0.73

540

3304

Other or unspecified ileus, impaction or obstruction

167

798

2.11

18.09

1.5

1.4

61.32

74.38

mu/l

0.23

146

712

Sequelae of external causes of morbidity and mortality

248

1359

1.84

18.07

1.4

52.38

59.36

mu/l

0.33

219

1205

Disorders of lacrimal system

388

2398

1.62

18.05

1.7

1.5

54.63

54.69

mu/l

0.00

342

2131

Other noninfective gastroenteritis and colitis

230

1231

1.88

18.00

1.7

1.4

70.41

69.71

mu/l

0.02

212

1097

Other disorders of glucose regulation and pancreatic internal secretion

327

2.80

17.99

2.3

1.4

60.54

81.98

mu/l

0.29

285

Diseases of the ear and mastoid process

1055

3909

1.36

17.90

1.6

62.08

67.47

mu/l

0.35

941

3523

Carpal tunnel syndrome

557

3297

1.50

17.74

1.5

76.82

59.21

mu/l

0.71

491

2946

Hernia

843

4064

1.40

17.72

1.4

1.6

65.90

65.45

mu/l

0.02

743

3639

Cervicocranial syndrome

112

457

2.48

17.72

1.4

1.5

61.91

66.41

mu/l

0.08

402

Substance abuse

505

3130

1.52

17.68

1.3

1.6

72.02

68.63

mu/l

0.09

434

2819

Benign neoplasm of other and ill-defined parts of digestive system

182

907

2.03

17.68

1.9

1.4

46.71

57.27

mu/l

0.58

158

806

Other systemic involvement of connective tissue

256

1426

1.81

17.68

1.6

1.4

47.08

56.35

mu/l

0.60

223

1261

Undetermined asthma, excluding more controls

128

555

2.33

17.64

1.5

50.03

57.82

mu/l

0.21

114

500

Non-ischemic cardiomyopathy

267

1203

1.80

17.48

1.4

61.20

49.05

mu/l

0.60

235

1068

Soft tissue disorders related to use, overuse and pressure

250

1388

1.82

17.45

1.5

91.36

55.36

mu/l

0.75

227

1225

Benign neoplasm of colon, rectum, anus and anal canal

548

3197

1.50

17.38

1.4

71.16

58.50

mu/l

0.61

486

2828

Cervicalgia

198

1022

1.96

17.37

1.4

1.5

53.88

63.08

mu/l

0.47

182

901

COPD

373

1877

1.63

17.30

1.2

1.4

80.86

63.80

mu/l

0.84

322

1653

Myocardial infarction, without ST-elevation

333

1824

1.67

17.25

1.2

1.4

81.55

56.90

mu/l

1.32

296

1606

Gout

237

1136

1.85

17.23

1.3

1.4

99.89

62.81

mu/l

1.38

200

1006

Disturbances of skin sensation

265

1503

1.78

17.23

1.6

62.46

56.32

mu/l

0.22

238

1353

Presence of other functional implants

512

2339

1.53

17.23

1.3

1.4

49.90

58.58

mu/l

0.61

431

2074

Clear cell adenocarcinoma of kidney

182

3.44

17.20

1.8

1.4

38.00

81.90

mu/l

1.22

162

Persons with potential health hazards related to communicable diseases

334

2000

1.67

17.18

1.6

1.7

63.19

67.22

mu/l

0.16

301

1820

Other diseases of urinary system

878

3574

1.39

17.17

1.5

1.6

61.24

66.72

mu/l

0.32

753

3235

Other joint disorders

777

2901

1.42

17.13

1.7

1.6

60.96

66.39

mu/l

0.30

688

2634

Other chronic obstructive pulmonary disease, including avohilmo

450

2403

1.56

17.02

1.2

1.4

75.06

61.30

mu/l

0.78

391

2124

Dysphagia

214

1142

1.89

16.97

1.5

1.4

59.03

57.97

mu/l

0.02

183

1007

Other and unspecified effects of external causes

259

1466

1.78

16.96

1.5

1.6

83.43

66.16

mu/l

0.31

236

1323

Type 1 diabetes, definitions combined

384

2.58

16.79

3.0

1.7

71.49

61.25

mu/l

0.21

353

Undetermined asthma

128

568

2.28

16.73

1.5

50.03

60.49

mu/l

0.30

114

511

Gonarthrosis [arthrosis of knee](FG)

664

2680

1.45

16.65

1.4

1.5

65.15

60.67

mu/l

0.24

594

2393

Diseases of the digestive system

385

2418

1.59

16.61

1.5

50.71

68.24

mu/l

1.32

336

2140

Diabetic nephropathy

196

1013

1.94

16.57

1.5

114.75

76.68

mu/l

1.00

169

904

Disorders of vestibular function (Vertigo)

414

2616

1.57

16.53

1.4

51.35

56.81

mu/l

0.28

373

2309

Disorders of lens

597

2547

1.47

16.48

1.5

58.12

68.19

mu/l

0.73

520

2287

Type 1 diabetes, strict (exclude DM2)

382

2.56

16.46

3.0

1.7

72.21

61.23

mu/l

0.23

351

Abnormal findings on diagnostic imaging of lung

406

2490

1.57

16.43

1.4

69.50

62.05

mu/l

0.26

360

2190

Sicca syndrome [Sjögren]

398

2.53

16.25

1.6

1.4

51.58

38.15

mu/l

0.45

359

Osteoporosis with pathological fracture (FG)

306

2.76

16.22

1.7

1.3

86.68

42.75

mu/l

0.83

271

Injuries to the knee and lower leg

1052

4390

1.33

16.17

1.5

1.6

63.05

65.25

mu/l

0.13

937

3941

Cyst of kidney

301

2.78

16.17

1.4

72.38

53.76

mu/l

0.30

262

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

330

2.68

16.08

1.7

1.4

85.86

52.43

mu/l

0.63

293

Chronic rhinitis, nasopharyngitis and pharyngitis

302

1812

1.68

16.04

1.7

1.5

102.63

57.88

mu/l

1.58

253

1625

Acute upper respiratory infections of multiple and unspecified sites

657

3425

1.43

16.04

1.8

1.5

71.15

63.47

mu/l

0.42

596

3068

Generalized anxiety disorder

147

703

2.11

15.98

1.6

1.7

50.45

54.23

mu/l

0.12

126

641

Periodontitis

862

4236

1.37

15.97

1.4

1.5

70.93

62.52

mu/l

0.45

777

3779

Falls/tendency to fall

978

3641

1.35

15.90

1.5

1.6

62.67

69.64

mu/l

0.49

870

3285

Other symptoms and signs involving the digestive system and abdomen

156

765

2.06

15.87

1.6

1.5

75.43

71.82

mu/l

0.05

136

673

Diseases of the respiratory system

580

1973

1.48

15.84

1.4

1.6

54.84

65.43

mu/l

0.69

513

1788

Chronic periodontitis, including avohilmo

859

4236

1.36

15.79

1.4

1.5

70.69

62.42

mu/l

0.44

775

3778

Myocardial infarction, strict

380

1703

1.60

15.76

1.2

1.4

81.54

62.97

mu/l

0.74

339

1506

Other chronic obstructive pulmonary disease

354

1817

1.62

15.74

1.2

1.4

80.45

63.27

mu/l

0.81

306

1601

Diaphragmatic hernia

316

1929

1.65

15.71

1.4

63.09

55.18

mu/l

0.29

272

1706

Disorders of synovium and tendon

465

2704

1.51

15.71

1.4

1.6

75.93

60.82

mu/l

0.49

412

2417

Noninfective enteritis and colitis

408

2642

1.55

15.69

1.6

1.5

67.47

64.23

mu/l

0.13

367

2356

Gestational [pregnancy-induced] hypertension

226

1256

1.81

15.67

1.7

1.8

43.33

49.99

mu/l

0.50

206

1150

Urticaria and erythema

328

2024

1.63

15.61

1.7

1.5

51.76

64.77

mu/l

0.74

291

1826

Arthrosis

633

2416

1.44

15.58

1.5

67.92

64.47

mu/l

0.15

572

2182

Disorders of conjunctiva

735

4263

1.39

15.57

1.7

1.6

73.68

61.69

mu/l

0.57

663

3809

Congenital malformations, deformations and chromosomal abnormalities

564

3596

1.45

15.57

1.7

1.6

85.00

63.23

mu/l

0.87

511

3232

Unspecified haematuria

349

1802

1.61

15.53

1.5

1.4

54.75

67.64

mu/l

0.73

306

1594

Vascular disorders of the intestines

241

2.95

15.50

1.1

1.4

136.25

66.44

mu/l

0.61

215

Other blood glucose lowering drugs, excl. Insulins

145

699

2.10

15.47

1.2

1.4

119.92

49.16

mu/l

2.12

122

615

Cutaneous abscess, furuncle and carbuncle

239

1360

1.77

15.43

1.5

62.30

69.05

mu/l

0.25

209

1213

Phobic anxiety disorders

122

549

2.24

15.42

1.8

1.7

106.30

58.97

mu/l

0.72

103

503

Benign neoplasm: Colon

459

2922

1.51

15.41

1.4

77.50

57.73

mu/l

0.91

401

2590

Transient ischemic attack

435

2310

1.53

15.38

1.4

72.37

56.53

mu/l

0.83

399

2024

Nontoxic multinodular goitre

180

940

1.93

15.33

1.4

1.3

46.41

52.51

mu/l

0.24

163

836

Aortic aneurysm

185

955

1.92

15.32

1.4

51.80

51.27

mu/l

0.02

168

842

Bronchitis

942

4444

1.34

15.24

1.6

1.5

63.47

61.37

mu/l

0.12

847

3977

Mixed hyperlipidaemia

111

3.95

14.99

2.0

1.3

88.28

60.38

mu/l

0.29

100

Vitamin deficiency, wide

163

3.38

14.96

1.4

1.3

118.89

51.95

mu/l

0.55

145

Vitamin deficiency

163

3.38

14.96

1.4

1.3

118.89

51.95

mu/l

0.55

145

Fracture of rib(s), sternum and thoracic spine

261

1539

1.71

14.86

1.4

71.99

59.41

mu/l

0.45

232

1356

Other and unspecified drugs and medicaments

374

2.50

14.78

1.5

1.4

58.39

66.40

mu/l

0.09

325

Gout, idiopatic and unspecified

210

1168

1.81

14.69

1.3

1.4

101.06

59.50

mu/l

1.43

178

1024

Acute sinusitis

455

2830

1.50

14.67

1.8

1.6

62.16

66.17

mu/l

0.19

405

2536

Panic disorder

133

634

2.12

14.63

1.6

1.7

55.46

54.37

mu/l

0.03

117

577

Ischaemic Stroke, excluding all haemorrhages

462

2305

1.50

14.58

1.4

75.47

57.45

mu/l

1.04

407

2022

Other symptoms and signs involving the urinary system

101

431

2.37

14.57

1.4

50.69

68.64

mu/l

0.61

382

Abnormal results of function studies

371

2.49

14.53

1.9

1.5

56.70

51.61

mu/l

0.08

330

Ulcer of lower limb, not elsewhere classified

134

644

2.10

14.46

1.4

89.59

58.81

mu/l

1.18

116

567

All influenza

218

1234

1.78

14.35

1.6

1.5

92.13

57.71

mu/l

1.31

196

1103

Congenital malformations, deformations and chromosomal abnormalities

508

3341

1.45

14.29

1.7

1.6

86.40

63.50

mu/l

0.82

461

3016

Intestinal stricture

265

1586

1.68

14.29

1.4

65.72

65.51

mu/l

0.00

235

1402

Gonarthrosis

565

2234

1.45

14.23

1.5

66.97

62.80

mu/l

0.19

505

2013

Ovarian dysfunction

226

2.91

14.17

3.1

1.3

78.38

46.46

mu/l

0.80

205

Persons encountering health services for specific procedures, not carried out

358

2.49

14.12

2.1

1.5

97.81

46.28

mu/l

0.63

319

Gout, FINNGEN

237

1377

1.73

14.12

1.3

1.4

99.89

60.78

mu/l

1.52

200

1211

Familial hypercholesterolemia

112

506

2.23

14.11

1.4

1.3

128.31

48.71

mu/l

1.85

100

451

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

395

2.41

14.07

1.5

1.4

57.11

68.04

mu/l

0.14

349

Gout, strict definition

157

807

1.97

14.07

1.3

1.4

124.98

60.33

mu/l

1.80

131

708

Other arthritis (FG)

269

1623

1.67

14.07

1.4

1.5

70.40

59.56

mu/l

0.36

238

1433

Deforming dorsopathies

246

1451

1.71

14.02

1.5

61.45

62.13

mu/l

0.02

216

1289

Senile cataract

534

2260

1.45

14.02

1.4

59.51

64.90

mu/l

0.29

464

2031

Conduction disorders

233

1089

1.75

13.92

1.3

1.5

81.00

55.27

mu/l

0.93

204

975

Disorders of skin appendages

418

2797

1.50

13.87

1.6

64.20

59.83

mu/l

0.21

381

2511

Substance use, excluding alcohol

185

1008

1.85

13.87

1.2

1.6

113.14

64.97

mu/l

0.74

157

914

Polyneuropathies and other disorders of the peripheral nervous system

191

1052

1.83

13.84

1.3

1.4

64.10

56.44

mu/l

0.26

175

928

Neuromuscular dysfunction of bladder

417

2.36

13.81

1.4

39.34

54.99

mu/l

0.50

373

Unknown and unspecified causes of morbidity

246

2.80

13.80

1.4

87.36

50.62

mu/l

0.63

217

ILD medications: azathioprine

138

683

2.04

13.77

1.7

1.6

78.73

56.20

mu/l

0.87

121

614

Diseases of the musculoskeletal system and connective tissue

453

1512

1.51

13.70

1.6

1.7

60.97

68.03

mu/l

0.27

400

1383

Sequelae with surgical and medical care as external cause

188

1034

1.84

13.70

1.3

1.4

48.39

59.69

mu/l

0.79

168

917

Disorders resulting from impaired renal tubular function

133

3.55

13.68

1.4

1.3

69.65

41.76

mu/l

1.11

121

Pain in thoracic spine

140

699

2.02

13.64

1.4

1.5

46.43

57.27

mu/l

0.51

125

622

Arthropathies

779

2907

1.36

13.59

1.7

1.6

60.82

66.91

mu/l

0.37

699

2640

L01XX Other antineoplastic agents

222

2.89

13.48

3.1

1.3

71.38

43.56

mu/l

0.37

196

Urticaria

267

1627

1.65

13.46

1.8

1.6

50.35

57.93

mu/l

0.34

235

1472

Allergic asthma (mode), excluding more controls

193

1051

1.81

13.44

1.5

1.6

85.42

56.75

mu/l

0.94

171

959

Other and unspecified polyneuropathies, also in other diseases

170

912

1.88

13.42

1.4

65.62

51.46

mu/l

0.51

157

800

Other symptoms and signs involving cognitive functions and awareness

365

2174

1.54

13.40

1.4

62.79

57.17

mu/l

0.22

321

1921

COPD related to multimorbidity

314

1673

1.59

13.38

1.2

1.4

84.64

59.84

mu/l

1.24

273

1476

Azathioprine

138

691

2.02

13.35

1.7

1.6

78.73

57.09

mu/l

0.82

121

620

Excessive, frequent and irregular menstruation

326

1118

1.61

13.23

1.7

1.6

49.83

52.71

mu/l

0.12

293

1003

Follow-up examination after treatment for conditions other than malignant neoplasms

351

1493

1.56

13.22

1.5

64.52

61.92

mu/l

0.06

320

1323

Abnormal involuntary movements

123

594

2.09

13.15

1.4

85.49

48.85

mu/l

0.71

107

523

Post-traumatic stress disorder

299

2.57

13.09

1.9

1.6

67.12

48.28

mu/l

0.32

271

Other disorders of eyelid

368

2312

1.52

13.08

1.4

51.56

56.70

mu/l

0.26

330

2040

Chronic periodontitis, complicated

469

3227

1.45

12.99

1.5

1.4

78.33

62.37

mu/l

0.59

424

2849

Chronic gastritis

227

1339

1.71

12.98

1.8

1.3

68.75

57.86

mu/l

0.41

190

1182

Spondylolisthesis/Spondylolysis

168

908

1.87

12.97

1.5

1.4

69.74

61.36

mu/l

0.20

148

805

Asthma and allergy

113

524

2.15

12.92

1.6

1.7

70.54

52.16

mu/l

0.48

481

Injuries to the thorax

376

2502

1.51

12.90

1.4

1.5

69.41

65.46

mu/l

0.14

334

2215

Enthesopathies of lower limb, excluding foot

198

1127

1.77

12.87

1.4

1.5

71.86

63.98

mu/l

0.17

179

1006

Gonarthrosis,primary

753

3450

1.35

12.86

1.4

1.5

62.94

63.12

mu/l

0.01

680

3057

Asthma and allergy, excluding more controls

113

525

2.14

12.86

1.6

1.7

70.54

50.37

mu/l

0.54

478

Heart failure and bmi 25plus

314

1340

1.59

12.84

1.3

1.4

89.55

55.54

mu/l

1.75

267

1194

Menorrhagia

296

1014

1.63

12.77

1.6

1.5

54.82

53.51

mu/l

0.04

269

906

Acute pharyngitis

134

669

2.00

12.76

2.3

1.5

48.77

67.88

mu/l

1.45

124

598

Immunodeficiencies

191

2.99

12.73

1.5

1.4

173.05

98.24

mu/l

0.42

171

Diseases of inner ear

460

3088

1.45

12.72

1.4

49.12

58.05

mu/l

0.60

414

2726

Focal epilepsy

186

1043

1.80

12.71

1.5

64.06

67.36

mu/l

0.09

170

924

Behavioural syndromes associated with physiological disturbances and physical factors

798

4272

1.33

12.61

1.5

1.6

67.65

64.46

mu/l

0.16

716

3829

Mouth breathing

351

2315

1.52

12.56

1.5

49.29

71.22

mu/l

1.94

317

2059

Implicit fungal Sepsis

254

2.68

12.49

1.4

82.01

39.54

mu/l

0.87

223

Malignant neoplasm, wide definition for exclusion

761

3336

1.34

12.47

1.6

1.5

56.67

67.69

mu/l

0.67

687

2998

Type 1 diabetes, strict definition

306

2.51

12.43

2.5

1.7

56.12

65.02

mu/l

0.27

281

Other external causes of accidental injury

724

2679

1.36

12.43

1.5

1.6

78.15

65.47

mu/l

0.40

647

2415

Allergic asthma (mode)

193

1078

1.76

12.39

1.5

1.6

85.42

58.73

mu/l

0.84

171

987

Other specified/unspecified arthritis

235

1419

1.67

12.33

1.4

1.5

74.46

61.14

mu/l

0.40

206

1264

Other diseases of blood and blood-forming organs

285

2.57

12.32

1.6

1.4

89.15

56.64

mu/l

0.55

253

Pruritus

104

485

2.17

12.22

1.5

44.82

47.47

mu/l

0.10

432

Extreme obesity with alveolar hypoventilation

159

3.15

12.16

1.2

1.3

123.54

62.80

mu/l

0.60

143

Intestinal malabsorption

180

3.00

12.15

1.6

1.4

36.50

39.87

mu/l

0.15

160

Cardiodefibrillation

286

1815

1.58

12.14

1.3

1.4

71.84

60.52

mu/l

0.41

251

1601

Type 1 diabetes, strict definition, subgroup 1

286

2.54

12.14

2.5

1.7

56.01

67.95

mu/l

0.37

262

Psychotic depression

224

2.76

12.09

2.0

1.6

28.86

45.09

mu/l

0.95

204

Other disorders of ear

790

3922

1.32

12.00

1.5

60.31

66.97

mu/l

0.40

688

3515

Other diseases of blood and blood-forming organs, wide

198

1152

1.73

11.97

1.7

1.4

74.80

70.02

mu/l

0.08

176

1029

Other diseases of upper respiratory tract

943

3797

1.30

11.97

1.5

1.6

67.31

63.85

mu/l

0.19

832

3416

Other abnormal findings of blood chemistry

171

3.04

11.96

1.1

1.4

130.00

52.02

mu/l

0.62

156

Dialysis

135

3.33

11.96

1.6

1.3

47.09

58.78

mu/l

0.28

123

Conjunctivitis

647

4003

1.35

11.94

1.7

1.6

70.79

60.12

mu/l

0.46

579

3589

Venous thromboembolism

438

2949

1.44

11.87

1.5

1.4

60.63

58.51

mu/l

0.09

395

2595

Diseases of salivary glands

281

1794

1.58

11.77

1.7

1.5

62.57

60.60

mu/l

0.06

243

1595

Other disorders of bladder

109

527

2.09

11.69

1.6

1.4

66.36

57.50

mu/l

0.18

470

Thiazolidinediones

101

475

2.15

11.64

1.3

1.4

128.05

47.78

mu/l

1.86

410

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

154

813

1.85

11.64

1.4

1.6

88.20

73.49

mu/l

0.20

137

733

Collagenous colitis

399

2.26

11.56

1.5

1.4

53.57

63.87

mu/l

0.16

352

Intracerebral haemorrhage

103

489

2.13

11.56

1.3

1.4

55.78

51.61

mu/l

0.08

428

469

3001

1.42

11.56

1.4

1.5

79.86

67.76

mu/l

0.32

410

2691

Nonorganic sleeping disorders, excluding more controls

160

884

1.82

11.55

1.5

1.6

66.96

70.56

mu/l

0.07

142

807

Other bacterial intestinal infections

192

1119

1.73

11.54

1.8

1.4

87.39

70.62

mu/l

0.33

166

993

Glomerulonephritis

425

2.22

11.53

1.2

1.4

98.47

53.52

mu/l

0.93

375

Pre-eclampsia or poor fetal growth

253

1578

1.61

11.52

1.8

1.7

55.47

53.28

mu/l

0.06

224

1436

Thyrotoxicosis

222

1346

1.66

11.52

2.0

1.4

60.83

54.53

mu/l

0.27

190

1197

COPD, hospital admissions

352

1994

1.50

11.50

1.2

1.4

80.79

60.46

mu/l

1.05

304

1754

Polyuria

182

1047

1.75

11.47

1.7

1.4

45.19

58.52

mu/l

0.88

160

926

Monoamine oxidase A inhibitors

112

552

2.05

11.41

1.5

1.4

64.39

59.95

mu/l

0.08

497

Noninfectious colitis NAS

121

613

1.99

11.41

1.7

1.5

71.11

71.87

mu/l

0.01

111

541

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

146

762

1.87

11.39

1.4

1.6

91.67

71.42

mu/l

0.27

130

688

COPD, early/later onset

354

2007

1.49

11.35

1.2

1.4

80.45

60.63

mu/l

1.02

306

1764

Sleep disorders

757

4167

1.32

11.33

1.5

1.6

68.56

64.16

mu/l

0.22

680

3734

Focal epilepsy, strict definition

169

955

1.78

11.33

1.6

1.5

65.78

68.22

mu/l

0.06

156

844

Pulmonary heart disease, diseases of pulmonary circulation

256

1614

1.60

11.32

1.6

1.4

56.53

57.97

mu/l

0.05

231

1430

Personality disorders

231

1422

1.63

11.29

1.6

61.14

59.15

mu/l

0.06

205

1296

Non-allergic asthma (mode), excluding more controls

153

833

1.83

11.22

1.5

45.35

62.65

mu/l

1.00

137

746

L04AD Calcineurin inhibitors

105

509

2.09

11.21

1.8

1.5

108.21

73.72

mu/l

0.38

466

Candidiasis

245

1533

1.61

11.21

1.9

1.5

63.66

56.33

mu/l

0.17

212

1365

Missing teeth due to accident, extraction or parodontitis

495

3356

1.40

11.20

1.6

1.4

68.59

56.00

mu/l

0.65

418

2988

Necrosis of pulp, including avohilmo

489

3508

1.40

11.17

1.6

52.38

70.59

mu/l

2.19

438

3153

490

3097

1.40

11.15

1.4

1.5

86.59

67.01

mu/l

0.59

430

2779

Benign paroxysmal vertigo

251

1582

1.60

11.15

1.5

1.4

46.19

57.14

mu/l

0.43

222

1407

External causes of morbidity and mortality

568

2060

1.39

11.14

1.5

1.6

77.22

61.25

mu/l

0.40

503

1858

Type1 diabetes, definitions combined, early onset

268

2.52

11.14

3.2

1.8

57.68

74.74

mu/l

0.53

241

Other acute lower respiratory infections

418

2787

1.43

11.11

1.4

1.5

63.88

66.09

mu/l

0.08

369

2489

Vitamin B12 deficiency anaemia

425

2.19

11.10

2.0

1.4

112.56

48.72

mu/l

0.85

378

Pulmonary embolism

238

1482

1.62

11.10

1.6

1.4

57.05

59.45

mu/l

0.07

215

1315

Viral hepatitis, IBD co-morbidity

131

3.24

11.09

1.4

1.7

101.85

65.17

mu/l

0.32

117

Mental and behavioural disorders due to alcohol

411

2758

1.44

11.08

1.4

1.5

73.40

70.62

mu/l

0.06

354

2480

Sequelae of cerebrovascular disease

274

1514

1.57

11.08

1.3

1.4

81.06

52.49

mu/l

1.34

241

1333

Thoracic aortic aneurysm

123

634

1.96

11.06

1.4

38.19

58.85

mu/l

1.16

112

561

Pulmonary heart disease

238

1484

1.61

11.04

1.6

1.4

57.05

59.45

mu/l

0.07

215

1317

Nontoxic goitre/thyroid nodule

255

1618

1.59

11.02

1.4

49.19

57.08

mu/l

0.42

228

1427

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

205

2.51

11.01

1.3

1.5

50.81

58.17

mu/l

0.15

181

Benign neoplasm of meninges

473

2.12

11.00

1.7

1.4

45.07

40.62

mu/l

0.09

415

Focal epilepsy, mode (most common among epilepsy diagnosis)

160

899

1.79

10.95

1.5

66.42

68.23

mu/l

0.04

146

792

Gout, unspecified

165

936

1.78

10.95

1.3

1.4

97.27

58.66

mu/l

1.16

136

820

Intracranial injury

473

3208

1.40

10.93

1.5

67.86

62.06

mu/l

0.23

426

2863

Cerebral palsy and other paralytic syndromes

475

2.11

10.86

1.5

1.4

82.19

58.23

mu/l

0.37

420

Cluster headache, wide

118

3.36

10.85

1.4

1.5

36.37

44.82

mu/l

0.27

101

Faecal incontinence

385

2.23

10.80

1.5

1.4

44.17

50.99

mu/l

0.11

342

Thyrotoxicosis, other and/or unspecified

168

962

1.76

10.80

1.9

1.4

51.28

55.38

mu/l

0.19

147

858

AV-block

135

629

1.89

10.80

1.3

1.5

70.32

48.44

mu/l

0.93

113

557

Congenital malformations of the urinary system

215

2.69

10.79

1.4

1.5

50.60

88.42

mu/l

0.39

194

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

217

1325

1.64

10.78

1.6

103.58

60.35

mu/l

0.76

189

1210

Abnormal findings on examination of urine, without diagnosis

160

2.99

10.77

1.9

1.3

60.35

45.03

mu/l

0.49

142

Gingivitis and periodontal diseases

873

3496

1.29

10.76

1.4

1.6

59.18

62.94

mu/l

0.27

772

3128

Other bacterial intestinal infections

150

832

1.82

10.74

1.8

1.4

96.13

72.63

mu/l

0.38

130

738

Congenital malformations of the urinary system

233

2.61

10.72

1.4

1.5

49.28

85.81

mu/l

0.41

208

Malignant neoplasm

725

3261

1.32

10.69

1.7

1.5

54.88

67.06

mu/l

0.85

650

2929

Malignant neoplasm of thyroid gland, including Hilmo

330

2.34

10.69

1.9

1.4

40.32

50.31

mu/l

0.37

295

Kidney transplant status

188

2.81

10.68

1.5

1.4

69.38

63.73

mu/l

0.07

170

Other congenital malformations

110

552

2.01

10.67

1.7

1.5

68.68

73.34

mu/l

0.08

103

492

Other diseases of stomach and duodenum

264

2.50

10.60

1.6

1.3

52.14

46.74

mu/l

0.14

236

Subjective visual disturbances

219

1355

1.63

10.54

1.6

1.5

55.83

57.67

mu/l

0.05

197

1201

Ventral hernia

202

1225

1.66

10.52

1.4

111.27

56.77

mu/l

1.38

181

1092

Abnormalities of gait and mobility

104

515

2.04

10.50

1.4

75.47

58.54

mu/l

0.32

451

Cardiac murmurs and other cardiac sounds

328

2.31

10.50

1.3

1.5

53.29

80.15

mu/l

0.37

287

Symptoms and signs involving speech and voice

279

1827

1.54

10.50

1.5

1.4

43.86

57.57

mu/l

1.07

240

1619

Fungal Sepsis

126

3.23

10.45

1.4

1.3

71.08

40.77

mu/l

0.68

109

Alcohol use disorder, Swedish definition

440

2879

1.41

10.45

1.4

1.5

79.18

69.22

mu/l

0.24

386

2578

Conjunctivitis (acute, non atopic)

236

1484

1.59

10.44

1.7

1.5

87.38

65.61

mu/l

0.38

214

1339

Other sleep disorders

423

2.15

10.42

1.6

1.5

59.37

54.64

mu/l

0.13

370

Injuries to the abdomen, lower back, lumbar spine and pelvis

318

2120

1.49

10.39

1.4

1.5

95.38

58.89

mu/l

0.97

279

1885

Unstable angina pectoris

280

1439

1.54

10.39

1.3

1.4

99.15

55.59

mu/l

1.10

246

1261

Hypercalcemia

180

2.83

10.39

3.2

1.3

76.34

40.76

mu/l

0.45

159

Any event in cancer register

779

3538

1.30

10.35

1.7

1.5

59.60

66.04

mu/l

0.33

699

3186

Peripheral arterial reconstruction

131

706

1.87

10.31

1.2

1.4

128.52

51.25

mu/l

2.65

112

618

Postmenopausal osteoporosis with pathological fracture

287

2.41

10.23

1.8

1.3

60.74

37.25

mu/l

0.51

250

Hyperkinetic disorders, excluding more controls

394

2.15

10.22

1.7

1.9

59.01

66.44

mu/l

0.19

367

Contact with and exposure to communicable diseases

245

1564

1.57

10.13

1.6

1.8

59.18

65.83

mu/l

0.23

225

1435

Specific personality disorders

195

1184

1.66

10.12

1.5

1.7

62.79

59.23

mu/l

0.10

173

1084

Injuries to the head

935

4554

1.27

10.11

1.5

1.6

78.99

62.60

mu/l

0.73

837

4086

Insomnia

733

4119

1.30

10.10

1.4

1.6

67.04

61.69

mu/l

0.29

662

3692

Personal history of other diseases and conditions

100

494

2.03

10.05

1.7

1.6

96.71

65.71

mu/l

0.36

446

Mycoses

709

4754

1.30

10.04

1.7

1.6

73.43

63.39

mu/l

0.39

615

4281

Other diseases of anus and rectum

228

1438

1.59

10.04

1.4

63.15

62.90

mu/l

0.01

198

1269

Oxicams

195

657

1.70

9.97

1.4

1.6

48.05

53.10

mu/l

0.21

176

583

Early onset COPD

191

1159

1.66

9.97

1.2

1.4

84.15

62.19

mu/l

0.66

168

1025

Accidents

702

2679

1.32

9.92

1.5

1.6

80.86

65.47

mu/l

0.49

626

2415

Agoraphobia

100

3.46

9.90

1.5

1.6

177.70

54.14

mu/l

0.49

Hernia of abdominal wall

371

2603

1.43

9.88

1.3

1.5

87.11

61.22

mu/l

1.04

331

2311

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

153

775

1.77

9.88

1.7

1.9

58.72

76.94

mu/l

0.54

138

706

Non-allergic asthma (mode)

153

867

1.76

9.88

1.5

45.35

61.04

mu/l

0.92

137

777

Gastroduodenal ulcer

196

1198

1.64

9.81

1.4

1.3

72.70

68.76

mu/l

0.08

170

1052

Persistent mood disorders

160

930

1.73

9.80

1.5

1.4

74.83

64.79

mu/l

0.18

140

837

Carbimazole or st.post thyroidectomy, condition for graves disease

184

1113

1.67

9.73

1.9

1.5

55.07

54.44

mu/l

0.02

155

996

Blepharochalasis

243

1573

1.55

9.69

1.3

1.4

47.44

60.04

mu/l

0.66

215

1394

Hypermobility syndrome

204

2.64

9.68

2.2

1.7

29.47

45.77

mu/l

0.99

189

Injuries to the ankle and foot

585

3928

1.33

9.67

1.5

1.6

69.14

65.18

mu/l

0.19

510

3544

Disorders of adult personality and behaviour

236

1519

1.56

9.64

1.5

1.6

64.90

59.51

mu/l

0.16

212

1381

Implicit fungal Sepsis

117

3.22

9.63

1.4

1.2

67.68

42.59

mu/l

0.50

101

Liquid cancers, helper endpoint

296

1737

1.49

9.63

1.3

1.4

71.62

64.75

mu/l

0.19

260

1547

Other and unspecified tonsillitis

269

1491

1.52

9.59

1.8

1.7

69.69

72.70

mu/l

0.10

247

1354

Mental and behavioural disorders due to alcohol, excluding acute intoxication

354

2466

1.43

9.55

1.4

1.5

62.81

73.25

mu/l

0.25

304

2200

Factors influencing health status and contact with health services

228

710

1.62

9.54

1.4

1.6

47.07

71.71

mu/l

0.89

203

648

conjunctival haemorrhage

328

2.26

9.52

2.0

1.4

100.72

52.12

mu/l

0.59

291

Dermatographic urticaria

278

2.37

9.51

1.6

35.78

48.43

mu/l

0.53

256

Mycoses

219

1391

1.58

9.50

1.9

1.4

68.54

61.07

mu/l

0.16

188

1237

Haemorrhoids and perianal venous thrombosis

241

1561

1.55

9.47

1.4

71.44

62.00

mu/l

0.35

216

1380

Nontraumatic intracranial haemmorrhage

153

887

1.74

9.47

1.3

1.4

55.03

55.25

mu/l

0.01

138

786

Cellulitis

183

1114

1.65

9.45

1.5

80.40

58.70

mu/l

0.62

155

989

Abnormal weight loss

401

2.12

9.42

1.4

66.23

51.14

mu/l

0.27

357

Need for other prophylactic measures

243

2.46

9.39

1.8

1.4

67.03

89.02

mu/l

0.22

211

Solid cancers, helper endpoint

706

3218

1.30

9.38

1.7

1.5

55.44

63.79

mu/l

0.52

632

2889

Cervicobrachial syndrome

182

1109

1.65

9.36

1.6

1.5

67.41

61.10

mu/l

0.17

163

990

Benign neoplasm of brain and other parts of central nervous system

256

2.42

9.32

1.6

1.4

39.21

53.86

mu/l

0.53

224

Other and unspecified nerve root and plexus disorders, also in other diseases

169

1013

1.68

9.28

1.3

1.5

51.75

59.37

mu/l

0.30

153

906

Retention of urine

248

1328

1.54

9.27

1.5

1.4

64.88

63.23

mu/l

0.05

212

1178

Weight loss

437

2.06

9.26

1.4

63.53

48.75

mu/l

0.28

388

COPD, hospital admission 2, with asthma infections

238

1322

1.55

9.24

1.2

1.4

80.45

61.58

mu/l

0.69

208

1161

Appendectomy

543

3914

1.33

9.23

1.5

1.6

51.78

66.52

mu/l

1.22

494

3504

Nephrotic syndrome

105

3.30

9.22

1.2

1.3

154.90

51.71

mu/l

0.80

Disorders of vitreous body

409

2854

1.39

9.19

1.4

55.83

56.96

mu/l

0.05

358

2525

Artificial joint operation, meniscal resection

752

3819

1.28

9.18

1.4

1.5

64.25

64.37

mu/l

0.01

685

3386

Adjustment and management of implanted device

145

836

1.75

9.18

1.4

1.3

67.93

55.16

mu/l

0.39

133

728

Cerebral aneurysm, nonruptured

392

2.12

9.18

1.3

1.5

66.77

38.31

mu/l

0.95

350

Disorders of continuity of bone

432

2.06

9.17

1.8

1.4

82.40

47.37

mu/l

0.66

385

Other enthesopathies

241

1577

1.54

9.17

1.6

1.5

106.06

55.87

mu/l

1.15

215

1403

Smoking dependency

399

2.11

9.16

1.2

1.5

182.32

56.27

mu/l

0.99

363

Viral pneumonia

111

591

1.89

9.14

1.3

1.4

94.89

68.96

mu/l

0.40

521

Other disorders of nervous system

277

2.34

9.13

1.4

72.13

53.32

mu/l

0.47

248

Bacterial intestinal infections, IBD co-morbidities

147

853

1.74

9.10

1.8

1.4

98.30

69.43

mu/l

0.48

126

758

Other arthrosis

431

2162

1.39

9.09

1.5

69.41

63.17

mu/l

0.25

389

1946

DVT of lower extremities and pulmonary embolism

321

2220

1.45

9.07

1.6

1.4

63.45

58.14

mu/l

0.19

290

1953

Inflammatory diseases of female pelvic organs

503

2750

1.35

9.06

1.6

44.94

53.44

mu/l

0.78

439

2481

Pacemaker

237

1483

1.54

9.05

1.3

1.4

62.69

53.75

mu/l

0.41

209

1297

Mental and behavioural disorders due to tobacco

401

2.09

9.04

1.2

1.5

182.32

56.05

mu/l

0.99

364

Periapical abscess

374

2675

1.40

8.98

1.5

60.91

66.19

mu/l

0.27

339

2382

Disorders of vitreous body and globe

415

2898

1.38

8.98

1.4

56.08

56.78

mu/l

0.03

364

2563

Later onset COPD, excluding more controls

160

730

1.70

8.92

1.2

1.4

76.79

61.20

mu/l

0.48

135

644

Other diseases of pleura

336

2064

1.43

8.89

1.4

90.43

66.09

mu/l

0.92

297

1808

Meniscus derangement

455

2247

1.37

8.87

1.5

52.56

68.29

mu/l

1.01

406

2030

Acute bronchitis

314

2138

1.45

8.86

1.4

1.5

65.48

60.07

mu/l

0.20

281

1908

Budesonide

118

648

1.84

8.83

1.6

1.5

54.37

55.55

mu/l

0.03

105

575

Extrapyramidal and movement disorders

294

2020

1.46

8.83

1.4

57.60

60.41

mu/l

0.11

259

1784

Other/unspecified disorders of vestibular function

151

2.83

8.79

1.5

1.4

48.09

52.41

mu/l

0.06

136

Other shoulder lesions

412

2.06

8.79

1.7

1.5

40.18

39.73

mu/l

0.02

371

Invasive ventilation

283

2.29

8.70

1.7

1.4

66.34

63.70

mu/l

0.06

243

Malignant neoplasm of thyroid gland

296

2.26

8.69

2.0

1.4

38.72

47.65

mu/l

0.30

263

Mental and behavioural disorders due to sedatives or hypnotics

277

2.30

8.68

1.1

1.5

48.36

51.72

mu/l

0.09

247

Disease of hard tissues of teeth, NOS

475

1830

1.36

8.61

1.6

1.5

65.44

65.20

mu/l

0.01

423

1642

Other cataract

348

1862

1.42

8.61

1.4

54.42

62.08

mu/l

0.45

299

1665

Diseases of the myoneural junction and muscle

106

568

1.88

8.60

1.6

1.4

53.18

57.16

mu/l

0.09

502

Other diseases of intestine

118

654

1.82

8.59

1.4

66.95

64.30

mu/l

0.06

109

586

Disorders of psychological development

447

1.96

8.56

1.6

1.7

58.01

87.85

mu/l

0.62

404

Artrosis, including avohilmo

685

2916

1.29

8.54

1.5

1.6

66.67

67.35

mu/l

0.03

621

2617

Diseases of pulp and periapical tissues and dental caries

533

2052

1.33

8.42

1.5

54.19

72.80

mu/l

1.13

467

1836

Other necrotizing vasculopathies (FG)

225

2.43

8.41

1.4

1.3

192.64

43.65

mu/l

0.76

199

Other disorders of white blood cells

213

2.48

8.41

1.6

1.3

42.07

40.53

mu/l

0.04

189

Radiculopathy

129

739

1.76

8.40

1.4

60.04

61.70

mu/l

0.04

119

649

Other symptoms and signs involving the circulatory and respiratory systems

225

2.43

8.40

1.2

1.4

94.07

90.18

mu/l

0.02

194

Other gastritis (incl. Duodenitis)

178

1113

1.61

8.32

1.5

1.4

95.91

57.72

mu/l

0.85

156

981

Anaemia in chronic diseases classified elsewhere

3.59

8.30

1.2

94.16

53.77

mu/l

0.38

Special screening examination for other diseases and disorders

455

1.97

8.29

1.7

1.5

86.77

64.95

mu/l

0.35

403

Thyrotoxicosis with diffuse goitre

114

633

1.82

8.26

2.6

1.4

47.60

47.87

mu/l

0.01

563

Voice disturbances

219

1439

1.53

8.24

1.5

42.44

58.26

mu/l

1.03

188

1285

Cardiomyopathy

129

744

1.75

8.21

1.3

1.5

66.06

55.28

mu/l

0.27

117

669

Pain and other conditions associated with female genital organs and menstrual cycle

154

854

1.67

8.19

1.6

38.90

54.72

mu/l

1.11

133

777

Pre-eclampsia or eclampsia

177

1110

1.61

8.19

1.7

1.6

65.11

51.40

mu/l

0.30

157

1003

Otalgia

330

2.15

8.16

1.3

1.6

40.53

69.38

mu/l

0.47

295

Cluster headache, strict

108

3.10

8.15

1.5

1.4

37.58

47.58

mu/l

0.28

Supplementary factors related to causes of morbidity and mortality classified elsewhere

252

1709

1.48

8.14

1.5

62.39

60.77

mu/l

0.05

221

1529

Heartburn

473

1.94

8.11

1.2

1.4

59.12

82.56

mu/l

0.44

418

Abnormal serum enzyme levels

220

1414

1.52

8.10

1.5

1.4

73.92

62.81

mu/l

0.36

201

1244

Cluster headache, wide,, including avohilmo

205

2.47

8.08

1.3

1.5

51.93

44.29

mu/l

0.18

183

Other complications of surgical and medical care, not elsewhere classified

440

1.97

8.04

1.5

118.33

68.38

mu/l

0.64

390

Urolithiasis

245

1657

1.49

8.03

1.5

1.4

73.89

65.43

mu/l

0.29

223

1458

Spontaneous rupture of synovium and tendon

359

2.08

8.02

1.3

1.4

90.45

33.61

mu/l

1.25

318

Benign neoplasm: Pancreas

3.20

8.01

2.4

1.3

40.80

40.91

mu/l

0.00

Transplanted organ and tissue status

441

1.97

7.99

1.4

1.5

110.04

48.19

mu/l

0.78

399

KRA_PSY_EATING, excluding more controls

267

2.25

7.94

2.0

1.8

78.86

82.19

mu/l

0.03

244

Other disorders of conjunctiva

118

671

1.77

7.93

2.0

1.4

82.48

58.03

mu/l

0.43

110

595

Caries of dentine, including avohilmo

640

2543

1.29

7.92

1.5

62.21

68.99

mu/l

0.32

558

2289

Cholecystitis

107

591

1.82

7.91

1.6

1.4

73.24

53.16

mu/l

0.82

102

514

Dissociative [conversion] disorders

132

2.84

7.88

1.6

35.90

50.16

mu/l

0.55

123

Use of pramipexole

179

1138

1.58

7.84

1.4

65.10

57.03

mu/l

0.20

156

1013

Other necrotizing vasculopathies

290

2.20

7.82

1.4

1.3

169.54

44.16

mu/l

0.76

261

Trochanteric bursitis

117

667

1.77

7.79

1.5

51.19

49.47

mu/l

0.05

104

595

Melanocytic naevi

239

1620

1.48

7.77

1.5

33.94

59.17

mu/l

5.24

214

1454

Alcohol use disorder, ICD-based

321

2297

1.40

7.77

1.3

1.5

64.01

73.91

mu/l

0.21

274

2050

Atopic dermatitis, strict definition with reimbursement

231

1500

1.49

7.75

1.6

1.7

83.34

62.36

mu/l

0.56

211

1364

L04AA Selective immunosuppressants

187

1205

1.56

7.73

1.6

1.5

67.87

60.46

mu/l

0.15

170

1076

Other extrapyramidal and movement disorders in other diseases

189

1221

1.56

7.72

1.5

1.4

70.70

58.57

mu/l

0.41

172

1085

Idiopathic gout

385

2.02

7.71

1.1

1.4

94.45

73.58

mu/l

0.28

341

Enlarged lymph nodes

118

677

1.75

7.68

1.7

1.4

57.79

78.47

mu/l

0.45

108

614

Gonarthrosis, primary, with knee surgery

444

2655

1.34

7.67

1.3

1.4

75.02

56.90

mu/l

1.06

410

2337

Aortic valve malfunction, age under 60 years

434

1.96

7.67

1.3

1.4

139.63

56.00

mu/l

0.95

398

Chronic sinusitis

343

2488

1.38

7.62

1.6

1.5

69.98

63.17

mu/l

0.25

295

2225

Other disorders of eye and adnexa

115

657

1.76

7.62

1.6

1.5

109.72

51.66

mu/l

1.11

104

580

Triptan medication for migraine, min. 3 purchases

455

2619

1.33

7.59

1.7

53.02

60.03

mu/l

0.48

418

2368

Left ventricular outflow tract obstruction (LVOTO), broad definition

464

1.92

7.56

1.3

1.4

135.80

73.73

mu/l

0.61

425

Primary gonarthrosis, bilateral

393

2492

1.36

7.56

1.3

1.4

79.57

57.25

mu/l

1.21

366

2196

Type of accident

233

1581

1.48

7.55

1.5

62.65

60.43

mu/l

0.06

205

1414

Aneurysms, operations, SAH

130

771

1.70

7.53

1.3

1.4

61.10

54.53

mu/l

0.20

119

690

Other diseases of the digestive system

231

1565

1.48

7.53

1.2

1.4

50.31

67.27

mu/l

0.72

201

1380

Other problems related to primary support group, including family circumstances

479

1.88

7.51

1.9

1.7

67.35

75.94

mu/l

0.11

435

Autoimmune hyperthyroidism

231

2.32

7.50

2.5

1.3

59.23

38.33

mu/l

0.88

209

Polyarthrosis

166

971

1.60

7.49

1.5

1.4

50.37

56.53

mu/l

0.17

153

865

Diseases of oral cavity, salivary glands and jaws

478

1853

1.33

7.49

1.4

1.5

55.98

70.30

mu/l

0.70

418

1664

Tinnitus

190

1238

1.54

7.49

1.5

97.01

58.44

mu/l

1.02

168

1113

Pre-eclampsia

161

1010

1.60

7.48

1.7

67.91

52.43

mu/l

0.32

144

916

Benign neoplasm: Colon, unspecified

198

1302

1.53

7.48

1.4

64.26

57.97

mu/l

0.19

171

1152

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

294

2078

1.41

7.45

1.6

1.7

55.88

55.32

mu/l

0.02

252

1891

Sequelae of injuries, of poisoning and of other consequences of external causes

190

1240

1.54

7.43

1.4

1.5

59.44

62.91

mu/l

0.10

172

1112

Other pleural conditions

425

1.95

7.42

1.6

1.4

88.68

63.63

mu/l

0.48

377

Nonorganic sleeping disorders

160

1005

1.60

7.40

1.5

1.6

66.96

66.44

mu/l

0.01

142

900

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

196

2.43

7.37

1.4

92.35

53.64

mu/l

0.42

174

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

209

1378

1.51

7.35

1.9

1.7

60.49

63.58

mu/l

0.09

185

1258

Dislocation, sprain and strain of joints and ligaments at neck level

119

694

1.73

7.34

1.7

1.6

55.23

49.84

mu/l

0.12

103

622

Sulfonylureas

227

1219

1.49

7.32

1.3

1.4

93.79

52.35

mu/l

1.59

191

1065

Obsessive-compulsive disorder

240

2.27

7.31

1.8

1.6

105.63

56.33

mu/l

0.56

216

Ptosis of eyelid

513

1.85

7.28

1.5

1.4

66.97

58.57

mu/l

0.16

454

Sarcoidosis

113

652

1.75

7.26

1.7

1.5

101.01

50.13

mu/l

0.75

579

Bipolar affective disorders

145

894

1.63

7.24

1.5

1.6

64.50

58.40

mu/l

0.19

127

816

Diseases of male genital organs

383

1416

1.37

7.21

1.6

1.5

77.00

84.74

mu/l

0.25

343

1275

Iron deficiency anaemia secondary to blood loss (chronic)

119

699

1.71

7.16

1.4

63.02

67.20

mu/l

0.07

100

624

Postprocedural disorders of nervous system

301

2.12

7.15

1.8

1.5

38.46

49.76

mu/l

0.45

270

Temporomandibular joint disorders, including avohilmo

345

2498

1.37

7.15

2.1

1.6

56.22

57.75

mu/l

0.06

307

2260

Speech therapy

210

1417

1.49

7.04

1.4

50.94

56.36

mu/l

0.18

195

1261

Speech and linguistic disorders, excluding more controls

278

2.11

7.00

1.5

1.6

47.39

101.82

mu/l

0.94

258

Disorders of sclera, cornea, iris and ciliary body

433

3302

1.32

6.99

1.8

1.5

52.13

65.26

mu/l

1.50

394

2931

Transport accidents

365

2329

1.35

6.98

1.6

75.98

64.93

mu/l

0.27

332

2098

Enterocolitis due to Clostridium difficile

442

1.89

6.95

1.6

1.4

85.28

76.05

mu/l

0.10

387

Sequelae of other external causes

227

2.27

6.92

1.4

81.27

54.07

mu/l

0.31

200

Leiomyoma of uterus

507

2218

1.30

6.87

1.5

52.40

52.93

mu/l

0.02

461

1977

Diplopia

106

611

1.75

6.86

1.9

1.4

73.71

53.38

mu/l

0.44

539

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

437

3250

1.31

6.85

1.6

58.57

55.99

mu/l

0.13

386

2923

Candidiasis

107

619

1.74

6.83

2.3

1.5

81.53

50.95

mu/l

0.41

546

Other and unspecified urticaria

156

994

1.58

6.83

1.8

1.6

36.88

55.78

mu/l

2.18

142

892

Dislocation, sprain and strain of joints and ligaments of knee

482

3444

1.29

6.80

1.4

1.6

78.08

68.87

mu/l

0.40

438

3104

Benign neoplasm: Cerebral meninges

446

1.88

6.79

1.6

1.4

48.31

32.58

mu/l

0.36

393

Other benign neoplasms of skin

284

2042

1.40

6.76

1.5

1.4

57.35

57.45

mu/l

0.00

253

1802

Other diseases of hard tissues of teeth

468

1852

1.31

6.67

1.5

61.27

70.34

mu/l

0.37

406

1663

GI-bleeding

226

1564

1.45

6.66

1.2

1.4

52.42

69.87

mu/l

0.71

193

1382

Cluster headache, strict, including avohilmo

187

2.38

6.64

1.3

1.5

54.95

46.32

mu/l

0.18

168

Benign neoplasm: Caecum

500

1.82

6.63

1.5

1.4

85.31

59.79

mu/l

0.39

443

Emotionally unstable personality disorder

514

1.80

6.63

1.4

1.7

84.42

53.05

mu/l

0.60

469

Chronic laryngitis and laryngotracheitis

113

670

1.70

6.62

1.6

1.4

69.90

62.34

mu/l

0.17

598

Other noninflammatory disorders of uterus, except cervix

172

750

1.55

6.62

1.3

1.4

61.21

51.23

mu/l

0.33

150

658

Calcific aortic valvular stenosis, operated

197

1288

1.49

6.61

1.2

1.4

90.69

54.44

mu/l

0.99

180

1124

Calcific aortic valvular stenosis

197

1288

1.49

6.61

1.2

1.4

90.69

54.44

mu/l

0.99

180

1124

Fissure and fistula of anal and rectal regions

180

1193

1.52

6.61

1.5

94.44

68.44

mu/l

0.64

161

1062

Benign neoplasm: Rectum

142

894

1.60

6.57

1.3

1.4

41.32

61.15

mu/l

1.24

128

796

Other inflammation of eyelid

106

619

1.73

6.57

1.5

71.51

54.79

mu/l

0.47

548

Other and unspecified myopathies

347

1.98

6.49

1.3

1.4

56.80

66.27

mu/l

0.16

303

Allergic conjunctivitis

456

3446

1.29

6.49

1.6

62.26

55.90

mu/l

0.35

402

3106

Restless leg syndrome

105

614

1.72

6.48

1.4

1.5

83.54

46.78

mu/l

0.93

538

Inflammatory disease of uterus

113

674

1.69

6.48

1.6

1.7

35.74

52.07

mu/l

1.29

603

Benign neoplasm: Rectum, anus and anal canal

157

1015

1.56

6.48

1.4

41.08

57.66

mu/l

1.09

143

902

All influenza (not pneumonia)

113

674

1.69

6.47

1.6

1.5

100.27

57.55

mu/l

0.98

104

604

Other postsurgical states

273

2.11

6.47

1.5

108.68

84.55

mu/l

0.15

244

Coxibs

206

726

1.50

6.46

1.5

1.6

74.21

52.18

mu/l

0.60

178

651

Osteomyelitis

247

2.17

6.45

1.5

1.4

64.12

54.53

mu/l

0.23

212

Visual impairment including blindness (binocular or monocular)

247

2.17

6.45

1.5

1.3

44.20

55.78

mu/l

0.32

214

Calculus of kidney and ureter

221

1534

1.45

6.44

1.5

1.4

78.58

65.58

mu/l

0.44

201

1350

Misadventures to patients during surgical and medical care

114

683

1.68

6.44

1.5

1.4

67.97

58.61

mu/l

0.34

100

609

Migraine, single triptan purchase ok & required. ICD-code if available is included

632

3436

1.25

6.43

1.6

51.51

64.03

mu/l

1.38

582

3075

Triptan medication for migraine, single purchase ok

632

3436

1.25

6.43

1.6

51.51

64.03

mu/l

1.38

582

3075

Endometriosis

257

1060

1.43

6.40

1.6

1.5

46.45

53.09

mu/l

0.34

233

951

Disturbance of activity and attention

445

1.84

6.39

1.7

1.8

59.91

70.07

mu/l

0.27

403

Other diseases of lip and oral mucosa

317

2345

1.36

6.36

1.7

1.5

51.74

60.91

mu/l

0.54

273

2088

Hyperkinetic disorders

488

1.80

6.35

1.7

58.52

68.25

mu/l

0.28

443

Viral infections of the central nervous system

323

2.00

6.32

1.6

1.4

31.11

73.87

mu/l

0.79

283

Myeloproliferative diseases

358

1.95

6.30

1.3

1.4

65.87

52.28

mu/l

0.17

316

Conductive and sensorineural hearing loss

616

3336

1.25

6.29

1.4

1.5

46.60

65.62

mu/l

2.44

538

2972

Gastric ulcer

129

803

1.62

6.27

1.4

1.3

93.22

51.50

mu/l

1.14

113

709

Operations 2 for CAVS

195

1287

1.48

6.27

1.2

1.4

91.31

54.44

mu/l

1.00

178

1124

Calcific aortic valvular stenosis, diagnosis (helper)

195

1287

1.48

6.27

1.2

1.4

91.31

54.44

mu/l

1.00

178

1124

Acute pancreatitis

145

929

1.57

6.24

1.4

65.82

60.86

mu/l

0.12

132

822

Isolated proteinuria

2.91

6.24

1.4

1.3

63.12

41.98

mu/l

0.54

Other obstetric conditions, not elsewhere classified

221

969

1.46

6.24

2.3

1.9

71.52

49.48

mu/l

0.84

203

892

Viral infections characterized by skin and mucous membrane lesions

683

4760

1.23

6.23

1.8

1.5

58.03

63.35

mu/l

0.31

610

4270

Calcific aortic valvular stenosis, including rheumatic fever

195

1288

1.47

6.22

1.2

1.4

91.31

54.44

mu/l

1.00

178

1124

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

215

937

1.46

6.21

2.3

1.9

70.67

50.32

mu/l

0.73

199

862

Allergic urticaria

360

1.93

6.20

1.7

1.6

79.70

45.93

mu/l

0.49

323

D07AA Corticosteroids, weak (group I)

116

705

1.65

6.17

1.3

1.6

51.99

63.45

mu/l

0.31

106

633

Disorders of muscles

446

1.83

6.16

1.3

1.5

49.80

43.80

mu/l

0.24

397

Hyperplasia of prostate

249

995

1.43

6.16

1.5

1.4

67.86

80.06

mu/l

0.38

216

887

Trigger finger

114

692

1.66

6.14

1.6

1.5

101.16

45.86

mu/l

0.53

623

Achilles tendinitis

469

1.81

6.11

1.3

1.4

105.11

56.41

mu/l

0.66

417

Exposure to other specified factors

593

4387

1.24

6.10

1.5

1.6

69.38

67.13

mu/l

0.09

532

3942

Postprocedural disorders of digestive system, not elsewhere classified

128

2.62

6.07

1.7

1.3

45.10

116.23

mu/l

0.48

115

Atopic dermatitis, strict definition

218

1495

1.43

6.07

1.6

1.7

86.18

65.57

mu/l

0.51

200

1361

Other respiratory disorders and diseases

142

912

1.57

6.06

1.3

1.4

93.95

62.86

mu/l

0.72

128

801

Other diseases of the respiratory system

142

912

1.57

6.06

1.3

1.4

93.95

62.86

mu/l

0.72

128

801

Ocular pain

356

1.93

6.06

1.6

1.5

60.86

47.46

mu/l

0.43

317

Abscess of anal and rectal regions

363

1.92

6.05

1.2

1.5

60.90

63.94

mu/l

0.06

327

Vitreous haemorrhage

443

1.82

5.99

1.6

1.4

84.05

54.51

mu/l

0.76

391

COPD, hospital admissions 3, with asthma pneumonia sepsis

181

1044

1.49

5.98

1.2

1.4

83.97

62.60

mu/l

0.61

158

916

Other medical care

336

2272

1.33

5.98

1.8

1.4

50.18

59.81

mu/l

0.84

298

2003

Injuries to the shoulder and upper arm

660

4337

1.23

5.98

1.4

1.5

61.42

64.05

mu/l

0.14

594

3873

Open wound of forearm

386

1.88

5.97

1.3

1.5

77.21

66.86

mu/l

0.11

332

Leisure time condition

139

892

1.57

5.97

1.5

50.16

54.78

mu/l

0.12

119

791

Fracture of foot, except ankle

188

1286

1.47

5.96

1.5

1.6

82.62

59.48

mu/l

0.69

162

1157

Coxarthrosis [arthrosis of hip](FG)

404

2184

1.31

5.96

1.4

61.30

60.82

mu/l

0.02

362

1936

Other and unspecified glaucoma

269

2.06

5.94

1.2

1.3

95.77

55.55

mu/l

0.56

233

Disorders of ocular muscles, binocular movement, accommodation and refraction

358

2704

1.32

5.89

1.6

50.38

65.15

mu/l

1.51

317

2441

Impotence

198

2.25

5.87

1.6

1.4

84.77

62.17

mu/l

0.29

179

Other disorders of bone

154

1015

1.53

5.87

1.6

1.5

64.87

60.04

mu/l

0.12

138

908

Melanocytic naevi of trunk

542

1.73

5.86

1.5

27.22

54.04

mu/l

2.84

481

Social phobias

332

1.94

5.86

1.9

1.7

38.48

51.94

mu/l

1.08

301

COPD-related respiratory insufficiency

483

1.77

5.85

1.3

1.4

123.50

62.35

mu/l

1.11

430

Noninflammatory disorders of female genital tract

306

1127

1.37

5.81

1.5

1.6

40.07

53.14

mu/l

1.16

271

1012

Traumatic subdural haemorrhage

449

1.78

5.81

1.3

1.5

37.39

55.51

mu/l

0.91

401

Other skin changes

138

890

1.56

5.81

1.4

44.22

57.31

mu/l

0.68

119

790

Dental caries, including avohilmo

581

2380

1.25

5.81

1.5

56.08

70.59

mu/l

0.89

510

2137

Chronic nephritic syndrome

137

2.52

5.80

1.2

1.3

83.31

45.07

mu/l

0.67

122

Rosacea

514

1.74

5.79

1.6

1.5

81.58

46.94

mu/l

0.72

456

Fibroblastic disorders

164

1099

1.50

5.77

1.3

1.5

50.40

55.28

mu/l

0.15

138

973

Injuries to the neck

170

1148

1.49

5.77

1.6

1.5

63.35

59.17

mu/l

0.10

150

1029

Other and unspecified disorders of white blood cells

156

2.41

5.74

1.6

1.4

52.83

40.41

mu/l

0.31

141

Decubitus ulcer and pressure area

226

2.15

5.74

1.1

1.3

51.46

60.24

mu/l

0.19

190

Speech and linguistic disorders

329

1.91

5.64

1.7

1.6

47.42

100.87

mu/l

1.09

297

Algoneurodystrophy

133

2.52

5.64

1.6

1.4

59.28

40.85

mu/l

0.53

121

Intestinal adhesions without obstruction

323

1.94

5.63

1.4

45.97

49.50

mu/l

0.10

286

Visual field defects

359

1.88

5.60

1.5

1.4

86.22

43.26

mu/l

0.51

316

Viral infections of the central nervous system

303

1.97

5.59

1.6

1.4

32.31

76.93

mu/l

0.76

264

Localized swelling, mass and lump of skin and subcutaneous tissue

238

1721

1.39

5.58

1.6

1.5

47.09

61.69

mu/l

0.94

214

1539

Superficial injury of lower leg

187

1296

1.45

5.57

1.6

1.5

68.04

61.69

mu/l

0.15

163

1162

Problems related to lifestyle

476

1.76

5.55

1.3

1.6

139.05

55.61

mu/l

0.58

427

Erosion of teeth , including avohilmo

189

1314

1.45

5.54

1.9

1.6

57.39

58.72

mu/l

0.05

165

1185

Hypertrophy of breast in women and men

153

1021

1.51

5.53

1.7

1.5

52.35

55.10

mu/l

0.08

137

909

Fracture of lower leg, including ankle

424

3299

1.28

5.52

1.4

1.5

56.20

65.06

mu/l

0.52

378

2940

Unspecified mental disorder

306

2304

1.33

5.51

1.4

1.6

51.87

64.81

mu/l

0.79

265

2071

Other/unspecified enthesopathies of lower limb, excluding foot

277

2.00

5.51

1.4

1.5

38.49

53.51

mu/l

0.50

244

Coeliac disease

553

1.69

5.47

1.9

1.5

55.72

48.88

mu/l

0.25

488

Benign neoplasm: Stomach

464

1.76

5.46

1.9

1.4

44.52

45.30

mu/l

0.02

403

Umbilical hernia

203

1434

1.42

5.46

1.3

1.5

84.35

63.41

mu/l

0.49

180

1270

Other abnormal immunological findings in serum

3.01

5.45

1.7

1.3

48.75

43.29

mu/l

0.08

Dentofacial anomalies [including malocclusion]

551

3580

1.24

5.44

2.0

1.6

60.14

61.38

mu/l

0.06

493

3221

Presence of cardiac and vascular implants and grafts

308

1719

1.34

5.44

1.2

1.4

70.06

62.83

mu/l

0.24

267

1533

Other local infections of skin and subcutaneous tissue

450

1.77

5.42

1.4

66.37

71.30

mu/l

0.06

400

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

217

1553

1.40

5.42

1.6

1.7

103.58

59.58

mu/l

0.78

189

1409

Other and unspecified rosacea

385

1.83

5.41

1.5

73.91

50.15

mu/l

0.51

347

Degeneration of macula and posterior pole

330

1998

1.32

5.38

1.4

44.44

58.51

mu/l

0.98

290

1759

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

444

1.77

5.38

1.5

1.4

55.53

51.87

mu/l

0.10

393

Diseases of appendix

586

4314

1.23

5.37

1.5

1.6

59.73

66.26

mu/l

0.38

525

3873

Eating disorders

414

1.80

5.37

2.4

1.7

70.27

73.75

mu/l

0.04

372

Trigeminal neuralgia

246

2.05

5.36

1.4

1.5

71.22

41.68

mu/l

0.48

222

Other diseases of biliary tract

372

1.84

5.34

1.4

59.52

46.81

mu/l

0.44

321

Appendicitis, broad definition

580

4284

1.23

5.34

1.5

1.6

59.86

66.43

mu/l

0.37

520

3845

Other disorders of optic [2nd] nerve and visual pathways

233

2.08

5.33

1.3

1.4

66.06

49.94

mu/l

0.41

206

Inflammatory diseases of the central nervous system

351

1.87

5.32

1.3

1.4

50.80

52.50

mu/l

0.05

311

Congenital malformations and deformations of the musculoskeletal system

472

1.74

5.32

1.6

48.96

80.23

mu/l

0.79

426

Crohn's disease NAS

247

2.04

5.30

1.5

28.65

45.35

mu/l

1.01

217

Dental operations

484

1973

1.26

5.29

1.5

57.20

71.22

mu/l

0.67

421

1761

Alzheimer’s disease, strict definition

860

0.53

5.28

1.1

1.3

49.26

53.96

mu/l

0.11

749

Pain associated with micturition

521

1.70

5.28

1.7

1.4

72.86

68.10

mu/l

0.06

454

Diabetes mellitus in pregnancy

227

1041

1.40

5.28

1.8

1.9

53.80

48.80

mu/l

0.15

210

952

Other and/or unspecified nontoxic goitre

374

1.83

5.26

1.4

1.3

65.40

45.22

mu/l

0.62

333

Abdominal aortic aneurysm (AAA)

300

1.93

5.25

1.3

1.4

89.23

73.37

mu/l

0.22

260

Injury of intra-abdominal organs

2.79

5.23

1.8

1.2

179.48

50.74

mu/l

0.81

Poisoning by drugs, medicaments and biological substances

178

1241

1.44

5.17

1.5

1.6

97.56

61.07

mu/l

0.53

156

1124

Hemiplegia

177

2.23

5.14

1.4

122.59

44.23

mu/l

0.61

158

Other viral diseases, not elsewhere classified

136

898

1.52

5.13

1.9

1.5

87.78

68.57

mu/l

0.36

128

806

Lichen simplex chronicus and prurigo

278

1.96

5.12

1.5

1.4

65.28

44.71

mu/l

0.32

249

Acute appendicitis

544

4146

1.23

5.12

1.5

1.6

60.12

67.14

mu/l

0.38

489

3727

Mental disorders, not otherwise specified

363

1.83

5.12

1.5

1.6

41.80

48.68

mu/l

0.31

329

Diseases of peritoneum

451

1.74

5.11

1.6

1.4

42.38

49.90

mu/l

0.31

403

Respiratory insufficiency

284

1.94

5.11

1.3

1.4

124.37

59.31

mu/l

0.84

248

Coxarthrosis

375

1924

1.29

5.11

1.4

1.5

63.09

63.44

mu/l

0.01

336

1718

Other disorders of the musculoskeletal system and connective tissue

114

728

1.58

5.08

1.4

69.14

51.52

mu/l

0.54

644

Other and unspecified local infections of skin and subcutaneous tissue

415

1.77

5.07

1.4

69.03

73.16

mu/l

0.05

367

Acute appendicitis, no complications

425

3364

1.26

5.07

1.5

1.6

67.26

68.25

mu/l

0.03

381

3035

Diagnoses used for exclusion with ILD

182

1280

1.43

5.05

1.8

1.4

83.98

62.03

mu/l

0.44

156

1141

Fracture of lumbar spine and pelvis

152

1032

1.48

5.04

1.2

1.4

78.03

52.61

mu/l

0.79

133

911

Other and unspecified disorders of vitreous body

325

2468

1.30

5.03

1.4

51.63

56.78

mu/l

0.26

287

2185

Disorders of refraction and accommodation

201

1434

1.40

5.03

1.7

1.6

62.65

69.34

mu/l

0.26

174

1299

Poor fetal growth

544

1.66

5.01

1.9

33.09

48.70

mu/l

1.48

502

Congenital malformations of the circulatory system

109

670

1.59

5.00

1.4

1.6

111.45

71.86

mu/l

0.47

603

Papillary adenocarcinoma of thyroid gland

219

2.08

5.00

1.6

1.4

40.91

46.19

mu/l

0.12

196

Diabetic retinopathy, excluding more controls

252

1037

1.37

4.99

1.6

69.96

77.28

mu/l

0.24

218

940

Emotional disorders and disorders of social functioning with onset specific to childhood

157

2.27

4.99

1.7

45.19

122.55

mu/l

0.70

139

Oter anti-inflammatory and antirheumatic agents, non-steroids

160

596

1.49

4.99

1.6

1.5

42.54

45.67

mu/l

0.15

146

527

Open wound of lower leg

111

708

1.58

4.97

1.7

1.4

65.61

57.67

mu/l

0.22

626

Follicular cysts of skin and subcutaneous tissue

137

916

1.50

4.96

1.4

1.5

53.71

62.73

mu/l

0.35

122

818

Colectomy operation

124

812

1.54

4.95

1.6

1.4

69.06

54.63

mu/l

0.41

113

720

Acetic acid derivatives and related substances

197

718

1.43

4.95

1.4

1.6

79.86

52.17

mu/l

0.83

173

643

Other and unspecified injuries of lower leg

310

1.89

4.93

1.6

1.4

61.46

50.95

mu/l

0.21

272

Second line medication for Crohn's disease

446

3583

1.25

4.88

1.6

1.5

71.50

63.87

mu/l

0.38

395

3194

Familial hypercholesterolemia, with ischemic heart disease

369

1.80

4.87

1.2

1.4

167.52

50.01

mu/l

1.51

317

Myopia

549

1.65

4.85

1.7

1.6

65.35

74.07

mu/l

0.17

496

Use of anticholinesterases

103

1262

0.64

4.80

1.2

1.4

35.70

58.22

mu/l

1.00

1103

N06DA Anticholinesterases

103

1262

0.64

4.80

1.2

1.4

35.70

58.22

mu/l

1.00

1103

Dermatophytosis

605

1.61

4.80

1.5

1.4

48.81

57.81

mu/l

0.30

538

Other viral diseases, not elsewhere classified

195

1394

1.40

4.80

1.9

1.6

75.23

64.54

mu/l

0.27

183

1255

Unspecific neurodegenerative disorder

146

1449

0.69

4.78

1.2

1.4

35.17

56.67

mu/l

1.93

119

1270

Other viral diseases

274

2061

1.32

4.78

1.8

1.6

70.22

68.83

mu/l

0.04

259

1861

Reimbursement for rheumatic diseases

438

3507

1.25

4.78

1.5

56.85

58.80

mu/l

0.09

396

3109

Alzheimer disease

1036

0.62

4.76

1.2

1.3

49.84

50.75

mu/l

0.02

899

Eating disorder

328

1.84

4.74

2.0

1.7

78.86

78.65

mu/l

0.00

297

Injury, poisoning and certain other consequences of external causes

417

1653

1.27

4.73

1.5

1.7

72.94

59.84

mu/l

0.23

369

1491

Iridocyclitis

169

1189

1.43

4.72

1.5

48.40

64.41

mu/l

1.11

153

1062

Poisoning by medicine

157

1090

1.45

4.71

1.5

1.6

100.95

61.78

mu/l

0.48

135

990

Sensorineural hearing loss

566

3162

1.22

4.71

1.4

48.74

64.80

mu/l

1.69

493

2813

Viral infections characterized by skin and mucous membrane lesions

313

2422

1.30

4.68

2.1

1.5

60.56

64.75

mu/l

0.14

286

2154

Malignant melanoma of skin

495

1.67

4.63

1.5

1.4

34.52

57.79

mu/l

1.46

439

Alkalosis

10.80

4.61

3.3

1.1

62.73

11.65

mu/l

—

Anterior Iridocyclitis

148

1021

1.46

4.61

1.6

1.5

50.30

62.11

mu/l

0.64

134

913

Lesion of ulnar nerve

101

643

1.58

4.60

1.4

1.5

66.38

59.96

mu/l

0.15

578

Thyrotoxicosis with toxic multinodular goitre

268

1.92

4.60

1.5

1.3

96.47

41.40

mu/l

0.91

240

Benign neoplasm: Descending colon

304

1.86

4.57

1.3

1.4

158.65

58.40

mu/l

0.74

267

Fenamates

112

489

1.56

4.57

1.4

1.6

44.40

49.24

mu/l

0.20

103

434

Myeloproliferative diseases (CML excluded)

319

1.83

4.55

1.3

1.4

74.25

47.88

mu/l

0.30

283

Acute pancreatitis (for exclusion)

145

1000

1.46

4.53

1.4

65.82

57.20

mu/l

0.24

132

885

Dystonia

235

1.98

4.51

1.3

1.4

55.82

45.11

mu/l

0.19

210

L04AX Other immunosuppressants

432

3494

1.24

4.49

1.6

1.5

72.15

64.17

mu/l

0.39

381

3113

Campylobacter enteritis

2.56

4.49

2.0

1.3

206.07

45.41

mu/l

0.54

COPD, hospital admissions 1, only main diagnosis

230

1466

1.35

4.48

1.2

1.4

88.11

60.84

mu/l

1.25

200

1283

Biological medication for rheuma

126

848

1.49

4.46

1.6

65.32

59.19

mu/l

0.14

118

768

Alzheimer’s disease (Late onset)

785

0.56

4.39

1.2

1.3

47.22

51.86

mu/l

0.11

679

Herpesviral [herpes simplex] infections

526

1.63

4.38

2.1

1.5

76.29

48.01

mu/l

0.41

464

Sequelae of injuries of upper limb

442

1.69

4.37

1.4

1.5

56.36

52.42

mu/l

0.08

396

Zoster [herpes zoster]

364

2854

1.26

4.35

1.6

1.4

59.87

57.12

mu/l

0.10

328

2514

Malignant melanoma

103

668

1.55

4.35

1.5

1.3

34.58

63.16

mu/l

2.19

594

Superficial injury of ankle and foot

519

1.63

4.35

1.5

1.6

90.78

55.19

mu/l

0.66

468

Postprocedural musculoskeletal disorders, not elsewhere classified

310

1.82

4.32

1.4

73.90

46.87

mu/l

0.57

278

Injuries to the wrist and hand

784

4642

1.17

4.31

1.5

1.6

59.26

64.40

mu/l

0.42

706

4160

Unspecified fall

360

2827

1.26

4.29

1.6

1.5

61.14

63.84

mu/l

0.10

313

2524

Juvenile arthritis (FINNGEN)

158

2.17

4.28

1.9

1.6

49.31

53.88

mu/l

0.13

139

Other specified/unspecified soft tissue disorders

178

2.10

4.27

1.2

1.4

20.76

32.41

mu/l

0.80

157

Dementia in Alzheimer disease

582

0.49

4.27

1.2

1.3

85.60

46.84

mu/l

0.44

505

Car occupant injured in other and unspecified transport accidents

134

922

1.46

4.26

1.6

106.40

57.20

mu/l

0.58

120

829

Benign neoplasm of middle ear and respiratory system

326

1.79

4.26

1.6

1.4

53.85

82.10

mu/l

0.38

290

Female infertility

210

937

1.37

4.24

2.1

1.6

65.44

55.33

mu/l

0.26

194

849

135

874

1.46

4.24

1.2

1.3

26.02

55.78

mu/l

3.97

118

771

Alzheimer disease, including avohilmo

117

1215

0.68

4.23

1.1

1.4

44.08

58.58

mu/l

0.53

1063

Retinal vascular disorders

531

1.61

4.23

1.4

54.83

63.41

mu/l

0.15

470

Otitis media, unspecified

424

1.66

4.21

1.7

80.78

89.04

mu/l

0.09

382

Zoster [herpes zoster]

130

892

1.46

4.20

1.8

1.4

64.77

61.31

mu/l

0.07

123

786

Malignant melanoma of skin, including Hilmo

102

666

1.54

4.20

1.4

1.3

34.33

63.50

mu/l

2.41

592

Fall on same level involving ice and snow

430

3506

1.23

4.19

1.5

54.32

57.40

mu/l

0.14

389

3116

Seronegative rheumatoid arthritis

548

1.60

4.19

1.7

1.4

77.67

55.73

mu/l

0.37

491

Schizophrenia or delusion, excluding more controls

206

1515

1.35

4.19

1.3

1.6

57.99

63.77

mu/l

0.18

177

1374

Internal derangement of knee

273

2102

1.30

4.17

1.6

1.5

69.18

64.66

mu/l

0.15

243

1891

Atopic dermatitis

430

2868

1.23

4.15

1.6

75.01

62.64

mu/l

0.54

388

2592

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

167

2.12

4.15

2.3

1.6

76.43

39.85

mu/l

1.02

154

Other infectious diseases

366

1.73

4.14

1.4

57.99

58.80

mu/l

0.02

319

Chronic ulcer of skin, not elsewhere classified

271

1.86

4.13

1.5

1.4

86.93

58.43

mu/l

0.39

233

Disorders of optic nerve and visual pathways

404

1.69

4.12

1.5

55.86

49.81

mu/l

0.18

363

Crohn disease

590

1.57

4.11

1.7

1.5

78.08

57.28

mu/l

0.37

528

Other viral diseases

209

1557

1.34

4.10

1.8

1.6

77.99

64.50

mu/l

0.39

198

1401

Redundant prepuce, phimosis and paraphimosis

140

969

1.44

4.10

1.6

1.5

120.68

83.60

mu/l

0.80

125

870

Parkinson's disease, excluding more controls

474

1.62

4.09

1.2

1.6

33.34

57.11

mu/l

1.22

424

Cramp and spasm

168

2.10

4.08

1.6

1.4

111.06

39.84

mu/l

0.39

152

Retinal vascular occlusion

521

1.60

4.06

1.4

55.43

63.64

mu/l

0.14

460

Other hearing loss

178

1271

1.37

4.06

1.5

1.4

43.29

66.18

mu/l

1.39

157

1127

Rheumatoid arthritis

230

1563

1.32

4.05

1.4

1.5

59.60

57.42

mu/l

0.07

206

1397

Malignant melanoma, including Hilmo

120

819

1.47

4.01

1.4

35.08

61.99

mu/l

2.41

106

727

Prurigo nodularis

2.46

3.99

1.2

1.3

97.87

48.35

mu/l

0.35

Hydronephrosis

469

1.63

3.99

1.8

1.5

93.38

54.60

mu/l

0.41

416

Adenomyosis (Endometriosis of uterus)

626

1.54

3.99

1.6

1.4

29.71

54.98

mu/l

2.67

552

Hypertrophy of breast

131

911

1.45

3.98

1.7

1.5

52.29

56.66

mu/l

0.12

118

818

Hypertrophic scar

204

1.98

3.97

1.7

1.5

35.31

51.33

mu/l

0.61

180

Polyp of the female genital tract

221

950

1.34

3.97

1.6

1.5

39.09

53.60

mu/l

1.11

197

847

Pleural effusion

101

667

1.52

3.96

1.4

133.93

55.68

mu/l

1.22

587

5-aminosalicylic acid

153

1095

1.40

3.95

1.6

64.63

60.82

mu/l

0.11

134

991

Preparatory care for dialysis

157

2.12

3.95

1.4

71.03

54.60

mu/l

0.17

141

Retinal detachments and breaks

245

1884

1.30

3.95

1.6

1.4

60.80

61.78

mu/l

0.03

204

1671

Complications of internal orthopaedic prosthetic devices, implants and grafts

159

1146

1.39

3.95

1.5

1.4

69.59

51.94

mu/l

0.70

136

1009

Coagulation defects, purpura and other haemorrhagic conditions

133

929

1.44

3.94

1.5

84.80

66.13

mu/l

0.29

120

823

Superficial injury of head

163

1181

1.38

3.91

1.3

1.5

55.22

53.92

mu/l

0.04

140

1058

Speech disturbances, not elsewhere classified

380

1.70

3.91

1.5

1.4

48.37

60.13

mu/l

0.37

331

Unspecified/other endometriosis

365

1.71

3.90

1.6

1.7

52.31

44.99

mu/l

0.20

333

Other and unspecified vascular occlusions

373

1.70

3.89

1.4

47.53

68.53

mu/l

0.34

330

Perforation of tympanic membrane

434

1.65

3.89

1.6

1.5

69.77

52.20

mu/l

0.38

383

Striking against or struck by other objects

235

1800

1.31

3.88

1.5

1.6

91.70

67.00

mu/l

0.74

211

1612

Alcohol dependence

184

1362

1.36

3.88

1.3

1.5

48.05

70.36

mu/l

2.25

153

1219

Other infectious diseases

299

1.79

3.87

1.4

59.46

62.96

mu/l

0.08

259

Amputation of toe

270

1.83

3.87

1.2

1.3

92.79

63.74

mu/l

0.66

234

Keratitis

259

2013

1.29

3.86

2.0

1.5

55.45

62.45

mu/l

0.45

240

1791

Other eating disorders

165

2.07

3.86

2.5

1.6

95.83

110.70

mu/l

0.08

148

Benign neoplasm: Ascending colon

101

672

1.51

3.85

1.3

1.4

78.65

57.99

mu/l

0.50

597

Seropositive rheumatoid arthritis

173

1265

1.37

3.84

1.4

47.54

55.61

mu/l

0.40

156

1121

Ulcerative colitis, NAS

649

1.52

3.81

1.5

72.70

59.06

mu/l

0.31

579

Congenital malformations of heart and great arteries

582

1.54

3.81

1.3

1.6

178.60

75.66

mu/l

0.71

523

Salpingitis and oophoritis

136

961

1.42

3.81

1.7

1.5

46.11

53.09

mu/l

0.26

120

865

Endometriosis of pelvic peritoneum

112

726

1.48

3.80

1.7

1.6

46.43

57.63

mu/l

0.54

106

658

Explicit bacterial Sepsis

406

1.66

3.79

1.4

77.72

57.88

mu/l

0.35

357

Glaucoma suspect

254

1976

1.29

3.77

1.4

71.80

60.55

mu/l

0.38

224

1741

Palmar fascial fibromatosis [Dupuytren]

651

1.51

3.76

1.3

1.4

62.40

50.55

mu/l

0.24

568

Other specified and unspecified personality disorders

392

1.67

3.76

1.3

1.5

42.02

52.92

mu/l

0.53

354

Fall involving bed

102

2.38

3.75

1.0

1.3

26.76

48.69

mu/l

0.87

Other inflammatory liver diseases

273

1.81

3.75

2.7

1.4

52.67

43.06

mu/l

0.40

244

Viral pneumonia (unknown virus, not influenza)

273

1.81

3.75

1.4

80.96

50.83

mu/l

0.41

239

Embolic stroke

147

2.12

3.74

1.3

130.99

45.85

mu/l

0.76

127

Bullous disorders

216

1.91

3.73

1.4

1.3

106.91

53.21

mu/l

0.70

188

Emotional disorders starting during childhood or adolecense, excluding more controls

137

2.15

3.72

1.6

1.7

44.31

50.80

mu/l

0.32

125

Astigmatism

230

1.88

3.72

1.4

1.5

53.36

49.93

mu/l

0.07

206

Haemolytic anaemias

128

2.21

3.72

2.3

1.4

55.06

46.95

mu/l

0.19

114

Multiple delivery

476

0.44

3.70

1.4

1.7

44.75

59.58

mu/l

0.63

421

Benign lipomatous neoplasm

215

1642

1.31

3.68

1.5

1.4

66.76

58.30

mu/l

0.19

200

1456

Glaucoma

394

2777

1.22

3.66

1.4

66.92

58.47

mu/l

0.38

352

2443

Acute and subacute iridocyclitis

136

969

1.41

3.65

1.6

1.5

51.04

60.96

mu/l

0.46

122

867

Any dementia

139

1341

0.72

3.64

1.2

1.4

71.24

56.42

mu/l

0.36

115

1178

Injuries to unspecified part of trunk, limb or body region

435

1.62

3.62

1.5

1.4

48.75

51.86

mu/l

0.09

382

Papulosquamous disorders

287

2280

1.26

3.62

1.6

1.5

60.22

63.24

mu/l

0.11

255

2017

Other bursopathies

609

1.52

3.61

1.4

41.10

49.22

mu/l

0.52

541

Other juvenile arthritis

143

2.12

3.60

2.0

1.6

44.98

59.58

mu/l

0.47

125

Impingement syndrome of shoulder

167

1234

1.36

3.59

1.4

1.5

53.10

62.32

mu/l

0.39

151

1090

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

206

1570

1.32

3.59

1.6

53.55

62.04

mu/l

0.49

188

1407

Polymyalgia rheumatica

586

1.53

3.59

1.3

51.16

58.02

mu/l

0.23

515

Preterm labour and delivery

192

1450

1.33

3.57

1.7

1.6

42.09

50.64

mu/l

0.72

172

1305

Peripheral artery operations in Hilmo

491

1.57

3.56

1.2

1.4

90.51

54.40

mu/l

1.45

437

Ganglion

145

1049

1.39

3.56

1.4

1.5

50.06

48.21

mu/l

0.04

130

940

Otitis externa

156

1144

1.37

3.53

1.4

1.5

65.60

61.41

mu/l

0.09

137

1021

Other condition

102

694

1.48

3.52

1.6

1.5

78.70

50.98

mu/l

0.63

618

Unspecified acute lower respiratory infection

102

694

1.48

3.52

1.5

72.31

63.66

mu/l

0.15

616

Other/unspecified synovitis and tenosynovitis

517

1.56

3.51

1.3

1.5

57.07

43.70

mu/l

0.31

466

Diabetic retinopathy, strict definition

168

1100

1.36

3.51

1.8

1.6

69.84

82.84

mu/l

0.46

143

982

Inflammatory bowel disease

227

1760

1.29

3.50

1.5

69.73

60.27

mu/l

0.31

202

1581

Haemorrhage in early pregnancy

197

1458

1.32

3.49

1.5

1.7

77.36

52.47

mu/l

0.70

174

1319

Covid-19 suspected case

154

1130

1.37

3.48

1.5

1.6

43.80

67.52

mu/l

1.41

142

1023

Cholangitis (primary sclerosing, PSC)

236

1.84

3.47

1.3

1.4

158.23

58.68

mu/l

0.60

205

Alcohol-induced chronic pancreatitis

273

1.77

3.46

1.2

1.4

67.48

57.21

mu/l

0.18

248

Fracture of shoulder and upper arm

253

1989

1.27

3.46

1.4

1.5

62.30

61.91

mu/l

0.01

226

1751

Haemorrhage, not elsewhere classified

119

2.20

3.45

1.2

1.3

65.71

45.10

mu/l

0.43

103

Acute suppurative otitis media

172

1198

1.34

3.44

1.9

1.8

49.70

66.16

mu/l

0.79

155

1095

Other abnormal uterine and vaginal bleeding

156

817

1.37

3.44

1.5

67.02

50.56

mu/l

0.55

144

718

Hypertrophic disorders of skin

230

1.84

3.42

1.8

1.5

38.00

49.85

mu/l

0.44

204

Bulimia nervosa (incl. atypical)

113

2.23

3.42

1.4

1.6

47.67

55.11

mu/l

0.18

101

Autonomic disorders

2.47

3.40

1.5

1.3

56.59

46.84

mu/l

0.13

Dermatophytosis

445

3722

1.20

3.39

1.5

80.14

63.39

mu/l

0.51

391

3325

Other and unspecified disorders of autonomic nervous system

5.97

3.39

1.5

1.3

26.48

18.93

mu/l

—

Other/unspecified enthesopathies, not elsewhere classified

350

1.67

3.38

1.6

1.4

106.15

33.81

mu/l

1.20

308

Ulcerative colitis

170

1273

1.34

3.38

1.5

63.69

65.09

mu/l

0.04

153

1137

Unspecified misadventure during surgical and medical care

225

1.84

3.33

1.5

1.4

58.29

63.27

mu/l

0.10

197

Other specific arthropathies, wide

2.65

3.32

1.6

1.3

49.51

52.27

mu/l

0.04

Psoriasis

208

1609

1.30

3.29

1.6

1.4

67.96

61.70

mu/l

0.18

185

1431

Other peripheral vertigo

415

1.60

3.29

1.4

23.35

47.09

mu/l

1.91

364

179

1178

1.33

3.29

1.2

1.4

44.60

60.15

mu/l

0.60

155

1036

Benign neoplasm: Transverse colon

502

1.54

3.29

1.3

1.4

92.11

58.67

mu/l

0.32

443

Assault

623

1.48

3.28

1.5

1.7

121.83

60.48

mu/l

0.82

569

Female infertility, cervical, vaginal, other or unspecified origin

187

920

1.33

3.27

2.0

1.6

48.26

55.42

mu/l

0.35

171

835

Otitis externa, unspecified

495

1.54

3.25

1.4

1.6

61.77

48.95

mu/l

0.20

441

Degenerative diseases of the nervous system

118

1210

0.71

3.25

1.2

1.4

50.61

58.52

mu/l

0.24

1063

Fall on and from stairs and steps

182

1386

1.32

3.24

1.5

71.67

59.03

mu/l

0.35

161

1234

Superficial injury of abdomen, lower back and pelvis

102

707

1.45

3.23

1.7

1.5

76.64

53.57

mu/l

0.40

624

Congenital malformations of the respiratory system

2.61

3.23

1.3

64.01

188.58

mu/l

0.43

Fracture of skull and facial bones

151

1120

1.35

3.22

1.6

1.5

83.39

59.46

mu/l

0.53

132

996

Use of other anti-dementia drugs

947

0.66

3.19

1.1

1.3

39.38

52.32

mu/l

0.57

821

Use of memantine

947

0.66

3.19

1.1

1.3

39.38

52.32

mu/l

0.57

821

Crohn disease (strict definition, require KELA, min 2 HDR)

258

1.76

3.18

1.7

1.5

68.93

42.38

mu/l

0.53

228

Suicide or other Intentional self-harm

171

1296

1.32

3.16

1.4

1.6

99.76

62.49

mu/l

0.51

149

1170

Peritonsillar abscess

145

1073

1.36

3.14

1.9

1.6

61.48

56.15

mu/l

0.18

127

974

Allergic contact dermatitis

646

1.46

3.13

1.7

1.5

91.96

53.88

mu/l

0.88

579

Biomechanical lesions, not elsewhere classified

187

1.89

3.11

1.2

1.4

63.14

49.22

mu/l

0.16

166

Female genital prolapse

205

892

1.30

3.11

1.4

1.5

37.10

54.38

mu/l

0.97

182

790

Other and unspecified haemorrhagic conditions

2.84

3.10

1.7

1.3

42.12

53.04

mu/l

0.15

Parkinson's disease, strict definition, excluding more controls

446

1.54

3.09

1.2

1.6

35.69

56.67

mu/l

0.92

399

Spondyloarthritis

113

805

1.41

3.09

1.6

1.4

57.05

54.23

mu/l

0.08

101

719

Congenital malformations of cardiac septa

259

1.73

3.09

1.4

1.5

58.46

95.50

mu/l

0.41

230

Cardiomyopathy, other and unspecified

321

1.66

3.08

1.3

1.4

70.93

62.55

mu/l

0.09

294

Crohn disease (strict definition, require KELA)

261

1.74

3.07

1.7

1.5

68.93

42.36

mu/l

0.53

229

Open wound of shoulder and upper arm

2.61

3.06

1.6

1.2

150.68

40.09

mu/l

0.59

Other coagulation defects

299

1.68

3.06

1.6

1.5

39.29

81.63

mu/l

0.66

264

Generalized epilepsy

153

1.98

3.05

1.2

1.5

32.75

111.84

mu/l

0.68

134

Gestational diabetes (for exclusion)

239

1315

1.27

3.04

1.8

1.9

68.69

51.47

mu/l

0.60

219

1203

Other diseases of oesophagus

408

1.58

3.03

1.4

1.3

66.28

84.00

mu/l

0.18

355

Ménière disease

432

1.56

3.03

1.3

1.4

70.66

44.01

mu/l

0.83

385

Adalimumab

440

1.55

3.03

1.8

1.6

88.43

57.32

mu/l

0.48

394

Emotional disorders starting during childhood or adolescence

159

1.95

3.02

1.5

1.6

44.92

70.35

mu/l

1.17

138

Colonic or urogenital fistula

189

1463

1.30

3.01

1.5

92.58

62.34

mu/l

0.86

169

1305

Adhesive capsulitis of shoulder

114

818

1.40

3.01

1.6

1.5

60.75

52.12

mu/l

0.33

102

733

Vasomotor and allergic rhinitis

265

2096

1.24

3.01

1.6

59.52

66.67

mu/l

0.24

230

1901

Kela-code for severe mental illness

259

2083

1.25

3.01

1.4

1.6

54.86

65.92

mu/l

0.52

222

1880

Essential (haemorrhagic) thrombocythaemia

154

1.97

3.01

1.1

1.4

33.70

53.40

mu/l

0.51

141

Other female pelvic inflammatory diseases

115

827

1.40

3.00

1.6

1.5

51.18

51.24

mu/l

0.00

738

IBD patients in KELA-register

155

1168

1.33

3.00

1.5

72.26

62.86

mu/l

0.28

137

1056

Flat foot [pes planus] (acquired)

458

1.54

2.97

1.7

1.4

39.42

53.04

mu/l

0.49

407

Congenital malformations of the respiratory system

2.58

2.97

1.3

62.69

194.80

mu/l

0.44

Other secondary gonarthrosis

212

1.81

2.97

1.4

51.52

54.63

mu/l

0.07

187

Superficial injury of wrist and hand

135

999

1.36

2.95

1.6

54.88

58.19

mu/l

0.10

127

891

Other disorders starting during childhood or adolecense, excluding more controls

148

1.95

2.95

1.6

1.7

85.95

137.78

mu/l

0.30

137

Other noninflammatory disorders of vulva and perineum

388

1.58

2.93

1.4

1.5

38.44

60.80

mu/l

1.00

345

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

110

789

1.40

2.92

1.6

129.81

61.86

mu/l

0.64

710

Arterial embolism and thrombosis

191

1.84

2.92

1.3

72.84

64.93

mu/l

0.08

164

Use of donepezil

781

0.62

2.92

1.3

30.34

47.84

mu/l

0.79

681

Septal defects

245

1.73

2.90

1.4

1.5

62.47

98.78

mu/l

0.38

218

Embolic stroke with flimmer

2.39

2.90

1.2

1.3

120.34

57.03

mu/l

0.63

Streptococcal septicaemia

343

1.61

2.88

1.4

1.3

56.12

66.65

mu/l

0.27

300

Dementia

177

1570

0.77

2.86

1.2

1.4

61.78

54.95

mu/l

0.18

145

1382

Rash and other nonspecific skin eruption

423

1.55

2.84

1.8

1.4

71.24

42.05

mu/l

0.46

374

Mucosal proctocolitis

585

1.46

2.84

1.6

65.35

62.47

mu/l

0.07

526

Suppurative and unspecified otitis media

241

1713

1.25

2.84

1.8

1.7

49.53

65.78

mu/l

1.00

216

1561

Lateral epicondylitis

635

1.44

2.83

1.4

1.5

159.10

47.75

mu/l

1.02

573

Later onset COPD

163

992

1.31

2.80

1.2

1.4

75.93

60.07

mu/l

0.55

138

864

Psoriasis vulgaris

126

932

1.36

2.79

1.7

1.5

59.81

58.26

mu/l

0.04

111

832

Spondylopathies (FG)

637

1.43

2.79

1.7

1.5

54.08

55.83

mu/l

0.04

571

Antenatal screening

739

0.70

2.78

1.7

1.9

43.13

47.17

mu/l

0.16

675

Other disorders of patella

120

882

1.37

2.77

1.7

1.5

97.85

56.08

mu/l

0.92

102

794

Emphysema

277

1.67

2.77

1.2

1.4

76.74

75.83

mu/l

0.01

243

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

410

1.55

2.77

1.3

1.6

49.48

56.79

mu/l

0.23

367

Herpesviral [herpes simplex] infections

172

1332

1.30

2.77

1.9

1.6

59.32

56.17

mu/l

0.07

153

1190

Bell's palsy

523

1.48

2.76

1.4

1.5

55.32

52.54

mu/l

0.07

465

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

159

1204

1.31

2.75

2.4

1.3

65.50

60.06

mu/l

0.13

143

1074

Bronchitis, not specified as acute or chronic

355

1.59

2.75

1.4

89.45

51.76

mu/l

0.47

313

Viral hepatitis

286

1.65

2.73

1.4

1.5

93.19

54.29

mu/l

0.42

258

Disorders of breast

358

2728

1.19

2.72

1.6

45.71

53.73

mu/l

0.58

323

2444

Unspecified jaundice

153

1.91

2.71

1.4

54.39

66.49

mu/l

0.15

131

Paracetamol or NSAID medication

107

383

1.41

2.70

1.4

1.8

57.11

64.98

mu/l

0.21

350

Graves disease, strict definition

453

1.51

2.69

2.3

1.5

56.83

45.86

mu/l

0.46

410

Diseases of external ear

230

1853

1.24

2.68

1.5

79.58

58.43

mu/l

0.68

200

1648

Tonsillectomy and adenotomy

403

2375

1.18

2.67

1.8

1.7

80.59

60.42

mu/l

0.89

365

2165

Tumor necrosis factor alpha inhibitors

104

752

1.39

2.67

1.5

1.6

67.78

61.28

mu/l

0.12

678

Other disorders of binocular vision

2.97

2.63

1.2

24.11

56.30

mu/l

0.64

Other fall from one level to another

146

1114

1.31

2.63

1.6

1.5

74.24

71.35

mu/l

0.06

133

995

Amputation of foot

2.27

2.62

1.4

1.3

99.61

49.42

mu/l

0.68

Childhood asthma (age<16), excluding more controls

382

1.49

2.61

1.9

1.7

45.61

57.54

mu/l

0.48

352

Anogenital herpesviral [herpes simplex] infection

448

1.50

2.61

1.6

1.7

28.34

56.44

mu/l

3.20

403

Postmenopausal bleeding

189

788

1.28

2.60

1.3

1.4

36.85

55.51

mu/l

1.36

166

696

Nummular dermatitis

345

1.57

2.59

1.8

1.4

81.62

54.68

mu/l

0.35

306

Corneal ulcer

125

936

1.34

2.59

2.2

1.5

49.22

65.09

mu/l

1.01

118

835

Hypermetropia

275

1.64

2.57

1.2

1.7

40.18

85.21

mu/l

0.68

252

Stomatitis and related lesions

134

1015

1.32

2.56

1.8

1.5

48.36

61.69

mu/l

0.68

117

899

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

202

1614

1.26

2.55

1.6

1.5

51.41

61.32

mu/l

0.46

191

1434

Other and unspecified mood [affective] disorders

284

1.63

2.54

1.4

1.6

45.40

54.19

mu/l

0.25

257

Lesion of lateral popliteal nerve

186

1.79

2.53

1.4

1.5

25.37

56.00

mu/l

1.39

171

Exposure to other and unspecified inanimate mechanical forces

300

1.61

2.53

1.4

1.5

66.32

49.78

mu/l

0.45

266

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

285

1.62

2.51

1.7

1.6

98.93

41.90

mu/l

0.83

250

Other viral hepatitis

239

1.68

2.51

1.4

1.5

101.48

52.00

mu/l

0.47

215

In situ neoplasms

247

2024

1.22

2.48

1.4

64.34

56.44

mu/l

0.26

220

1792

Haemangioma, any site

381

1.53

2.48

1.6

1.4

73.24

67.59

mu/l

0.06

343

Chondropathies

100

729

1.38

2.47

1.4

1.5

70.61

51.61

mu/l

0.41

649

Acute nasopharyngitis (common cold)

574

1.42

2.46

1.6

1.5

78.21

73.29

mu/l

0.06

512

Fibrosis and cirrhosis of liver

334

1.57

2.46

1.5

1.4

150.41

39.16

mu/l

0.88

294

Event of undetermined intent

241

1.67

2.44

1.2

1.5

77.63

47.55

mu/l

0.37

214

Other specified/unspecified bacterial intestinal infections

272

1.63

2.44

2.0

1.4

65.58

45.26

mu/l

0.75

239

Psoriatic and enteropathic arthropathies

538

1.44

2.43

1.6

1.5

95.50

55.08

mu/l

0.74

484

Benign neoplasm: Skin of trunk

152

1.86

2.43

1.4

56.10

43.71

mu/l

0.24

137

Other peripheral vascular diseases

335

1.56

2.43

1.8

1.4

59.62

38.39

mu/l

0.64

301

Childhood asthma (age<16)

389

1.46

2.42

1.9

1.7

45.61

59.38

mu/l

0.58

359

Urethral stricture

212

1.71

2.39

1.5

1.3

67.38

73.70

mu/l

0.06

187

Open wound of head

367

3016

1.17

2.38

1.4

1.5

88.84

65.28

mu/l

0.42

330

2690

Vestibular neuronitis

401

1.50

2.38

1.4

47.53

53.91

mu/l

0.16

360

Injuries to the elbow and forearm

514

3948

1.15

2.38

1.6

1.5

68.51

61.55

mu/l

0.21

462

3522

Other noninfective disorders of lymphatic vessels and lymph nodes

146

1.87

2.38

1.4

38.93

52.60

mu/l

0.37

130

Postpartum haemorrhage due to retained placenta

541

0.59

2.37

1.7

48.54

49.06

mu/l

0.01

502

Inflammatory bowel disease, strict (require KELA)

155

1212

1.28

2.37

1.5

1.6

72.26

61.70

mu/l

0.32

137

1098

Rheumatoid arthritis, including avohilmo

263

2182

1.21

2.35

1.4

57.03

58.62

mu/l

0.05

235

1933

Ethmoidectomy

626

1.40

2.35

1.6

1.5

74.48

48.84

mu/l

0.51

563

Acute laryngitis and tracheitis

484

1.45

2.34

1.7

1.6

94.43

69.19

mu/l

0.39

430

Injury of muscle and tendon at shoulder and upper arm level

242

1993

1.22

2.34

1.4

60.16

69.06

mu/l

0.38

216

1758

Purpura and other haemorrhagic conditions

619

1.40

2.32

1.5

1.4

107.68

57.03

mu/l

0.71

550

Benign neoplasm of ovary

122

928

1.32

2.31

1.5

1.4

27.37

56.75

mu/l

4.35

113

824

Cardiomyopathies, Primary/intrinsic

494

1.44

2.31

1.3

1.4

68.37

54.83

mu/l

0.33

445

Other Crohn's disease

284

1.59

2.31

1.3

1.5

40.70

42.46

mu/l

0.04

252

Skin changes due to chronic exposure to nonionizing radiation

240

1822

1.22

2.31

1.3

1.4

31.34

58.45

mu/l

5.39

211

1595

Malignant neoplasm of skin

337

1955

1.18

2.30

1.4

33.89

58.88

mu/l

5.82

291

1744

Primary_lymphoid and hematopoietic malignant neoplasms

152

1191

1.28

2.30

1.3

1.4

51.41

67.54

mu/l

0.67

137

1053

Plantar fascial fibromatosis

454

1.46

2.29

1.4

1.5

36.91

47.67

mu/l

0.58

411

255

1938

1.21

2.28

1.4

32.28

58.88

mu/l

5.51

225

1703

Acute epiglottitis

2.58

2.28

1.6

1.3

59.58

56.96

mu/l

0.03

Seborrhoeic dermatitis

430

1.47

2.27

1.7

1.4

81.77

80.15

mu/l

0.02

383

Other articular cartilage disorders

2.04

2.27

1.1

1.5

220.10

61.74

mu/l

0.82

Presbycusis

516

1.43

2.26

1.3

31.90

53.74

mu/l

1.59

455

FESS (DNB20)

597

1.40

2.26

1.6

1.5

77.37

49.85

mu/l

0.52

535

Pyogenic arthritis

270

1.60

2.26

1.3

1.4

50.34

55.09

mu/l

0.10

240

Carcinoma in situ of colon

2.30

2.26

2.0

1.3

65.77

53.04

mu/l

0.18

Other degenerative diseases of the nervous system

154

901

1.28

2.25

1.3

1.5

36.96

56.87

mu/l

1.57

125

801

Diseases of middle ear and mastoid

393

2767

1.16

2.24

1.7

55.86

63.01

mu/l

0.40

355

2490

Other puerperal infections

310

1.56

2.24

1.7

1.9

68.30

53.76

mu/l

0.34

279

Alcohol abuse counselling and surveillance

0.00

2.23

0.0

1.4

—

55.42

—

Amputation

391

1.49

2.22

1.3

1.4

88.64

60.63

mu/l

0.78

346

Need for immunization against other single viral diseases

2.22

1.6

1.4

44.75

55.97

mu/l

0.27

Cardiomyopathy (excluding other)

515

1.42

2.22

1.3

1.4

67.42

54.59

mu/l

0.32

462

Other maternal disorders predominantly related to pregnancy

407

2200

1.16

2.20

1.6

70.30

52.49

mu/l

0.88

366

1984

Metatarsalgia

425

1.47

2.20

1.6

1.5

47.41

48.61

mu/l

0.04

382

Benign neoplasm: Skin of other and unspecified parts of face

483

1.44

2.19

1.3

1.4

29.43

50.55

mu/l

1.53

426

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

336

1.53

2.19

1.4

61.89

43.12

mu/l

0.50

298

Scoliosis

344

1.52

2.19

1.3

1.5

56.01

48.17

mu/l

0.25

303

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

401

1.48

2.19

1.8

1.4

61.26

49.25

mu/l

0.19

357

Artificial opening status

226

1.65

2.18

1.6

1.5

50.18

87.12

mu/l

0.40

201

Mixed and other personality disorders

345

1.51

2.16

1.3

1.6

66.56

58.84

mu/l

0.10

312

Single spontaneous delivery

214

1383

0.82

2.16

1.5

1.6

34.79

55.04

mu/l

2.35

198

1222

Other diseases of arteries and capillaries

362

1.50

2.14

1.2

1.4

115.73

45.93

mu/l

1.29

325

Haemangioma and lymphangioma, any site

403

1.47

2.14

1.6

1.4

72.94

74.10

mu/l

0.01

362

Dementia, including avohilmo

200

1682

0.82

2.14

1.2

1.4

60.56

53.81

mu/l

0.20

165

1489

Disorders in reading

2.39

2.13

1.5

1.3

39.62

53.73

mu/l

0.40

L02BA Anti-estrogens

919

0.70

2.13

1.7

1.5

89.69

51.03

mu/l

0.33

827

Hordeolum and other deep inflammation of eyelid

220

1.65

2.12

1.4

1.5

24.66

46.89

mu/l

1.41

192

Open wound of wrist and hand

305

2535

1.18

2.10

1.6

52.49

69.91

mu/l

1.68

271

2262

Other enthesopathy of foot (+metatarsalgia)

471

1.43

2.10

1.6

1.5

45.95

47.37

mu/l

0.05

424

Vasomotor rhinitis (mode)

316

1.53

2.08

1.7

1.5

79.96

45.08

mu/l

0.43

284

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

187

1.69

2.08

1.6

1.7

82.20

118.05

mu/l

0.24

168

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

712

4094

1.11

2.08

1.4

1.5

63.12

64.18

mu/l

0.04

631

3661

Alcoholic liver disease

439

1.44

2.07

1.2

1.4

109.28

58.47

mu/l

0.41

397

Residual foreign body in soft tissue

191

1.69

2.07

1.5

1.4

53.60

40.73

mu/l

0.23

172

Other specified disorders of muscle

2.00

2.06

1.2

1.3

48.61

38.92

mu/l

0.15

Fall on and from ladder

309

1.53

2.06

1.3

1.4

50.95

65.36

mu/l

0.39

271

Use of antiglaucoma preparations and miotics

318

1.52

2.03

1.6

1.3

48.98

56.47

mu/l

0.18

271

Other disorders starting during childhood or adolescence

175

1.71

2.03

1.6

1.7

85.95

127.41

mu/l

0.26

155

Pollen allergy

116

885

1.30

2.00

1.7

75.81

65.24

mu/l

0.20

103

812

Other ulcerative colitis

224

1.62

1.99

1.8

1.4

113.74

38.32

mu/l

1.32

199

Procreative management

236

1646

1.20

1.96

1.7

45.09

66.12

mu/l

1.91

217

1490

Lung cancer and mesothelioma

111

731

1.30

1.95

1.5

1.4

109.41

60.48

mu/l

0.79

646

Spondylopathies in diseases classified elsewhere

2.60

1.95

1.3

1.2

47.90

59.34

mu/l

—

Malignant neoplasm of bladder, including Hilmo

450

1.42

1.95

1.2

1.3

74.27

73.33

mu/l

0.01

397

Postpartum haemorrhage

103

1128

0.77

1.95

1.9

1.8

69.48

49.57

mu/l

0.45

1025

Any dementia, excluding more controls

136

1178

0.79

1.93

1.2

1.4

72.76

53.25

mu/l

0.50

112

1038

Benign neoplasm: Skin of eyelid, including canthus

100

762

1.32

1.93

1.5

1.4

85.12

50.52

mu/l

0.61

673

Sequelae of injuries of lower limb

421

1.43

1.92

1.3

1.4

24.04

49.40

mu/l

2.73

373

Left bundle-branch block

290

1.52

1.92

1.5

1.4

102.54

58.18

mu/l

0.33

261

Nonsuppurative otitis media

138

947

1.26

1.92

1.6

1.8

74.34

69.69

mu/l

0.09

122

857

Sacroiliitis, not elsewhere classified

173

1.69

1.90

2.0

1.6

73.26

44.38

mu/l

0.41

155

Complications of other internal prosthetic devices, implants and grafts

158

1.72

1.89

1.2

1.4

44.75

41.46

mu/l

0.08

139

Excessive earwax

369

3137

1.15

1.89

1.6

1.5

64.73

60.64

mu/l

0.16

315

2786

Assault by bodily force

340

1.48

1.89

1.4

1.7

55.77

60.71

mu/l

0.08

305

Benign mammary dysplasia

714

1.32

1.87

1.7

1.4

56.57

51.92

mu/l

0.10

634

Acute and transient psychotic disorders

542

1.37

1.86

1.2

1.6

56.91

61.03

mu/l

0.09

489

Allergic rhinitis

199

1632

1.21

1.86

1.7

68.53

64.91

mu/l

0.09

173

1482

Superficial injury of thorax

697

1.32

1.86

1.3

1.5

60.04

49.95

mu/l

0.29

618

Sequelae of injuries of head

190

1.64

1.84

1.6

1.5

79.01

59.77

mu/l

0.23

169

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

412

2866

1.14

1.83

1.8

1.6

57.54

57.73

mu/l

0.01

373

2580

Complications predominantly related to the puerperium

170

1392

1.22

1.83

1.5

1.7

57.54

54.19

mu/l

0.13

155

1261

Endometriosis of rectovaginal septum and vagina

310

1.49

1.83

1.4

1.5

71.88

64.85

mu/l

0.09

275

Degenerative macular diseases

519

1.37

1.82

1.3

1.4

37.30

60.70

mu/l

1.01

458

Fentanyl

392

1.43

1.82

1.8

1.3

42.52

49.41

mu/l

0.24

344

Acute alcohol intoxication

157

1276

1.23

1.81

1.4

1.5

117.18

65.50

mu/l

0.59

130

1138

Other and unspecified disorders of adult personality and behaviour

3.11

1.81

1.1

1.3

208.89

53.52

mu/l

—

Other retinal artery occlusion

2.07

1.81

1.2

86.70

47.81

mu/l

—

Fracture at wrist and hand level

232

1954

1.19

1.81

1.8

1.5

75.18

66.21

mu/l

0.31

208

1745

Other menopausal disorders

186

860

1.22

1.81

1.7

1.5

56.09

54.62

mu/l

0.03

168

768

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

675

1.32

1.80

1.6

1.4

41.49

52.67

mu/l

0.52

603

Arthropathic psoriasis

521

1.37

1.78

1.5

97.62

51.95

mu/l

0.78

467

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

117

922

1.27

1.78

1.9

1.3

58.12

62.09

mu/l

0.09

101

817

Macular pucker

764

1.30

1.77

1.7

1.4

43.89

66.35

mu/l

1.06

679

Toxic liver disease

2.25

1.75

1.5

1.2

70.34

53.48

mu/l

0.22

Sulfasalazine

186

1545

1.21

1.74

1.4

1.5

54.67

63.57

mu/l

0.30

169

1383

Phlebitis and thrombophlebitis (not including DVT)

149

1213

1.23

1.71

1.4

61.71

54.51

mu/l

0.20

134

1088

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

282

1.50

1.71

1.2

1.7

34.43

64.90

mu/l

1.57

254

Duodenal ulcer

449

1.39

1.70

1.4

1.3

32.77

77.73

mu/l

1.23

393

Scabies

647

1.32

1.69

1.4

1.6

60.58

72.05

mu/l

0.26

583

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

102

797

1.28

1.68

1.5

57.89

61.86

mu/l

0.11

715

Delivery

222

1385

0.84

1.67

1.5

1.6

34.02

54.99

mu/l

2.58

204

1224

Benign neoplasm: Sigmoid colon

121

966

1.26

1.67

1.5

1.4

79.61

57.44

mu/l

0.62

101

860

Right ventricular outflow tract obstruction

3.20

1.67

2.3

1.3

454.77

632.79

mu/l

—

Pediculosis, acariasis and other infestations

100

780

1.29

1.67

1.4

1.5

56.04

67.78

mu/l

0.32

697

Actinic keratosis

225

1768

1.18

1.66

1.4

29.91

57.27

mu/l

5.51

198

1548

Any death

354

2884

0.88

1.65

1.6

1.4

74.04

60.21

mu/l

0.72

304

2549

Demyelinating diseases of the central nervous system

376

1.42

1.64

1.4

1.6

28.55

55.03

mu/l

1.77

341

Abscess of external ear

2.27

1.64

2.0

1.2

48.93

26.61

mu/l

0.62

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

103

810

1.28

1.62

1.8

1.7

38.76

54.81

mu/l

1.40

727

Burns and corrosions confined to eye and internal organs

1.88

1.61

1.2

1.3

45.89

42.95

mu/l

0.07

Open wound of ankle and foot

463

1.37

1.60

1.4

1.5

82.32

59.84

mu/l

0.74

405

Seropositive rheumatoid arthritis, wide

173

1442

1.20

1.60

1.4

47.54

59.29

mu/l

0.68

156

1282

Other hammer toe(s) (acquired)

113

830

1.26

1.59

1.3

53.32

57.41

mu/l

0.07

104

739

Suggestive for eosinophilic asthma

404

1.39

1.59

1.4

33.25

56.63

mu/l

1.04

352

Endometriosis of fallopian tube

3.04

1.59

1.3

1.2

6.12

41.16

mu/l

—

Ulcerative rectosigmoiditis

337

1.43

1.59

1.6

1.4

53.72

52.53

mu/l

0.02

305

Scabies

167

1.63

1.58

1.1

1.5

37.01

60.55

mu/l

0.73

151

Outcome of delivery

554

0.75

1.57

1.4

1.9

98.83

44.31

mu/l

0.62

509

Postpartum hemorraghe, all women as controls

103

1274

0.79

1.56

1.9

1.8

69.48

52.24

mu/l

0.37

1171

Raynaud syndrome

381

1.40

1.54

2.0

1.5

77.86

47.26

mu/l

0.87

347

Abnormal spermatozoa

535

1.33

1.54

1.5

1.4

67.33

70.61

mu/l

0.04

478

Use of rivastigmine

575

0.69

1.54

1.2

1.3

23.53

55.17

mu/l

2.84

495

Nasal polyp

121

978

1.24

1.53

1.5

1.4

50.65

65.60

mu/l

0.42

102

872

Malignant neoplasm of pancreas, including Hilmo

340

1.42

1.52

1.5

1.3

38.43

63.95

mu/l

1.02

304

Endometriosis ASRM stages 1,2

115

925

1.25

1.52

1.7

1.6

45.32

54.40

mu/l

0.49

109

832

Schizophrenia, schizotypal and delusional disorders

208

1772

1.18

1.51

1.3

1.5

57.62

66.30

mu/l

0.29

179

1595

Strabismus

166

1383

1.20

1.51

1.5

38.83

73.20

mu/l

3.23

153

1239

Exposure to other and unspecified animate mechanical forces

108

1.77

1.51

1.8

1.4

59.13

50.04

mu/l

0.13

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

154

1.63

1.50

1.6

1.3

79.95

45.34

mu/l

0.43

139

Mixed specific developmental disorders

1.97

1.50

1.6

1.7

68.46

247.80

mu/l

0.66

Atrophic disorders of skin

749

1.27

1.49

1.6

1.4

54.07

55.23

mu/l

0.03

665

Idiopathic thrombocytopenic purpura

101

1.79

1.49

1.1

1.3

114.16

54.39

mu/l

0.82

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

316

1880

1.14

1.48

1.4

34.04

58.42

mu/l

5.31

267

1675

Suppurative and necrotic conditions of lower respiratory tract

202

1.54

1.48

1.5

1.4

106.54

64.35

mu/l

0.32

179

Orchitis and epididymitis

359

1.40

1.48

1.9

1.4

123.49

76.90

mu/l

0.42

319

Other (seronegative) rheumatoid arthritis, wide

119

965

1.24

1.47

1.6

1.4

63.49

59.08

mu/l

0.08

105

863

Other appendicitis

360

1.39

1.46

1.4

45.01

41.19

mu/l

0.13

317

Alcohol withdrawal state with delirium

293

1.44

1.46

1.0

1.4

35.90

64.96

mu/l

1.24

263

Reactive arthropathies

394

1.38

1.46

1.3

1.4

53.67

49.30

mu/l

0.12

351

Crohn disease (strict definition, all UC cases excluded)

195

1.55

1.46

1.6

1.5

50.67

43.32

mu/l

0.17

173

6-mercaptopurine

117

1.72

1.45

2.0

1.4

50.20

121.11

mu/l

0.39

100

Excessive attrition of teeth

385

3436

1.12

1.45

1.7

1.6

57.98

65.29

mu/l

0.38

344

3076

Hallux rigidus

717

1.27

1.45

1.4

36.11

68.80

mu/l

1.21

640

Schizophrenia or delusion

206

1762

1.17

1.44

1.3

1.5

57.99

66.64

mu/l

0.29

177

1586

Other and unspecified mononeuropathies of lower limb

110

1.74

1.43

1.9

1.4

128.43

36.75

mu/l

0.54

102

Female infertility, tubal origin

180

1.56

1.43

2.3

1.6

58.11

60.89

mu/l

0.04

163

Seborrhoeic keratosis

141

1168

1.21

1.43

1.7

1.4

60.04

57.78

mu/l

0.05

126

1032

Recurrent aphthous stomatitis , including avohilmo

683

1.28

1.42

2.0

1.5

51.19

53.54

mu/l

0.06

600

Other melanin hyperpigmentation

1.83

1.42

1.1

1.3

32.82

61.27

mu/l

0.53

Palindromic rheumatism

2.28

1.41

1.2

1.3

47.17

62.27

mu/l

—

Leukaemia of unspecified cell type

2.44

1.40

1.0

1.1

48.96

25.02

mu/l

—

Abrasion of teeth

228

1972

1.16

1.40

1.8

1.5

49.13

57.90

mu/l

0.58

203

1758

Agranulocytosis

527

1.31

1.40

1.8

1.4

90.19

65.46

mu/l

0.22

466

Exfoliative dermatitis

2.44

1.40

1.4

113.91

35.11

mu/l

—

Carcinoma in situ of skin

355

1.39

1.4

1.3

52.98

48.45

mu/l

0.10

305

Propionic acid derivatives

179

757

1.19

1.39

1.4

1.6

37.89

55.23

mu/l

1.71

151

681

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

166

1400

1.19

1.39

1.4

47.30

59.54

mu/l

0.70

151

1249

Anomalies of dental arch relationship, including avohilmo

119

875

1.23

1.39

2.9

1.5

78.77

52.67

mu/l

0.67

113

793

Special screening examination for infectious and parasitic diseases

136

826

1.21

1.39

2.0

1.7

67.75

63.86

mu/l

0.10

122

758

Perioral dermatitis

1.95

1.39

1.8

1.3

134.66

50.01

mu/l

0.30

Deviated nasal septum

213

1832

1.16

1.38

1.5

76.94

71.12

mu/l

0.14

191

1636

Injury of muscle and tendon at hip and thigh level

459

1.33

1.37

1.6

1.4

43.47

55.03

mu/l

0.43

409

Varicose veins

427

2901

1.11

1.36

1.4

1.5

52.51

57.35

mu/l

0.25

366

2573

Polycystic ovarian syndrome, broad definition

400

1.35

1.4

53.55

42.72

mu/l

0.17

363

Use of rotigotine

2.17

1.34

1.3

22.92

58.51

mu/l

—

Other congenital malformations of intestine

2.17

1.34

1.4

1.2

64.97

287.32

mu/l

—

Fitting and adjustment of other devices

216

1686

1.16

1.32

1.2

1.4

55.32

57.07

mu/l

0.06

189

1474

Other and unspecified iridocyclitis

176

1.54

1.32

1.3

42.08

52.52

mu/l

0.26

157

Use of disulfiram, acamprosate or naltrexone

402

1.35

1.31

1.4

1.5

88.98

62.11

mu/l

0.53

363

Other embolism and thrombosis

647

1.27

1.31

1.4

38.26

58.50

mu/l

1.17

579

Reactive arthropathies, FINNGEN

283

1.42

1.31

1.4

60.28

57.63

mu/l

0.05

255

Ectopic pregnancy

115

943

1.22

1.31

1.7

1.6

65.85

50.26

mu/l

0.44

104

860

Psoriatic arthropathies

489

1.31

1.5

1.4

102.50

58.74

mu/l

0.66

441

Hidradenitis suppurativa

121

1.66

1.31

1.7

1.3

64.80

42.30

mu/l

0.39

106

Endometriosis diagnosis and infertility diagnosis occurring together

498

1.31

1.30

1.5

1.7

44.02

47.55

mu/l

0.11

455

Pleural plaque

343

1.37

1.30

1.3

62.65

66.47

mu/l

0.05

295

Effects of foreign body entering through natural orifice

151

1273

1.19

1.29

2.1

1.5

69.42

61.91

mu/l

0.19

138

1136

Other/unspecified seropositive rheumatoid arthritis

167

1421

1.18

1.28

1.4

47.30

59.21

mu/l

0.67

151

1265

Endometriosis of ovary

100

791

1.24

1.27

1.3

1.5

50.96

53.28

mu/l

0.07

706

Bacterial, viral and other infectious agents

370

1.36

1.27

1.8

1.5

122.37

57.06

mu/l

0.66

332

Malignant neoplasm of larynx

2.06

1.27

1.1

1.3

24.17

49.69

mu/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

793

1.24

1.27

1.2

1.5

155.00

54.51

mu/l

0.48

705

Other and unspecified nonorganic psychotic disorders

116

956

1.22

1.27

1.3

1.6

48.50

60.79

mu/l

0.50

100

873

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

264

1.42

1.27

3.0

1.6

47.08

55.85

mu/l

0.32

234

Other disorders of breast

642

1.27

1.26

1.5

1.4

57.49

57.72

mu/l

0.00

576

Psoriatic arthropathies, ICD10

492

1.31

1.26

1.5

102.50

48.86

mu/l

0.89

442

Other specified/unspecified systemic involvement of connective tissue

252

1.44

1.26

1.7

1.4

48.40

43.01

mu/l

0.14

230

Coxarthrosis, primary

389

2967

1.11

1.25

1.4

63.01

57.97

mu/l

0.23

350

2618

Maternal care for other conditions predominantly related to pregnancy

122

992

1.21

1.25

1.8

91.77

49.74

mu/l

0.92

110

902

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

706

1.25

1.24

1.4

119.89

60.29

mu/l

0.72

636

Mixed connective tissue disease

295

1.40

1.24

1.6

1.4

47.68

40.64

mu/l

0.22

270

Other disorders of the genitourinary system

644

1.26

1.24

1.7

1.4

61.51

47.35

mu/l

0.27

571

Puerperal sepsis

680

1.25

1.23

1.2

1.4

50.02

58.41

mu/l

0.27

612

Burn and corrosion confined to eye and adnexa

1.78

1.23

1.2

1.4

47.46

47.89

mu/l

0.01

Ulcerative colitis (strict definition, require KELA)

102

833

1.23

1.5

57.89

61.67

mu/l

0.11

747

Von Willebrand disease

2.06

1.22

1.6

1.4

26.97

60.90

mu/l

—

Other psoriatic arthropathies

486

1.30

1.22

1.5

103.61

49.09

mu/l

0.89

437

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

109

897

1.22

1.5

62.12

65.04

mu/l

0.08

808

Conductive hearing loss, unspecified

356

1.35

1.22

1.3

1.5

22.50

52.92

mu/l

2.75

320

Diabetic neuropathy

723

1.24

1.21

1.5

1.4

80.80

85.00

mu/l

0.09

642

Other disorders of skin and subcutaneous tissue, not elsewhere classified

665

1.25

1.19

1.4

92.12

54.46

mu/l

0.70

587

Other respiratory diseases principally affecting the interstitium

809

1.23

1.19

1.3

1.4

45.60

53.88

mu/l

0.32

709

Myocardial infarction, with ST-elevation

746

1.24

1.19

1.3

1.4

86.59

66.13

mu/l

0.32

655

Congenital malformations of uterus and cervix

1.89

1.18

1.1

1.5

29.57

64.94

mu/l

0.65

Postpartum hemorraghe, parous women as controls

103

1063

0.82

1.17

1.9

1.8

69.48

53.41

mu/l

0.34

981

Spontaneous abortion

311

1872

1.12

1.17

1.6

1.7

61.89

50.18

mu/l

0.43

277

1691

Maternal care related to the fetus and amniotic cavity and possible delivery problems

237

1581

0.88

1.16

1.6

1.7

46.74

59.74

mu/l

0.70

215

1437

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.02

1.16

1.7

1.3

31.87

31.24

mu/l

—

Subarachnoid haemorrhage

438

1.31

1.15

1.3

1.4

48.80

48.05

mu/l

0.02

385

Pediculosis, acariasis and other infestations

232

1.43

1.15

1.2

1.5

33.48

56.14

mu/l

0.99

210

Alcohol abuse, main dg, excluding more controls

678

1.24

1.14

1.5

114.90

60.95

mu/l

0.35

610

L01XE Protein kinase inhibitors

224

1.44

1.14

1.7

1.3

33.96

55.29

mu/l

0.84

197

Other strabismus

133

1120

1.19

1.14

1.5

1.6

32.62

71.27

mu/l

3.54

122

1007

Medical abortion

436

2151

1.10

1.13

1.5

1.6

56.63

47.80

mu/l

0.49

389

1937

Chalazion

494

1.28

1.10

1.4

1.5

64.64

49.94

mu/l

0.38

436

Bacterial pneumoniae

247

1930

1.13

1.10

1.3

1.4

69.61

61.63

mu/l

0.24

215

1705

Melanoma in situ

160

1.51

1.09

1.5

1.3

37.97

44.33

mu/l

0.14

141

Eustachian salpingitis and obstruction

320

1.35

1.09

1.2

1.7

81.63

59.91

mu/l

0.26

289

Valvular operations

584

1.25

1.09

1.2

1.4

94.11

51.94

mu/l

0.60

524

Parkinson's disease, including avohilmo

719

1.23

1.09

1.2

1.4

32.22

55.97

mu/l

1.57

634

Malignant neoplasm of small intestine, including Hilmo

120

1.59

1.09

1.4

1.3

149.26

62.43

mu/l

0.54

105

Secondary and unspecified malignant neoplasm of lymph nodes

338

1.34

1.08

1.4

49.96

67.50

mu/l

0.40

301

Convalescence

227

1.42

1.08

1.5

1.4

38.90

44.43

mu/l

0.18

202

Benign leiomyoma with endometriosis

103

857

1.21

1.07

1.2

1.4

33.78

53.60

mu/l

1.73

769

Ovarian hyperstimulation (induction)

1.94

1.06

3.2

1.6

13.31

32.69

mu/l

—

Acute appendicitis, with complications

119

1004

1.19

1.06

1.5

34.91

62.44

mu/l

3.00

108

895

Maternal care for known or suspected abnormality of pelvic organs

157

919

1.16

1.06

1.9

1.8

38.23

51.18

mu/l

1.09

149

840

Melanocytic naevi of other and unspecified parts of face

245

1.39

1.05

1.7

1.5

21.82

45.69

mu/l

1.88

221

Diabetic retinopathy

294

1644

1.12

1.05

1.6

1.5

70.56

79.56

mu/l

0.38

253

1472

MS-disease / Multiple Sclerosis

314

1.34

1.04

1.4

1.6

21.08

47.58

mu/l

2.47

283

Pedal cyclist injured in transport accident

136

1163

1.17

1.04

1.6

1.5

64.19

61.80

mu/l

0.05

125

1037

Exclusion endpoint for supernumerary teeth

1.97

1.04

1.9

1.2

25.19

244.94

mu/l

—

Entropion and trichiasis of eyelid

323

1.34

1.04

1.3

80.90

67.17

mu/l

0.16

281

Viral warts

428

1.29

1.04

2.0

1.5

44.36

52.83

mu/l

0.28

376

Disorders of tooth development and eruption

665

1.21

1.03

2.2

1.6

54.35

77.21

mu/l

0.64

606

Medicines for HER+ breast cancer

196

2108

0.88

1.03

1.4

58.43

49.19

mu/l

0.22

174

1868

Lichen sclerosus et atrophicus

518

1.26

1.02

1.7

1.4

51.19

51.55

mu/l

0.01

460

Foreign body entering into or through eye or natural orifice

324

1.33

1.02

1.6

1.5

28.04

61.03

mu/l

2.59

291

Diabetic maculopathy

107

846

1.20

1.02

2.1

1.6

78.19

79.14

mu/l

0.02

756

Benign neoplasm: Vulva

1.70

1.02

2.0

1.4

26.05

44.23

mu/l

0.55

Alcoholic gastritis

1.90

1.02

1.1

1.3

73.09

58.98

mu/l

—

Acute alcohol intoxication, ICD10

121

1028

1.18

1.01

1.3

1.5

139.40

64.37

mu/l

0.70

101

919

Injury of muscle and tendon at wrist and hand level

663

1.22

1.00

1.5

56.85

58.39

mu/l

0.04

593

Infections with a predominantly sexual mode of transmission

184

1612

1.14

1.00

1.8

1.7

73.98

55.12

mu/l

0.57

166

1462

Postmenopausal atrophic vaginitis

168

804

1.15

1.00

1.5

1.4

33.18

55.95

mu/l

1.36

154

713

Unspecified privation

484

1.26

1.00

1.4

134.60

52.17

mu/l

1.17

427

Certain conditions originating in the perinatal period

288

1.33

1.00

2.2

1.8

103.98

93.04

mu/l

0.08

261

Complications of labour and delivery

375

2284

0.91

0.98

1.5

1.6

62.46

49.96

mu/l

0.59

336

2050

Superficial injury of hip and thigh

665

1.22

0.98

1.5

1.4

50.01

54.57

mu/l

0.09

579

Anti-inflammatory and antirheumatic products, non-steroids

173

757

1.15

0.97

1.4

1.6

53.33

55.23

mu/l

0.06

150

681

severe traumatic brain injury, does not include concussion

123

1051

1.17

0.97

1.3

1.4

84.15

52.22

mu/l

0.64

111

921

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

284

1.34

0.96

1.5

1.6

83.87

49.00

mu/l

0.28

253

Chronic diseases of tonsils and adenoids

565

3319

1.08

0.95

1.6

72.35

66.83

mu/l

0.25

516

2988

Childhood allergy (age < 16)

467

1.24

0.95

1.7

2.0

80.98

84.20

mu/l

0.03

427

Pneumonia due to Streptococcus pneumoniae

141

1.50

0.95

1.2

1.4

74.79

55.74

mu/l

0.25

128

Benign neoplasm: Choroid

277

1.34

0.93

1.5

1.4

23.01

50.89

mu/l

1.62

248

Arthropod-borne viral fevers and viral haemorrhagic fevers

106

898

1.18

0.93

1.2

1.5

144.71

56.50

mu/l

0.45

798

Ulcerative colitis (strict definition, all Crohn cases excluded)

697

1.21

0.93

1.4

1.5

71.94

59.77

mu/l

0.24

625

Tuberculosis, IBD comorbidity

260

1.35

0.93

1.4

42.56

58.76

mu/l

0.43

227

Malignant neoplasm of colon, including Hilmo

104

880

1.18

0.92

1.3

92.68

63.60

mu/l

0.39

780

Other superficial mycoses

1.68

0.92

1.1

1.3

86.73

44.71

mu/l

—

Benign neoplasm of eye and adnexa

464

1.25

0.91

1.6

1.4

37.11

47.78

mu/l

0.37

411

Pregnancy with abortive outcome

449

2161

1.08

0.90

1.4

1.6

51.27

47.72

mu/l

0.18

404

1946

Cysts of oral region, not elsewhere classified

227

1.37

0.90

1.3

1.4

93.72

62.68

mu/l

0.28

199

Infections with a predominantly sexual mode of transmission

241

2018

1.11

0.90

1.7

1.8

65.29

58.02

mu/l

0.24

219

1833

Lyme disease

153

1745

0.88

0.90

1.4

1.5

71.37

59.94

mu/l

0.27

135

1555

Urethritis and urethral syndrome

1.66

0.88

1.5

1.4

32.25

38.70

mu/l

0.19

Bacterial pneumonia, not elsewhere classified

230

1819

1.11

0.88

1.3

1.4

68.45

61.05

mu/l

0.21

203

1608

LSIL lesion of the cervix uteri, vagina or vulva

693

1.20

0.87

2.1

1.6

85.04

51.37

mu/l

0.57

633

Other spirochaetal diseases

158

1793

0.88

0.87

1.4

1.5

69.88

60.52

mu/l

0.22

140

1594

Other spirochaetal diseases

155

1761

0.88

0.87

1.4

1.5

70.51

59.96

mu/l

0.25

137

1569

Inflammatory diseases of prostate (prostatitis)

521

1.23

0.87

1.5

1.4

69.17

75.01

mu/l

0.09

460

Exclusion endpoint for clefts

1.73

0.86

1.3

1.4

25.41

218.52

mu/l

0.70

Malignant neoplasm of small intestine

1.64

0.85

1.1

1.4

75.13

75.03

mu/l

0.00

Bacterial, viral and other infectious agents

406

1.26

0.84

1.8

1.5

119.57

55.68

mu/l

0.66

366

Pemphigoid

1.57

0.84

1.1

1.3

91.60

45.67

mu/l

—

Other infective otitis externa

239

1.34

0.84

1.6

1.4

56.14

43.90

mu/l

0.19

217

Tuberculosis, wide

265

1.32

0.84

1.4

42.56

58.43

mu/l

0.42

230

Presence of other devices

126

1090

1.15

0.84

1.3

1.4

42.44

62.53

mu/l

1.03

107

967

Infliximab

1.77

0.84

1.0

1.2

58.17

33.35

mu/l

—

Contraceptive management

237

1840

0.90

0.84

1.4

1.6

52.38

60.88

mu/l

0.39

207

1668

Oral lichen planus, including avohilmo , including avohilmo

318

1.29

0.83

1.8

1.4

60.71

40.34

mu/l

0.57

289

Spirochaetal infections, other/unspecified

398

1.26

0.83

1.6

1.4

79.80

48.22

mu/l

0.42

352

Malignant neoplasm of eye, brain and central nervous system

154

1.43

0.83

1.8

1.4

19.94

74.18

mu/l

2.38

138

Chronic viral hepatitis

205

1.37

0.83

1.5

107.73

54.19

mu/l

0.35

183

Spirochaetal infections, other/unspecified

156

1764

0.88

0.83

1.4

1.5

70.71

60.38

mu/l

0.25

138

1572

Chronic suppurative otitis media, including avohilmo

301

1.30

0.82

1.4

1.5

32.60

74.66

mu/l

0.69

260

Other/unspecified reactive arthropathies

266

1.32

0.82

1.4

1.5

65.89

42.67

mu/l

0.65

241

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

726

1.19

0.82

1.5

1.4

77.05

62.98

mu/l

0.20

646

Other congenital malformations of intestine

1.89

0.82

1.7

1.3

89.90

375.51

mu/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.71

0.81

1.6

1.2

54.20

69.79

mu/l

—

Basal cell carcinoma, including avohilmo

283

1778

1.10

0.80

1.4

1.3

30.99

57.72

mu/l

6.01

240

1584

Drug-induced osteoporosis

1.74

0.80

2.3

1.3

178.47

42.29

mu/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

281

1757

1.10

0.80

1.4

1.3

33.25

56.97

mu/l

4.83

240

1567

Contact with machinery

482

1.23

0.79

1.2

1.4

57.26

65.35

mu/l

0.23

435

Mandibular retrognathia

267

1.31

0.79

2.8

1.6

97.12

43.49

mu/l

0.94

244

Alzheimer’s disease (Late onset), excluding more controls

386

0.80

0.79

1.2

1.6

49.98

57.90

mu/l

0.15

343

Mandibular retrognathia AND surgery (BSSO)

1.54

0.78

3.3

1.4

94.34

47.40

mu/l

0.65

Carcinoma in situ of skin of scalp and neck

1.63

0.78

1.2

32.00

42.17

mu/l

—

malignant neoplasm of female genital organs

745

1.18

0.77

1.2

1.3

43.03

53.20

mu/l

0.49

664

Coronary artery bypass grafting

133

869

1.14

0.76

1.2

1.4

129.71

53.37

mu/l

1.76

115

764

Fracture of forearm

370

3143

1.08

0.75

1.7

1.5

67.26

55.61

mu/l

0.31

329

2801

Inguinal hernia

376

2329

1.08

0.75

1.4

1.5

58.91

73.50

mu/l

0.57

334

2087

Osteonecrosis due to drugs

1.68

0.75

1.6

1.4

56.12

46.39

mu/l

—

Injuries to the hip and thigh

288

2396

1.09

0.74

1.5

1.4

47.28

60.57

mu/l

1.07

253

2117

Retinal detachment with retinal break

615

1.19

0.73

1.9

1.4

50.52

62.47

mu/l

0.41

545

Basal cell carcinoma

267

1690

1.09

0.73

1.4

1.3

31.08

56.91

mu/l

5.44

229

1506

Viral warts

123

1080

1.14

0.73

1.7

1.5

54.00

58.98

mu/l

0.15

111

962

Transient synovitis

2.01

0.73

1.0

1.4

43.78

27.67

mu/l

—

Nonischemic cardiomyopathy

424

1.23

0.72

1.3

1.5

56.95

51.28

mu/l

0.11

376

Other abnormal products of conception

194

1157

1.11

0.72

1.6

1.9

93.17

48.15

mu/l

1.04

179

1066

Dysplasia of cervi uteri

134

856

1.13

0.71

2.1

1.6

49.63

56.26

mu/l

0.20

124

774

Other specified/unspecified deforming dorsopathies

1.59

0.71

1.8

1.3

18.21

44.03

mu/l

—

Bacterial pneumonia (organism specified)

261

2171

1.09

0.70

1.3

1.4

68.64

63.94

mu/l

0.14

227

1907

Benign neoplasm: Anus and anal canal

101

1.49

0.70

1.9

1.3

55.22

42.47

mu/l

0.21

Contact with venomous snakes and lizards

1.72

0.70

1.1

41.10

52.01

mu/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

354

1.25

0.70

1.7

1.5

34.69

48.06

mu/l

0.59

320

Medical treatment for female infertility

114

994

1.14

0.70

2.5

1.9

105.40

52.11

mu/l

0.84

105

921

Obstructed labour due to malposition and malpresentation of fetus

104

1110

0.87

0.70

1.6

1.8

106.87

50.90

mu/l

0.81

1010

Injury of eye and orbit

693

1.17

0.69

1.7

1.5

109.09

56.51

mu/l

0.85

622

L02BG Aromatase inhibitors

161

1787

0.90

0.68

1.4

62.34

48.81

mu/l

0.28

145

1572

DVT of lower extremities

109

956

1.14

0.68

1.4

69.50

55.13

mu/l

0.29

857

L02BB Anti-androgens

330

1.25

0.66

3.3

1.3

114.51

72.13

mu/l

0.49

284

Parkinson's disease

697

1.16

0.66

1.2

1.4

33.34

56.98

mu/l

1.40

618

Benign neoplasm: Conjunctiva

128

1.41

0.66

1.9

1.4

57.38

41.56

mu/l

0.22

116

Unspecified lump in breast

809

1.15

0.66

1.7

1.4

26.97

52.93

mu/l

2.76

718

Chronic myeloproliferative disease

1.60

0.65

1.1

1.2

57.66

52.84

mu/l

—

Other benign neoplasms of connective and other soft tissue

440

1.21

0.65

1.1

1.4

48.96

48.91

mu/l

0.00

392

Lung diseases due to external agents

569

1.18

0.64

2.0

1.4

56.27

62.90

mu/l

0.18

503

Other disorders of veins

262

2405

1.08

0.64

1.4

1.5

48.05

55.13

mu/l

0.30

233

2161

Dislocation, sprain and strain of joints and ligaments of elbow

269

1.27

0.63

1.4

1.5

28.10

83.70

mu/l

0.90

237

Delivery, wide proxy

186

1088

0.91

0.63

1.4

1.6

40.63

47.47

mu/l

0.27

167

964

Exposure to other specified electric current

1.53

0.62

1.3

27.68

48.39

mu/l

0.73

Hallux valgus (acquired)

211

1387

1.09

0.62

1.4

1.5

54.17

57.88

mu/l

0.11

191

1253

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.60

0.62

2.9

1.2

162.35

44.06

mu/l

—

LSIL lesion of the cervix uteri

516

1.18

0.62

2.2

1.6

76.90

48.14

mu/l

0.56

476

Malignant neoplasm of corpus uteri

406

1.21

0.62

1.2

1.4

47.86

45.33

mu/l

0.07

359

Respiratory and cardiovascular disorders specific to the perinatal period

1.50

0.62

2.0

1.9

166.91

186.60

mu/l

0.04

Undescended testis, unilateral

1.68

0.61

1.0

1.7

40.46

54.51

mu/l

—

Malignant neoplasm of prostate, including Hilmo

157

841

1.11

0.61

1.8

1.3

84.39

72.09

mu/l

0.24

135

749

Malignant neoplasm of brain

122

1.40

0.60

2.1

1.4

23.37

72.46

mu/l

1.89

108

Abnormal findings in secretions and smears from cervix uteri vagina vulva

322

2269

1.07

0.60

1.8

1.6

55.38

54.90

mu/l

0.02

292

2049

Motor disorders

1.54

0.59

1.8

1.7

44.35

284.70

mu/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

519

1.18

0.59

1.8

1.4

73.67

55.50

mu/l

0.15

455

Long labour

116

1112

0.89

0.58

1.7

1.8

43.88

49.57

mu/l

0.29

110

1007

Other specified congenital malformation syndromes affecting multiple systems

1.51

0.58

1.3

29.09

207.74

mu/l

—

Pedal cyclist injured in collision with motor vehicle

116

0.60

0.57

1.3

105.16

49.70

mu/l

—

105

Other and unspecified intracranial injuries

1.43

0.56

1.7

1.3

23.55

50.95

mu/l

1.35

Barrett oesophagus

194

1.29

0.56

1.2

1.4

39.21

53.15

mu/l

0.26

171

Osteomalacia

1.63

0.56

1.3

1.1

82.98

52.94

mu/l

—

Non-small cell lung cancer, including Hilmo

632

1.15

0.55

1.5

1.3

137.52

66.36

mu/l

0.85

562

Right hemicolectomy

221

1.27

0.55

1.1

1.3

46.39

47.89

mu/l

0.03

191

Stenosis and insufficiency of lacrimal passages

403

1.19

0.55

1.8

1.4

37.30

40.34

mu/l

0.09

356

Memory loss

394

1.20

0.54

1.7

1.3

88.02

50.98

mu/l

0.32

346

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.51

0.54

1.4

1.2

77.88

47.59

mu/l

—

Deep endometriosis

450

1.18

0.54

1.6

1.5

64.37

46.22

mu/l

0.31

401

Parkinson's disease, strict definition

627

1.15

0.53

1.2

1.3

35.69

58.20

mu/l

1.15

557

Malignant neoplasm of bladder

222

1.26

0.53

1.4

1.3

42.73

79.59

mu/l

1.16

194

Undescended testicle

1.54

0.53

1.2

1.6

43.30

53.22

mu/l

—

Fracture of femur

140

1152

1.10

0.53

1.5

1.4

42.58

53.79

mu/l

0.66

118

1011

Other/unspecified cytomegaloviral diseases

1.41

0.51

1.8

1.3

64.90

50.50

mu/l

—

Foreign body on external eye

724

1.13

0.51

2.0

1.5

73.87

66.00

mu/l

0.11

653

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.48

0.51

1.1

1.3

329.21

48.66

mu/l

0.54

Laparoscopic left hemicolectomy

1.39

0.50

1.1

1.4

44.58

47.62

mu/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.39

0.50

1.1

1.3

37.74

47.61

mu/l

—

Use of levodopa decarboxylase inhibitor

612

1.15

0.50

1.3

1.4

26.17

59.32

mu/l

3.22

537

Congenital deformities of hip

1.50

0.49

2.0

1.4

44.99

188.29

mu/l

—

Bilateral sagittal split ramus osteotomy operation

127

1.34

0.49

3.1

1.4

89.94

40.62

mu/l

0.85

117

Lichen planus

632

1.14

0.49

1.5

1.4

39.25

55.04

mu/l

0.77

560

Other congenital malformations of peripheral vascular system

1.56

0.49

1.3

1.2

97.99

242.15

mu/l

—

False labour

177

1016

1.09

0.48

1.8

1.9

41.99

54.80

mu/l

0.92

165

930

Injury of muscle and tendon at lower leg level

718

1.13

0.48

1.4

56.36

57.72

mu/l

0.04

641

Alzheimer’s disease (Atypical or mixed)

330

0.81

0.47

1.2

1.3

88.22

48.90

mu/l

0.36

278

1.48

0.47

3.1

1.6

50.44

48.51

mu/l

—

Shoulder region

1.46

0.47

1.3

1.2

202.10

58.46

mu/l

—

Polyhydramnios

191

1.26

0.46

3.3

1.8

26.28

45.74

mu/l

1.42

174

Benign neoplasm: Connective and other soft tissue, unspecified

1.44

0.46

1.0

1.2

9.87

53.95

mu/l

—

Hepatocellular carcinoma, including Hilmo

1.39

0.46

1.1

1.2

296.23

73.10

mu/l

0.42

Cytomegalovirus infection, IBD co-morbidity

1.43

0.45

1.7

1.3

53.87

44.73

mu/l

0.11

Persons encountering health services in circumstances related to reproduction

362

2570

0.95

0.45

1.5

1.6

58.51

69.56

mu/l

0.58

326

2321

Adhesive middle ear disease

1.38

0.44

1.1

1.2

12.44

38.27

mu/l

—

Secondary uncertain malignant neoplasm

582

1.14

0.44

1.4

1.3

76.79

67.60

mu/l

0.09

511

Other disorders of amniotic fluid and membranes

651

1.13

0.44

1.7

1.9

43.56

54.51

mu/l

0.62

599

Periodontal disease, other/unspecified

1.37

0.44

1.6

1.4

44.53

62.98

mu/l

0.32

Specific developmental disorder of motor function

1.45

0.43

1.7

1.8

44.35

282.54

mu/l

—

Embedded and impacted teeth

118

1065

0.91

0.42

2.0

1.9

83.14

57.32

mu/l

0.52

108

972

Status post-ami

129

901

1.09

0.42

1.2

1.5

79.58

49.73

mu/l

0.82

111

797

Cleft lip, lip and palate or palate

1.41

0.42

1.3

1.2

17.43

211.80

mu/l

—

Malignant neoplasm of rectum, including Hilmo

556

1.13

0.42

1.3

1.4

51.11

63.20

mu/l

0.44

497

Alcohol abuse, main dg

755

1.11

0.42

1.5

114.90

65.50

mu/l

0.31

676

Colon adenocarcinoma

500

1.14

0.41

1.2

1.3

85.73

60.75

mu/l

0.33

443

Hydrocele

444

1.15

0.41

1.4

41.75

76.51

mu/l

1.05

393

Malignant neoplasm of corpus uteri, including Hilmo

482

1.14

0.41

1.2

1.3

43.87

46.59

mu/l

0.08

427

Cerebral palsy

1.36

0.41

1.0

1.2

21.86

51.08

mu/l

—

Wet age-related macular degeneration

716

1.11

0.40

1.1

1.3

64.15

50.10

mu/l

0.22

627

Malignant neoplasm of breast, HER-positive

178

1487

0.93

0.40

1.4

41.52

50.72

mu/l

0.50

156

1336

Infections of genitourinary tract in pregnancy

427

1.15

0.40

1.5

1.6

54.73

47.28

mu/l

0.17

380

Glucosamine medication

296

2239

1.06

0.39

1.4

49.90

56.21

mu/l

0.36

258

1972

Amputation of ankle bones

1.41

0.39

1.7

1.3

76.75

38.98

mu/l

—

Mixed conductive and sensorineural hearing loss

550

1.13

0.39

1.5

1.4

26.71

60.80

mu/l

2.60

490

Other disorders of cornea

437

1.15

0.39

1.6

1.4

55.20

45.41

mu/l

0.24

390

Malignant neoplasm of bronchus and lung, including Hilmo

110

843

1.09

0.38

1.5

1.3

110.46

60.86

mu/l

0.80

746

Other specified disorders of external ear

133

1.28

0.38

1.2

1.3

32.81

51.41

mu/l

0.46

123

LeFortI or BSSO operation

160

1.25

0.38

3.1

1.5

77.56

43.22

mu/l

0.62

147

Viral haemorrhagic fevers, not elsewhere classified/unspecified

335

1.17

0.38

1.3

1.4

58.13

55.06

mu/l

0.06

298

Other interstitial pulmonary diseases

684

1.11

0.38

1.3

1.4

46.44

55.90

mu/l

0.30

596

ILD, hospital admissions

675

1.11

0.38

1.3

1.4

46.81

56.27

mu/l

0.30

589

Erosion and ectropion of cervix uteri

116

1.30

0.37

1.9

1.5

44.35

45.58

mu/l

0.02

105

Golimumab

134

1.27

0.37

1.5

1.3

43.96

45.36

mu/l

0.03

119

Malignant neoplasm of head and neck

327

1.16

0.37

1.2

1.4

39.17

67.10

mu/l

0.91

296

Other noninflammatory disorders of cervix uteri

207

1.21

0.36

1.5

28.44

63.00

mu/l

1.34

188

Interstitial lung disease

687

1.11

0.36

1.3

1.4

46.44

55.74

mu/l

0.29

598

Interstitial lung disease endpoints

687

1.11

0.36

1.3

1.4

46.44

55.74

mu/l

0.29

598

Other superficial mycoses

450

1.13

0.36

1.5

1.6

56.93

60.39

mu/l

0.07

401

Seropositive rheumatoid arthritis, strict definition

764

1.10

0.36

1.2

1.4

55.16

56.67

mu/l

0.03

676

Sequelae of other and unspecified infectious and parasitic diseases

226

1.20

0.35

1.7

1.4

71.76

53.28

mu/l

0.26

203

Communicating hydrocephalus

0.64

0.35

1.0

1.4

28.84

41.30

mu/l

—

Burns and corrosions

660

1.11

0.35

1.4

1.5

52.25

58.45

mu/l

0.24

589

Other disorders of breast and lactation associated with childbirth

1.37

0.34

3.5

1.3

24.63

42.00

mu/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

183

1499

0.94

0.34

1.4

40.78

51.80

mu/l

0.65

161

1347

Inflammatory disease of cervix uteri

284

1.16

0.33

1.2

1.4

64.93

37.03

mu/l

0.35

250

Carcinoma in situ of skin of other and unspecified parts of face

331

1.15

0.33

1.4

1.3

43.83

62.19

mu/l

0.50

280

Migraine without aura, drug-induced

1.28

0.32

1.8

1.3

296.45

56.58

mu/l

—

Pleural plaque with presence of asbestos

266

1.17

0.32

1.1

1.4

62.86

75.70

mu/l

0.18

231

Myocardial infarction, unclassifiable

806

1.09

0.32

1.2

1.3

69.98

69.03

mu/l

0.02

701

Tooth eruption problems

582

1.11

0.32

2.0

1.8

106.88

61.41

mu/l

0.51

529

Traumatic ischaemia of muscle

1.35

0.31

1.6

1.3

84.74

44.46

mu/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

239

1.17

0.31

1.1

1.3

138.11

53.85

mu/l

0.82

206

Primary coxarthrosis, bilateral

161

1516

1.06

0.31

1.4

1.3

68.77

57.19

mu/l

0.34

141

1347

Dilated cardiomyopathy

532

1.11

0.31

1.4

65.05

65.03

mu/l

0.00

474

Guttate psoriasis

1.32

0.31

1.9

1.3

295.06

54.21

mu/l

—

Non-small cell lung cancer, adenocarcinoma

240

1.17

0.30

1.1

1.3

138.11

68.74

mu/l

0.62

215

Personal history of certain other diseases

1.28

0.30

1.7

1.3

54.34

37.83

mu/l

—

Squamous cell neoplasms and carcinomas of the skin

292

0.85

0.29

1.2

1.3

38.53

58.15

mu/l

0.64

255

Arthropod-borne viral fevers and viral haemorrhagic fevers

420

1.12

0.29

1.3

1.4

52.56

50.45

mu/l

0.05

370

Pregnancy, childbirth and the puerperium

161

892

0.94

0.29

1.4

1.7

33.63

45.48

mu/l

0.78

146

793

Crystal arthropathies, rheuma endpoint

1.23

0.29

1.1

1.2

74.99

53.47

mu/l

—

Subacute thyroiditis

158

1.21

0.28

1.9

1.4

204.92

44.87

mu/l

1.03

141

Traumatic amputation of wrist and hand

158

1.20

0.28

1.3

1.4

45.56

50.05

mu/l

0.07

136

Congenital deformities of hip

1.27

0.28

2.1

1.4

39.15

196.42

mu/l

—

Hepatocellular carcinoma

1.27

0.28

1.1

1.2

447.64

62.23

mu/l

—

Toxic effects of substances chiefly nonmedicinal as to source

508

1.10

0.27

1.5

47.95

56.45

mu/l

0.23

451

Endometriosis ASRM stages 3,4

132

1245

1.06

0.26

1.4

1.6

57.58

50.60

mu/l

0.22

120

1119

malignant neoplasm of male genital organs

149

858

1.06

0.26

1.8

1.3

84.10

72.59

mu/l

0.21

131

760

Other benign neoplasm of uterus: Other parts/unspecified

170

0.82

0.25

1.3

22.18

31.57

mu/l

0.50

146

Pedal cyclist injured in noncollision transport accidents

531

1.09

0.25

1.7

1.5

78.60

51.58

mu/l

0.39

473

All dysplastic lesions of the cervix uteri, vagina or vulva

165

1547

1.05

0.24

2.1

1.7

58.48

53.12

mu/l

0.13

152

1405

conjunctival degenerations and deposits

0.74

0.24

3.7

1.3

34.37

42.91

mu/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

125

1125

1.06

0.24

1.4

68.60

50.99

mu/l

0.45

111

1004

Primary open-angle glaucoma

167

1540

1.05

0.23

1.3

1.4

40.08

57.60

mu/l

1.37

148

1348

Primary open-angle glaucoma, strict

137

1298

1.05

0.22

1.3

1.4

42.95

58.01

mu/l

0.85

120

1138

Congenital musculoskeletal deformities of head, face, spine and chest

1.25

0.22

1.4

35.88

66.21

mu/l

—

Routine general health check-up of defined subpopulation

1.27

0.22

1.2

1.5

18.51

35.59

mu/l

—

Intentional self-harm by sharp object

1.27

0.22

1.0

1.5

33.19

55.47

mu/l

—

Overjet

1.25

0.21

2.7

1.4

43.93

62.42

mu/l

0.53

Malignant neoplasm of accessory sinuses

0.00

0.21

0.0

1.3

—

16.05

—

Actinomycosis

0.00

0.21

0.0

1.1

—

99.85

—

Use of riluzole

0.00

0.21

0.0

1.2

—

16.08

—

Maternal care for other known or suspected fetal problems

127

763

1.05

0.21

1.9

36.97

50.39

mu/l

1.05

115

701

Mesothelioma, including Hilmo

1.16

0.21

1.0

1.3

21.42

50.59

mu/l

—

Fourth [trochlear] nerve palsy

1.25

0.20

1.4

1.3

25.16

48.16

mu/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

127

1209

1.05

0.20

1.8

1.4

47.62

60.09

mu/l

0.74

114

1079

Retinal breaks without detachment

858

1.06

0.20

2.0

1.4

70.44

60.07

mu/l

0.20

768

Alzheimer’s disease (undefined)

0.00

0.20

0.0

1.1

—

18.33

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

428

0.91

0.20

1.3

38.77

61.00

mu/l

1.04

379

Lichen planus, including avohilmo

108

1024

1.06

0.20

1.7

1.4

39.64

57.96

mu/l

1.38

912

Malignant neoplasm of testis

1.23

0.20

1.3

1.6

46.53

73.79

mu/l

—

Malignant neoplasm of pancreas

269

1.12

0.19

1.6

1.3

41.72

70.66

mu/l

0.87

243

Malignant neoplasm of prostate

142

811

1.05

0.19

1.8

1.3

86.52

73.07

mu/l

0.24

124

723

Caries of enamel

601

4426

0.98

0.19

1.6

60.88

66.67

mu/l

0.27

537

3974

Unspecified urinary incontinence

394

1.09

0.19

1.5

1.3

44.04

37.16

mu/l

0.25

343

Other predominantly sexually transmitted diseases, not elsewhere classified

106

1006

1.05

0.19

1.8

59.07

55.36

mu/l

0.09

914

Coxarthrosis, primary, with hip surgery

275

2494

1.03

0.19

1.4

44.83

56.56

mu/l

0.95

247

2192

Follow-up care involving plastic surgery

175

0.86

0.19

1.3

1.4

23.74

45.83

mu/l

—

156

Obstructed labour due to maternal pelvic abnormality

828

0.94

0.18

1.5

71.71

46.89

mu/l

0.54

744

Persistent delusional disorders

328

1.10

0.18

1.3

1.4

22.86

48.66

mu/l

1.51

291

Pterygium

100

1.20

0.18

1.8

1.3

41.98

50.26

mu/l

0.15

Premature rupture of membranes

106

796

0.95

0.17

2.2

1.9

50.62

53.24

mu/l

0.09

727

Toxic effect of carbon monoxide

1.13

0.17

1.1

1.3

43.57

55.34

mu/l

—

Brain glioblastoma and astrocytoma

1.11

0.17

3.6

1.3

21.83

58.26

mu/l

—

Malignant neoplasm of rectum

423

0.92

0.17

1.4

40.83

58.79

mu/l

0.78

377

Other sexually transmitted chlamydial diseases

392

0.92

0.16

1.9

1.7

54.43

63.37

mu/l

0.28

351

Schizoid personality disorder

1.14

0.16

1.3

1.2

40.18

56.01

mu/l

—

Schizophrenia

778

1.05

0.16

1.2

1.6

49.43

61.57

mu/l

0.26

712

Undefined dementia

314

1.09

0.15

1.0

1.3

98.28

44.13

mu/l

0.60

265

Torsion of testis

0.77

0.15

2.0

1.6

69.93

63.62

mu/l

—

Superficial injury of shoulder and upper arm

507

1.07

0.15

1.2

1.5

46.49

52.00

mu/l

0.12

449

Benign neoplasm: Lip

1.11

0.15

1.3

11.12

49.17

mu/l

—

Other and unspecified nail disorders

1.10

0.15

1.9

1.3

9.72

41.72

mu/l

—

Dementia in other diseases classified elsewhere

169

1.13

0.14

1.3

106.41

46.97

mu/l

0.64

148

Non-Hodgkin lymphoma, all, including Hilmo

616

1.06

0.14

1.2

1.3

50.23

66.89

mu/l

0.55

545

Maternal care for known or suspected malpresentation of fetus

674

0.96

0.13

2.0

1.9

58.01

52.26

mu/l

0.17

616

Benign neoplasm: other/unspecified salivary gland

0.81

0.13

1.4

1.2

62.73

47.40

mu/l

—

Colorectal adenocarcinoma

909

1.04

0.13

1.3

67.76

63.04

mu/l

0.08

808

Organic, including symptomatic, mental disorders

274

1994

0.98

0.13

1.4

69.73

53.38

mu/l

0.55

233

1758

Other benign neoplasms of uterus

229

1.09

0.12

1.2

1.3

52.39

37.87

mu/l

0.21

200

Malignant neoplasm of colon

659

1.05

0.12

1.3

75.36

60.31

mu/l

0.22

586

Malignant neoplasm of breast, HER-negative

108

1025

1.03

0.11

1.4

66.55

52.01

mu/l

0.36

913

ILD, hospital admissions 1, main diag only

612

1.05

0.11

1.3

1.4

45.59

58.43

mu/l

0.40

533

Pregnancy examination and test

514

1.04

0.10

1.9

2.0

52.64

43.47

mu/l

0.30

473

Arteriovenous malformation of cerebral vessels

1.14

0.10

1.2

142.74

49.55

mu/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

466

1.05

0.09

1.2

1.3

29.81

60.59

mu/l

2.21

411

Tuberculosis

213

1.08

0.09

1.5

1.3

21.77

59.08

mu/l

2.22

184

Impacted teeth

776

1.03

0.08

1.8

72.66

58.59

mu/l

0.22

706

Hypersensitivity pneumonitis due to organic dust

1.07

0.08

2.2

1.2

61.12

43.13

mu/l

—

Superficial injury of neck

1.07

0.08

1.0

1.2

28.95

54.27

mu/l

—

ILD, hospital admission 2, with pulmonary infections

379

0.95

0.08

1.4

38.92

58.24

mu/l

0.70

334

Other meningitis

1.09

0.08

1.6

1.3

66.24

50.14

mu/l

—

Other assisted single delivery

1.09

0.08

1.1

2.0

22.30

53.91

mu/l

—

ILD, hospital admissions 3, with pneumonia sepsis

348

0.95

0.08

1.4

33.08

57.71

mu/l

1.05

308

Malignant neoplasm of respiratory system and intrathoracic organs

803

1.03

0.07

1.3

1.4

108.16

58.85

mu/l

0.75

712

Problems related to social environment

1.07

0.07

1.7

1.4

28.32

41.54

mu/l

—

Suppurative otitis media, unspecified

1.06

0.07

1.3

1.4

41.71

55.66

mu/l

—

Colorectal cancer

113

1082

1.02

0.06

1.3

61.21

60.70

mu/l

0.01

964

Disturbances of smell and taste

178

1.07

0.05

1.4

65.42

50.68

mu/l

0.17

159

Benign neoplasm: Other and unspecified parts of mouth

131

0.92

0.05

1.5

1.4

60.89

57.63

mu/l

0.03

116

Malignant neoplasm of digestive organs

198

1584

0.99

0.05

1.4

1.3

82.51

61.36

mu/l

0.44

172

1408

Diffuse brain injury

1.11

0.05

2.3

1.5

44.32

34.09

mu/l

—

Non-follicular lymphoma

415

1.04

0.05

1.3

1.4

45.99

63.04

mu/l

0.44

367

Adenocarcinoma and papilloma adenocarcinoma of rectum

404

0.96

0.05

1.3

38.77

61.26

mu/l

1.01

360

Alzheimer’s disease (Atypical or mixed), excluding more controls

209

0.95

0.05

1.2

1.6

92.50

42.43

mu/l

0.47

188

Non-small cell lung cancer

400

0.97

0.04

1.1

1.3

155.25

70.64

mu/l

0.86

352

Malignant neoplasm of breast, including Hilmo

264

1725

0.99

0.04

1.4

1.5

50.00

52.94

mu/l

0.12

235

1553

Malignant neoplasm of breast, HER2-negative, including Hilmo

264

1725

0.99

0.04

1.4

1.5

50.00

52.94

mu/l

0.12

235

1553

Alzheimer disease, excluding more controls

484

0.98

0.03

1.2

1.6

42.63

57.33

mu/l

0.49

428

Failed induction of labour

230

1.04

0.03

2.4

1.9

26.43

43.24

mu/l

1.80

204

HSIL lesion of the cervix uteri

884

0.98

0.03

2.0

1.8

32.73

51.87

mu/l

1.82

811

Malignant neoplasm of breast

258

1696

0.99

0.03

1.4

1.5

51.42

53.21

mu/l

0.07

227

1525

Multiple myeloma

1.09

0.03

1.2

1.3

15.80

53.56

mu/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.09

0.03

1.2

1.3

15.80

53.56

mu/l

—

Retained placenta and membranes, without haemorrhage

628

1.02

0.03

1.6

88.20

45.18

mu/l

0.60

565

Malignant neoplasm of breast, HER2-negative

255

1679

0.99

0.02

1.4

1.5

51.98

53.47

mu/l

0.05

224

1508

Malignant neoplasm of liver and intrahepatic bile ducts

1.08

0.02

1.2

366.52

80.13

mu/l

—

Other ill-defined and unspecified causes of mortality

282

1.03

0.02

1.1

1.3

43.16

65.64

mu/l

0.57

240

Other predominantly sexually transmitted diseases, not elsewhere classified

841

1.01

0.01

1.9

1.8

61.31

57.58

mu/l

0.07

762

Burns and corrosions of external body surface, specified by site

492

1.02

0.01

1.3

1.5

54.20

54.25

mu/l

0.00

436

Malignant neoplasm of bronchus and lung

704

0.99

0.01

1.3

123.92

63.05

mu/l

0.78

624

Ill-defined and unknown causes of mortality

314

1.02

0.00

1.1

1.3

38.86

62.56

mu/l

0.71

272

Single delivery by caesarean section

107

614

1.00

0.00

1.7

2.0

42.25

56.72

mu/l

1.01

553

Benign neoplasm of breast

606

1.01

0.00

1.7

1.5

51.53

52.11

mu/l

0.01

541

Impacted cerumen

448

1.00

0.00

1.6

1.4

143.31

56.43

mu/l

0.68

391

Vascular dementia (undefined)

1.04

0.00

1.3

1.2

31.54

72.43

mu/l

—

Transient global amnesia

456

1.01

0.00

1.3

37.16

44.46

mu/l

0.30

398

All dysplastic lesions of the cervix uteri

133

1318

1.00

0.00

2.2

1.8

51.30

55.00

mu/l

0.11

124

1206

Unspecified dementia

328

1.01

0.00

1.0

1.3

98.28

48.49

mu/l

0.53

279

Erythrasma

0.00

0.0

1.1

—

13.50

—

Macrocephaly

0.00

0.0

1.8

—

1716.26

—

Other drug-induced osteomalacia in adults

0.00

0.0

1.0

—

24.18

—

Other crystal arthropathies

1.01

0.00

1.1

1.3

74.99

51.46

mu/l

—

Other conditions originating in the perinatal period

0.00

0.0

1.7

—

41.63

—

Defect, injury or illness of skull

0.00

0.0

1.0

—

15.68

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.1

—

28.94

—

Exposure to electric transmission lines

0.00

-0.00

0.0

1.0

—

19.08

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

24.11

—

Contact with lifting and transmission devices, not elsewhere classified

0.89

-0.00

1.3

25.03

60.32

mu/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.89

-0.00

1.0

1.3

9.20

36.11

mu/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.01

-0.00

1.1

1.3

16.69

43.57

mu/l

—

Disorders of globe

0.90

-0.00

2.0

1.3

56.49

38.70

mu/l

—

Digeorge syndrome

0.00

-0.00

0.0

1.2

—

1686.02

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

1.0

—

26.71

—

Congenital absence of the uterus

0.00

-0.00

0.0

1.2

—

40.34

—

Kidney diseases associated to Fabry's disease

0.00

-0.00

0.0

1.0

—

22.15

—

Toxic effect of ethanol

140

1.00

-0.00

2.4

1.4

22.88

47.00

mu/l

1.77

125

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.0

—

19.20

—

HSIL lesion of the cervix uteri, vagina or vulva

990

1.00

-0.00

1.9

1.8

33.43

55.44

mu/l

2.27

906

Tuberculosis of nervous system

0.00

-0.00

0.0

1.2

—

22.02

—

Other infestations

0.89

-0.00

1.2

1.3

36.08

44.60

mu/l

—

Malignant neoplasm of testis, including Hilmo

1.02

-0.00

1.3

1.5

46.53

65.87

mu/l

—

Accidental poisoning by and exposure to alcohol

0.85

-0.00

4.4

1.3

50.06

33.10

mu/l

—

Portal vein thrombosis

0.92

-0.00

1.0

1.2

75.88

51.41

mu/l

—

Hypotony of eye

0.00

-0.00

0.0

1.0

—

15.64

—

Congenital edentulism

0.00

-0.00

0.0

1.2

—

24.07

—

Café au lait spots

0.00

-0.00

0.0

1.2

—

31.94

—

Mucinosis of skin

0.00

-0.00

0.0

1.2

—

17.80

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

26.08

—

Flexion deformity

0.00

-0.00

0.0

1.1

—

14.31

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

15.54

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.0

—

31.44

—

Neuralgic amyotrophy

0.00

-0.00

0.0

1.1

—

17.32

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

25.70

—

Constitutional tall stature

0.00

-0.00

0.0

1.8

—

60.38

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

22.52

—

Thyroid crisis or storm

0.00

-0.00

0.0

1.0

—

15.66

—

Toxic encephalopathy

0.00

-0.00

0.0

1.6

—

10.54

—

Sphingolipidosis, other/unspecified

0.00

-0.00

0.0

1.0

—

21.16

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.4

—

11.26

—

Congenital absence of the vagina

0.00

-0.00

0.0

1.0

—

39.78

—

Lipodystrophy, not elsewhere classified

0.00

-0.00

0.0

1.0

—

22.17

—

Microcephaly

0.00

-0.00

0.0

1.8

—

1701.38

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.4

—

40.98

—

Beta thalassaemia

0.00

-0.00

0.0

1.2

—

10.98

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.1

—

32.28

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.6

—

1685.48

—

Turner's syndrome

0.00

-0.00

0.0

1.0

—

38.52

—

Polydactyly

0.00

-0.00

0.0

1.0

—

23.67

—

Single ventricle heart

0.00

-0.00

0.0

1.6

—

38.88

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.2

—

13.14

—

Injury of muscle and tendon at ankle and foot level

0.94

-0.00

1.0

1.4

195.58

44.54

mu/l

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

20.52

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

15.02

—

Nightmares

0.00

-0.00

0.0

1.1

—

31.70

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Renin [Units/volume] in Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS